Content uploaded by Fernando Ramos
Author content
All content in this area was uploaded by Fernando Ramos on May 23, 2016
Content may be subject to copyright.
CHLORAMPHENICOL
First draft prepared by
J. Wongtavatchai1,J.G. McLean2,F. Ramos3and D. Arnold4
1Faculty of Veterinary Medicine, Chulalongkorn University,
Bangkok, Thailand;
2Camberwell, Victoria, Australia;
3Laboratório de Bromatologia, Nutrição e Hidrologia, Faculdade de
Farmácia, Universidade de Coimbra, Portugal; and
4Berlin, Germany
Explanation............................................................................... 8
Biological data .......................................................................... 9
Biochemical aspects .......................................................... 9
Toxicological studies .......................................................... 11
Cytotoxicity and genotoxicity ....................................... 11
Haematoxicity .............................................................. 13
Observations in humans .................................................... 15
Problems in trade caused by residues in foods ...................... 18
Analytical methods ................................................................... 22
Preparation of the primary extract of the sample.............. 22
Purification of the primary extract...................................... 23
Detection and quantification of residues of
chloramphenicol........................................................... 23
Production, occurrence and fate of chloramphenicol
in the environment ....................................................... 26
Discovery............................................................................ 26
Biosynthesis ....................................................................... 26
Production and stability in soil ........................................... 26
Environmental fate of chloramphenicol.............................. 28
Results of environmental monitoring for
chloramphenicol........................................................... 31
Microbial resistance to chloramphenoicol in the
environment—is it an argument for the
presence of the drug? ................................................. 32
Feed and soil intakes and growth of some terrestrial
farm animals ................................................................ 33
Pigs ............................................................................... 33
Chicken .............................................................................. 35
Cattle ............................................................................... 35
Hypothetical intake of chloramphenicol from the
environment by soil ingestion ...................................... 35
Soil ingestion by farm animals........................................... 35
Intake of chloramphenicol and resulting residues
in tissues ............................................................... 36
Pigs .............................................................................. 36
Chickens ...................................................................... 41
Hypothetical exposure to persisting environmental residues... 43
–7–
39834 FOOD TEXT 26/5/05 9:52 am Page 7
Examples of integrated farming......................................... 45
Processing and use of manure.......................................... 45
Production of excreta by farm animals.............................. 46
Residues in manure resulting from therapeutic
treatment of farm animals............................................ 47
Stability of chloramphenicol in manure.............................. 48
Uptake by farm animals of residues from manure ............ 49
Human intakes resulting from the consumption of
contaminated fish and shellfish.......................................... 51
Comparison of dietary intakes with low-level exposure
from ophthalmic formulations ...................................... 52
Systemic effects following ocular administration of
drugs as evidence for systemic bioavailability ............ 53
Pharmacokinetic evidence of systemic absorption
of ophthalmic drugs ..................................................... 53
Results obtained with ophthalmic formulations of
chloramphenicol........................................................... 54
Quantitative considerations................................................ 54
Comments ............................................................................... 55
Evaluation ............................................................................... 61
References ............................................................................... 62
Appendix I ............................................................................... 77
Appendix II ............................................................................... 82
1. EXPLANATION
Chloramphenicol is a broad-spectrum antibiotic with historical veterinary uses
in all major food-producing animals and with current uses in humans and com-
panion animals. Chloramphenicol was evaluated previously by the Committee at
its twelfth, thirty-second and forty-second meetings (Annex 1, references
17
,
80
and
110
). A number of other agencies have also reviewed chloramphenicol (e.g.
International Agency for Research on Cancer (IARC), 1990; European Committee
for Veterinary Medicinal Products, 1994; United States Food and Drug Adminis-
tration, 1985). Concerns have been expressed about the genotoxicity of chloram-
phenicol and its metabolites, its embryo- and fetotoxicity, its carcinogenic potential
in humans and the lack of a dose–response relationship for aplastic anaemia
caused by treatment with chloramphenicol in humans. Deficiencies identified in
data on the toxicity of chloramphenicol include information necessary for the
assessment of carcinogenicity and effects on reproduction. An acceptable daily
intake (ADI) has never been allocated and consequently a maximum residue limit
(MRL) has not been assigned. This has resulted in the restriction of the use of
chloramphenicol in veterinary medicine to non-food use.
Chloramphenicol was originally isolated from the soil organism
Streptomyces
venezuelae
in 1947, but is now produced synthetically.Three common forms are
used for systemic therapy, depending on the route of administration; a free base
form of chloramphenicol, chloramphenicol palmitate and chloramphenicol succi-
nate. Other formulations are also available for topical use. Chloramphenicol usually
acts as a bacteriostatic, but at higher concentrations or against some very sus-
ceptible organisms it can be bactericidal. It is used in the treatment of human infec-
tion with
Salmonella typhi
(typhoid) and other forms of salmonellosis, and other
8
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 8
life-threatening infections of the central nervous system and respiratory tract
(Parfitt, 1999). In veterinary medicine, chloramphenicol is used for the treatment
of a variety of infections in animals, particularly those caused by anaerobic bac-
teria or those that are resistant to other antimicrobial agents. Chloramphenicol in
animals is well absorbed by both oral and parenteral routes (Plumb, 2002).
There is good evidence for a haemotoxic effect of chloramphenicol in humans,
with two forms of toxicity being described. The first is a commonly occurring, dose-
related reversible bone-marrow depression, which develops during treatment and
is reversible following the withdrawal of the drug. The second is a severe aplastic
anaemia, which is non-dose-related and often irreversible.
This monograph summarizes the recently published literature and submitted
unpublished information on the toxicity of chloramphenicol.
2. BIOLOGICAL DATA
2.1 Biochemical aspects
The usual therapeutic range for chloramphenicol in serum in most animal
species is 5–15 mg/ml. After dosing, chloramphenicol is widely distributed through-
out the body. The volume of distribution of chloramphenicol reported in compan-
ion animals is 1.8 l/kg in the dog, 2.4 l/kg in the cat and 1.41 l/kg in the horse.
Hepatic metabolism by a glucuronidative mechanism is the principle pathway foy
whichr chloramphenicol undergoes biotransformation to an inactive metabolite,
chloramphenicol glucuronide. Only about 5–15% of the drug is excreted
unchanged in the urine. Dogs excrete only about 6% of unchanged drug into the
urine. Cats have a limited ability to form glucuronide conjugates with drugs and
therefore excrete chloramphenicol more slowly than other animals, with 25%
or more of the administered dose excreted unchanged in the urine. The elimina-
tion half-life of chloramphenicol is 1.1–5.0 hin dog, <1hin foals and ponies, and
4–8 h in cats (Adams, 1995; Plumb, 2002).
The pharmacokinetic properties of orally administered chloramphenicol in
broiler chickens indicate that chloramphenicol is rapidly absorbed. At a dose of 30
or 50 mg/kg bw, the drug reached the maximum plasma concentration at 0.72 h or
0.60 h, it was eliminated with a mean half-life (t1/2 b)of 6.87 or 7.41hand had a
bioavailability of 29% or 38% respectively. A concentration of chloramphenicol of
>5mg/ml was achieved in plasma at 15min, and persisted up to 2 or 4 hafter admin-
istration of chloramphenicol at a dose of 30 or 50 mg/kg bw. When chickens
received an oral dose of chloramphenicol at 50 mg/kg bw once daily for 4 days,
three metabolites, dehydrochloramphenicol; nitrophenylaminopropanedione-
chloramphenicol (NPAP-chloramphenicol); and nitrosochloramphenicol were
found in kidney, liver and muscle. The study found a slow clearance of residues,
particularly of the NPAP and nitrosochloramphenicol residues, which were
detected in tissues at 12 days after dosing (Anadon et al., 1994).
Plasma concentrations of chloramphenicol were determined in four calves
given four oral doses of chloramphenicol palmitate, each corresponding to a dose
of chloramphenicol of 25 mg/kg bw, at 12 h intervals. After the fourth dose, the
CHLORAMPHENICOL
9
39834 FOOD TEXT 26/5/05 9:52 am Page 9
plasma concentration of chloramphenicol reached a steady state of 5–6mg/ml. The
half-life of elimination was 4.5 h. Dehydrochloramphenicol at a concentration of
3–7 mg/ml was also detected in the plasma. The authors suggested that dehy-
drochloramphenicol, which is a metabolite produced by intestinal bacteria and sug-
gested to be associated with fatal aplastic anaemia in human, may occur in edible
tissues of animals treated with chloramphenicol (Gassner & Wuethrich, 1994).
Several metabolites of chloramphenicol were identified in urine samples
obtained from male Wistar rats and from a human volunteer given tritiated
chloramphenicol at a dose of 10 mg/kg bw by mouth. In rats, the two most abun-
dant metabolites detected in the first 24 h by high-performance liquid chromatog-
raphy (HPLC) and gas chromatography–mass spectrometry (GC–MS) were
chloramphenicol-base and chloramphenicol-acetylarylamine. The remaining
metabolites were unchanged chloramphenicol, chloramphenicol-oxamic acid,
chloramphenicol-alcohol, chloramphenicol-glucuronide and chloramphenicol-
oxamylethanolamine. Similar end-products were also found in the human
volunteer.The amount of chloramphenicol-oxamylethanolamine, which is an end-
product of chloramphenicol biotransformation that was previously reported in birds,
represented 0.74% and 1.37% of the ingested radioactivity found in the rat and
human urine samples. The formation of chloramphenicol-oxamylethanolamine as
an end-product of the metabolism of chloramphenicol by the liver was proven by
the release of chloramphenicol-oxamylethanolamine after incubation of tritiated
chloramphenicol with hepatocyte microsomes from rats treated with phenobarbi-
tal (Cravedi et al., 1995).
Chloramphenicol-aldehyde as a metabolic product of chloramphenicol was
identified in a study in four children with major infections treated with chloram-
phenicol at a dose of 50 mg/kg bw per day). The residues in samples of urine col-
lected during the treatment were analysed using HPLC and GC–MS. Results
indicated the existence of compounds with characteristics corresponding to the
synthesized chloramphenicol-aldehyde derivatives. The author concluded that
chloramphenicol-aldehyde, a metabolite that was toxic to bone marrow and previ-
ously observed only in rat hepatic tissue, was a new metabolite in humans (Holt,
1995).
A study performed in vitro in human bone-marrow cells from 72 donors showed
that chloramphenicol succinate was metabolized to chloramphenicol and other
metabolites. In all 72 samples, the HPLC analysis of cell-free supernatant obtained
from samples of bone marrow incubated with chloramphenicol succinate for 3 h at
37 °C revealed a substance with a retention time corresponding to that of chlo-
ramphenicol. Other metabolites, nitrosochloramphenicol and unidentified metabo-
lites, were also presented in some bone marrow samples. The study referred to
the ultimate toxic derivatives of chloramphenicol produced in the bone marrow in
situ as resulting from the metabolic biotransformation of the prodrug, thus indicat-
ing the marrow as both the site of metabolic conversion and the target of injury
(Ambekar et al., 2000).
10
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 10
2.2 Toxicological studies
2.2.1 Cytotoxicity and genotoxicity
Catalan et al. (1993) reported that chloramphenicol induced sister chromatid
exchange in bovine lymphocyte cultures, an effect that is indicative of DNA damage
and repair, and also observed a delay in the cell cycle.
The cytotoxicity and genotoxicity of chloramphenicol and six metabolites were
investigated in human bone-marrow cells (RiBM cells) in vitro. The six metabolites
tested in the study were: nitrosochloramphenicol, chloramphenicol-glucuronide,
chloramphenicol base (NAPD), and an alcohol derivative (hydroxy-amphenicol,
HAP), dehydrochloramphenicol and nitrophenyl-aminopropanedione-
chloramphenicol (NPAP-chloramphenicol). The cytotoxic effect was demonstrated
by inhibition of incorporation of tritiated thymidine into DNA. The genotoxic
effect was evaluated by the induction of DNA single-strand breaks. Cytotoxic
effects were found with three metabolites, nitrosochloramphenicol, dehydrochlo-
ramphenicol and NPAP-chloramphenicol, at concentrations ranging from 2 ¥10-5
to 2 ¥10-4mol/l. Nitrosochloramphenicol appeared to be the most potent cytotoxic
compound tested, while chloramphenicol-glucuronide and HAP were not cytotoxic
in RiBM cells. A similar cytotoxic response was reported earlier in human peri-
pheral blood lymphocytes, but dehydrochloramphenicol was the most inhibitory
compound. Genotoxic potential was observed with nitrosochloramphenicol
and dehydrochloramphenicol at a concentration of 1–2 ¥10-4mol/l, with a
dose–response pattern; chloramphenicol and other metabolites were devoid of
genotoxic effect at concentrations up to 4 ¥10-3mol/l. On the basis of the response
found in RiBM cells compared with the previous investigation using peripheral
blood lymphocytes, the authors concluded that RiBM cells were much less sus-
ceptible to the genotoxic effect of chloramphenicol metabolites than were human
lymphocytes (Lafarge-Frayssinet et al., 1994; Robbana-Barnat et al., 1997).
An increase in apoptosis in marrow progenitor cells was reported in patients
with aplastic anaemia (Philpott et al., 1995). The first evaluation of apoptosis in
toxicity caused by chloramphenicol was assessed in vitro in a study using a
monkey kidney-derived cell line and human haematopoietic progenitor cells from
human neonatal cord blood. At a concentration of 2–5mmol/l, chloramphenicol
caused apoptosis in dividing cells of both systems. In a subsequent study of myelo-
toxicity in vivo, morphological evidence of apoptosis was seen in erythroid and
myeloid precursors in femoral marrow of B6C3F1mice given chloramphenicol at
adose of 200 mg/kg bw. The authors suggested that effect of chloramphenicol is
at the differentiation stage of the committed marrow progenitor cells, rather than
the replication stage of the stem cells, and therefore this response appears to be
paralleling the reversible bone-marrow depression seen in the treated patient (Holt
et al., 1997, 1998).
The observation that chloramphenicol induces apoptosis in haemopoietic
stem cells was confirmed by additional studies using models in vitro and in vivo.
Phenotypic analyses using flow cytometry (with a fluorescence-activated cell
sorter, FACS) have demonstrated the induction of apoptosis in purified human
bone-marrow CD34+cells treated with chloramphenicol (Kong et al., 1999). Alink
CHLORAMPHENICOL
11
39834 FOOD TEXT 26/5/05 9:52 am Page 11
between this cytotoxicity and chloramphenicol-induced apoptosis was confirmed
in vivo in BALB/c mice treated orally with a single high dose of chloramphenicol
at 4000 mg/kg bw or with thiamphenicol. Apoptosis in femoral mononuclear cells
sampled at 36 h after dosing, as indicated by morphological evidence for increased
numbers of apoptotic nucleated marrow cells, was only induced by chloram-
phenicol, while thiamphenicol gave a negative result. The authors suggested
that the induction of apoptosis in marrow progenitor cells might account for
chloramphenicol-induced toxicity associated with aplastic anaemia in humans
(Turton et al., 2002b).
Inhibition of protein synthesis in the mitochondria of bone-marrow cells has
been considered as a mechanism by which bone-marrow depression is induced
by chloramphenicol. The underlying cytotoxicity may be caused by the similarity
between mitochondrial ribosomes and bacterial ribosomes, both of which are 70S.
Thus chloramphenicol can also inhibit mitochondrial protein synthesis in mam-
malian cells, particularly in erythropoietic cells, which appear to be sensitive to the
drug (Sande & Mandell, 1993; Kucers et al., 1997). It was reasoned that the inhi-
bition of mitochondrial protein synthesis suppressed the division of mitochondria
and resulted in the formation of megamitochondria. Investigation of the toxicity
caused by chloramphenicol in mouse hepatic cells in vivo, however, showed that
antioxidants prevented the formation of megamitochondria (Matsuhashi et al.,
1996). The role of antioxidants in reducing the cytotoxic effects of chlorampheni-
col was also reported to occur in vitro in a study using a monkey kidney-derived
cell line and haematopoietic progenitor cells from human neonatal cord blood. Also,
in cells in culture, the cytotoxic effects of chloramphenicol on apoptosis and sup-
pression of progenitor cell growth were not pronounced when cells were co-
cultured with antioxidants such as mercaptoethylamine or vitamin C (Holt et al.,
1997). Both studies suggested that toxicity caused by chloramphenicol relates inti-
mately to oxidative stress, with a possible link between a metabolic event—the
production of free radicals—and bone marrow suppression.
The cytotoxic potential of chloramphenicol with regard to cell membrane func-
tion was examined in a study investigating inhibition of protozoan motility.The
effect of chloramphenicol on the locomotion of the protozoan
Tetrahymena pyri-
formis
,amodel widely used for the evaluation of toxicity in excitable tissue, was
tested. Chloramphenicol appeared to depress the motility of the test organism
more effectively than did chloramphenicol succinate, the hydrophilic form of chlo-
ramphenicol. Results suggested that chloramphenicol, with its hydrophobic free
form, has the ability to partition into the lipid bilayer of the cell membrane and thus
the potential to cause membrane-mediated toxic effects. The authors postulated
that such effects might explain the acute toxicity of chloramphenicol in excitable
tissues, such as myocardium, and are a possible mechanism for chloramphenicol-
induced cardiovascular collapse in neonates, or “grey baby syndrome” (Wu et al.,
1996).
In contrast to the membrane-mediated toxic effects observed in
Tetrahymena
spp., chloramphenicol had no adverse effects on the morphologic characteristics
and migration of canine corneal epithelial cells in vitro. A monolayer of cultured
cells from the canine corneal epithelium was treated with a number of different
12
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 12
antibiotics after a defect had been made on the monolayer. The toxicity of the
antibiotics was determined by the morphologic characteristics and the migration
of treated cells. Pure antibiotics were used at a concentration similar to that in
tears, obtained with topical use of the commercially available antibiotic products
in humans. Comparison between control cells and cells treated with antibiotics indi-
cated that chloramphenicol had no cytopathologic effects on the monolayer and
cellular morphologic characteristics, and migration of the treated cells was similar
to that of control cells (Hendrix et al., 2001).
2.2.2 Haematoxicity
Two types of chloramphenicol-induced toxicity in humans have been widely
discussed. The first is a frequently occurring, dose-related, bone-marrow depres-
sion that develops during treatment with chloramphenicol. The condition is seen
as a mild anaemia, with decreased haemoglobin concentrations and reticulocy-
topenia, with the bone marrow showing reduced erythroid precursors, increased
myeloid : erythroid cell ratio and vacuolation of erythroid cells. The patient returns
to normal after drug withdrawal. Inhibition of protein synthesis in bone-marrow cells
has been proposed as the mechanism of these effects (Kucers et al., 1997). The
second is a severe, non-dose-related aplastic anaemia, which is irreversible.
Aplastic anaemia is evident as severe pancytopenia in peripheral blood, with an
acellular or hypocellular bone marrow. This might also result in leukaemia in
humans (Dollery,1999; Turton et al., 2002a).
Severe bone-marrow failure induced by chloramphenicol in man is relatively
infrequent. Susceptibility to chloramphenicol-induced aplastic anaemia and
leukaemia in man is considered to involve a genetic element. It has been sug-
gested that chloramphenicol-induced aplastic anaemia and leukaemia are related
to the DNA damage caused by nitrosochloramphenicol, which is a product of
the reduction of the para-nitro group of chloramphenicol. The ability to reduce the
para-nitro group to the nitroso derivative is genetically determined, and thus gives
rise to an individual metabolic predisposition to such drug-induced conditions.
The assumption is supported by investigations in vitro and in vivo demonstrating
that the haematological response to chloramphenicol in mice is partly strain-
dependent (Festing et al., 2001). However,the exact biochemical mechanism
responsible for aplastic anaemia in man has not yet been elucidated.
A battery of toxicological studies was performed in an attempt to develop a
rodent model for chloramphenicol-induced aplastic anaemia in humans. However,
recent studies have confirmed several previous reports that no suitable or reliable
laboratory animal model of aplastic anaemia exists, although administration of
chloramphenicol succinate in rodent models induces haematological changes
comparable to the chloramphenicol-induced reversible, dose-dependent bone-
marrow depression seen in humans (Young & Maciejewski, 1997; Holt et al., 1998;
Yallop et al., 1998; Turton et al., 1999).
Haematoxicity induced by chloramphenicol was investigated in a study in CD-
1weanling mice. Animals were given chloramphenicol at a dose of 1400mg/kg bw
by gavage daily for 10 days, and blood samples were taken at 1, 4 and 15 days
CHLORAMPHENICOL
13
39834 FOOD TEXT 26/5/05 9:52 am Page 13
after the last dose. Haematological data at day 1 after dosing showed a significant
reduction in erythrocytes, erythrocyte volume fraction and haemoglobin values,
which returned to normal by day 4 or 15. The investigator suggested that the
reversible, dose-dependent anaemia seen in man could develop in CD-1 mice
given chloramphenicol succinate (Turton et al., 1999).
In a study of the potential of chloramphenicol succinate and thiamphenicol to
induce aplastic anaemia, female BALB/c mice were given chloramphenicol succi-
nate at 2000 mg/kg bw per day or thiamphenicol at 850mg/kg bw per day by gavage
for 17 days. On days 1, 13, 22, 41, 98 and 179 after the final dose, blood and
marrow samples were collected for haematological examination and assays for
haematopoietic stem cells. Chloramphenicol succinate and thiamphenicol were
found to have similar effects. Significant reductions in values for peripheral blood
parameters (erythrocyte count, erythrocyte volume fraction and haemoglobin
concentration) and bone marrow parameters (erythroid colony forming units and
granulocyte-macrophage colony forming units) were found in samples at day 1
after dosing. At the later sampling times, values for all the observed parameters
gradually returned to normal, and there was no evidence of marrow suppression
by the end of the experiment. On the basis of this observation, the authors deter-
mined that chloramphenicol succinate and thiamphenicol induced reversible
anaemia in BALB/c mice; however, aplastic anaemia does not appear in the
BALB/c mouse (Turton et al., 2000).
The induction of haematoxicity by administration of chloramphenicol was
attempted in another rodent species, after the induction in mice was unsuccess-
ful. Guinea-pigs were examined for susceptibility to bone-marrow depression
induced by chloramphenicol succinate. In a dose range-finding study,chloram-
phenicol succinate administered at a dose of 825 mg/kg bw for 16 days induced
changes comparable to the reversible bone-marrow depression seen in humans,
but there was no evidence of late-stage marrow depression, as would be seen in
marrow aplasia. The authors concluded that rodents are not susceptible to myelo-
toxicity induced by chloramphenicol. The guinea-pig, like the mouse and rat, serves
as a model for early events, but is not a good model for aplastic anaemia induced
by chloramphenicol in man (Turton et al., 2002a).
Despite the well-recognized potential toxicity of chloramphenicol in humans,
the drug is considered by most experts to be of low toxicity in adult companion
animals when they are appropriately dosed. The development of aplastic anaemia
as seen in humans does not appear to be a significant problem in animals.
However, a dose-related reversible bone-marrow suppression is seen in all
species, primarily after long-term therapy. Early signs of bone-marrow toxicity can
include vacuolation of many of the early cells of the myeloid and erythroid series,
lymphocytopenia, and neutropenia. Other adverse effects that may be noted in
animals treated with chloramphenicol include anorexia, vomiting, diarrhoea and
depression. Cats tend to be more sensitive to developing adverse reactions to
chloramphenicol than are dogs; cats given chloramphenicol at a dose of 50mg/kg
bw every 12 h for 2–3 weeks do develop in high incidence of adverse effects
(Plumb, 2002).
A bone marrow disorder was reported in a study of toxicity in a dog that was
dosed orally with chloramphenicol at 300 mg/kg bw per day for 14 days. The results
14
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 14
showed a decrease in the number of total erythroid cells, with proportional increase
in myeloid cells, yielding a significantly increased myeloid to erythroid cell ratio
(Baig et al., 1994).
Breeder turkey hens given drinking-water containing chloramphenicol at a con-
centration of 500 mg/l for 4 days showed a decrease in egg production. The toxic
effects of chloramphenicol were mortality and cessation of egg production, which
were more severe when a combination of chloramphenicol and monensin was
given (Friedman et al., 1998).
Overall analysis of toxicity with chloramphenicol has suggested that the most
serious toxic effect, aplastic anaemia reported in humans, is not seen in animals.
However,reversible, dose-related bone-marrow suppression can be observed in
all species given chloramphenicol in excessive doses or for prolonged periods.
Other signs of toxicity caused by chloramphenicol are evident in animals in sus-
ceptible states, e.g. in neonatal animals or pregnant animals in which the hepatic
biotransformation of chloramphenicol is impaired, or where the drug causes a
decrease in protein synthesis in the fetus. However, owing to the potential toxic-
ity of chloramphenicol in humans, and because of the possibility that metabolites
of chloramphenicol might be found in the edible tissues of animals treated with
chloramphenicol, the use of chloramphenicol in veterinary practice is not permit-
ted in food-producing animals in many countries.
2.3 Observations in humans
Toxicity caused by chloramphenicol in humans has been widely discussed
because it induces bone-marrow depression. The more common dose-related
bone-marrow depression is evident when the daily dose of chloramphenicol is
>4 g in humans. Toxicity is reversible if the treatment is discontinued or the dosage
is reduced. A more serious and unpredictable reaction is aplastic anaemia, which
is not considered to be dose-related. Although the incidence of aplastic anaemia
has been shown to correlate with several risk factors, it is estimated to occur with
afrequency of 1 in 24 000–40 000 courses of treatment with chloramphenicol. Mor-
tality from aplastic anaemia occurs in >50% of cases (Greenwood, 2000; Maluf
et al., 2002).
Rappeport & Bunn (1994) suggested that aplastic anaemia in humans is an
idiosyncratic reaction to chloramphenicol, which has an immunological basis and
which is related to the nitrobenzene structure. This hypothesis is supported by clin-
ical evidence showing that 40–50% patients with aplastic anaemia have a partial
or complete response to a variety of immunosuppressive agents.
Young (2002) reviewed the pathophysiology of aplastic anaemia and reported
that most cases can be characterized by a T-cell mediated destruction of bone-
marrow haematopoietic cells.
This aberrant immune response may be a reaction to chemicals, drugs or viral
infections, but endogenous antigens may also be involved. Many drugs can cause
idiosyncratic haematopoietic failure; however, it is rare that patients, some of whom
may have only ingested small quantities of the drug, show bone-marrow failure as
acomplication. Owing to the idiosyncratic nature of the response, it is difficult to
CHLORAMPHENICOL
15
39834 FOOD TEXT 26/5/05 9:52 am Page 15
study aplastic anaemia, and animal models do not exist (Young & Maciejewski,
1997). The therapeutic use of chloramphenicol has been followed by the devel-
opment of aplastic anaemia in humans. This was particularly notable in the period
following the introduction of chloramphenicol as a therapeutic agent in 1948, and
before its association with aplastic anaemia had been recognized.
Other indications of toxicity associated with treatment with chloramphenicol in
humans have been recognized. Circulatory collapse (“grey baby syndrome”) has
occurred in human neonates treated with chloramphenicol. This adverse reaction
may be explained by the poor hepatic biotransformation of the drug in neonates
as a result of slow glucuronidation of chloramphenicol. Toxic concentrations of
chloramphenicol in blood and tissues develop secondary to an inability to conju-
gate the drug or to excrete the conjugate efficiently. However, the precise reason
for the occurrence of cardiovascular collapse in grey baby syndrome is poorly
understood. It has been stated that nitro-reduction derivatives of chloramphenicol
might play a role in causing hypotension, and the hypothesis was assessed by
perfusion of chloramphenicol through the isolated lobules of human placenta. A
decrease in blood pressure was found at the time coinciding with a peak in con-
centration of nitric oxide, which is a product of the nitroreduction of chloram-
phenicol (Holt & Bajoria, 1999).
The potential for an adverse reaction induced by treatment with chloram-
phenicol is of critical importance in seriously ill or compromised patients. In patients
with pre-existing haematologic abnormalities or hepatic failure, or in neonates,
chloramphenicol is only used when no other effective antibiotics are available.
Chloramphenicol has not been determined to be safe for use during pregnancy.
The drug may decrease protein synthesis in the fetus, particularly in the bone
marrow. Chloramphenicol is found in human milk at 50% of serum concentrations
in humans and therefore the drug should be given with extreme caution to nursing
mothers (Greenwood, 2000; Plumb, 2002).
The most serious adverse effect of treatment with chloramphenicol in humans
is its association with acquired aplastic anaemia. Many population-based studies
have been carried out to identify etiological factors associated with aplastic
anaemia and to determine a link between the use of chloramphenicol and the
development of marrow aplasia. Young & Alter (1994) reported that the published
estimates of incidence of aplastic anaemia are significantly influenced by the
methods used to acquire the data, and the diagnostic exclusion criteria. The inci-
dence estimates reported in some former studies were too high owing to the inclu-
sion of cases improperly classified as aplastic anaemia; the reported incidence of
aplastic anaemia declines when rigorous diagnostic criteria have been applied. On
the basis of an extensive review, the authors concluded that the incidence rate for
aplastic anaemia is 2–6 cases per million population, with most cases of aplastic
anaemia being classified as idiopathic (Young & Alter, 1994).
There are only a few recently documented cases of aplastic anaemia in patients
that were sensitive to chloramphenicol. Possible etiologic factors associated with
aplastic anaemia were identified in 151 Turkish patients who met the diagnostic
criteria. The findings suggested that these cases of aplastic anaemia were most
often idiopathic (99 out of 151 cases). The most common identifiable etiologic
16
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 16
factor was the use of drugs (23 out of 151 cases), which were mainly non-steroidal
anti-inflammatory agents, while chloramphenicol appeared to be specified in 1 out
of 23 cases of drug use associated with aplastic anaemia. Exposure to benzene
was the second most common causal agent in the studied cases (19 out of 151
cases) (Alnigenis et al., 2001).
In an investigation of potential risk factors associated with aplastic anaemia in
the state of Parana, Brazil, the statistical evaluation of 125 cases of aplastic
anaemia showed no positive association between use of chloramphenicol and
development of aplastic anaemia. Instead, the causes of aplastic anaemia in Brazil
were apparently identified as common factors related to the disease, such as expo-
sure to certain chemicals. The incidence found in this study was similar to that
reported in Thailand and Europe (Maluf et al., 2002).
Additional reports evaluating the correlations between the incidence of aplas-
tic anaemia and use of chloramphenicol were documented in cases of aplastic
anaemia in Nigeria and in Nepal. In a 5-year prospective study in Nigeria, it was
estimated that aplastic anaemia developed in 0.002% of non-obstetric patients
treated with chloramphenicol. Of 18 cases of aplastic anaemia diagnosed in Nepal,
16 were identified as being idiopathic and one was found to be associated with
toxicity caused by treatment with chloramphenicol. Both studies concluded that
chloramphenicol-induced aplastic anaemia is rare (Durosinmi & Ajayi, 1993; Sah
et al., 1999).
It has been claimed that the topical ophthalmic use of chloramphenicol causes
bone-marrow aplasia, but this issue has not been completely resolved.
Recent observations have shown that the use of chloramphenicol as a topical
eye medication is unlikely to introduce aplastic anaemia. Two extensive popula-
tion-based studies in industrialized and developing countries presented no support
for the claim that eyedrops containing chloramphenicol increase the risk of
aplastic anaemia. The investigators found that there was no history of use of eye-
drops containing chloramphenicol in more than 400 cases of aplastic anaemia
examined. On the basis of this observation, the authors disagreed with the
general recommendation stating that use of eyedrops containing chloramphenicol
should be avoided because of an increased risk of aplastic anaemia (Wiholm
et al., 1998).
Serum concentrations of chloramphenicol were monitored in a study in 40
patients treated with eyedrops containing chloramphenicol. HPLC with a minimum
limit of detection (LOD) of 1 mg/l was used to measure the serum accumulation of
chloramphenicol after topical therapy. After a course of treatment in which the
mean dose of chloramphenicol received in 1 week of treatment was 8.0 mg, and
in2weeks was 15.3 mg, serum concentrations of chloramphenicol were below the
limit of detection. The authors considered that the topical use of chloramphenicol
was not a risk factor for induction of dose-related toxicity in bone marrow, and the
suspension of use of topical chloramphenicol in ophthalmic practice was ques-
tioned (Walker et al., 1998).
Despite the failure of epidemiological studies to find an association between
the topical use chloramphenicol and development of aplastic anaemia, the
CHLORAMPHENICOL
17
39834 FOOD TEXT 26/5/05 9:52 am Page 17
hypothesis of a metabolic predisposition in individuals predisposed to blood
dyscrasias cannot be disregarded. Small doses of chloramphenicol similar to those
used in topical therapy may cause this idiosyncratic reaction in certain individuals.
In 1993, 23 cases of blood dyscrasias in patients treated topically with chloram-
phenicol for ophthalmic purposes were reported to the national register of drug-
induced ocular side-effects in Oregon, USA (Fraunfelder et al., 1993).
In a critical review of the potential risk of developing aplastic anaemia attribut-
able to topical use of chloramphenicol, the authors postulated that the risk posed
by topical use of chloramphenicol may be similar to that of orally administered chlo-
ramphenicol. This is because topical administration achieves systemic effects by
absorption through the conjunctival membrane or through drainage down the
lacrimal duct followed by absorption from the gastrointestinal tract. In their view, it
is not possible to justify subjecting patients to such potential risk, and therefore
ocular chloramphenicol should be used only when there is no alternative (Doona
& Walsh, 1995).
Contact sensitivity to chloramphenicol is rare in humans. Two cases of skin
ulcer, secondary to contact dermatitis, were reported in a woman aged 48 years
and a man aged 46 years. Both patients had applied chloramphenicol in the form
of chloromycetin cream to their wounds for about 1 month and developed skin
ulcer at the application sites. Hypersensitivity to chloramphenicol was confirmed
by patch tests in both patients. The ulcer healed after use of the drug was dis-
continued (Matsumoto et al., 1998).
The teratogenic risk of chloramphenicol was studied in a population-based
dataset of the Hungarian case–control surveillance of congenital abnormalities,
1980–1996. Retrospective investigation of the effects of oral treatment with chlo-
ramphenicol during pregnancy was implemented in 38 151 pregnant women who
had healthy babies (control group) and 22 865 pregnant women who had con-
genitally abnormal newborns or fetuses. The case–control pair analysis of preg-
nant women who were treated in the second month or third month of pregnancy
did not reveal any teratogenic potential of chloramphenicol in humans. The authors
concluded that treatment with chloramphenicol during early pregnancy presents
little, if any, teratogenic risk to the fetus in humans (Czeizel et al., 2000). However,
the human embryo implants at day 6–7 of gestation and organogenesis begins at
day 21; heightened susceptibility to malformations occurs during this period
(Rogers & Kavlock, 2001). Therefore, this study may have overlooked the occur-
rence of early abnormalities.
3. PROBLEMS IN TRADE CAUSED BY RESIDUES IN FOODS
Although the use of chloramphenicol in veterinary medicine has been restricted
to non-food animals, residues have been found in samples taken from domesti-
cally produced animals in national monitoring programmes and foods, and in
samples moving in international trade. For example, results of analyses carried out
in Germany in the years 2000–2002 in accordance with directive 96/23/EEC
showed that a small fraction (<0.2%) of all samples (
n
>17 500) taken at farms
and slaughter houses contained residues of chloramphenicol. The concentrations
18
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 18
that were found in a total of 11 positive samples from fattening cattle, swine and
poultry ranged from 0.3 to 3.3 mg/kg with eight values of <1mg/kg (BVL, 2003).
Unfortunately, comparable information was not available from many countries and,
the limits of detection or quantification (LOD or LOQ) of the analytical methods
used in some countries were—until recently—too high to allow quantification of
traces of chloramphenicol.
The Health and Consumer Protection Directorate-General of the European
Commission communicated ranges of concentrations of chloramphenicol in some
food items. These had been reported by Member States during the years
2000–2003 (European Commission, 2004). The information included concentra-
tions for the following commodities: skimmed milk powder (range, 0.021–
1.23 mg/kg), milk products (range, 0.3–1.27 mg/kg), honey (range, 0.3–4.0 mg/kg;
one sample at 38.7 mg/kg), washed pollen (0.58 mg/kg), shrimps (range, 0.1–
7.7 mg/kg; two samples at 31.89 and 297mg/kg), crabmeat (range, 0.3–1 mg/kg),
crayfish (range, 0.14–6.3 mg/kg), casings (range, 0.5–2.9 mg/kg), rabbit meat
(0.3 mg/kg), turkey breasts (0.82 mg/kg), and chicken breasts (range, 0.4–
1.2 mg/kg).
The presence of residues of chloramphenicol has caused major food scares
in the past 2 to 3 years. Shrimps, prawns, food products from other aquatic
animals, honey,royal jelly,meat and offal, casings, rabbit, poultry meat and milk
powder are among the commodities in which the drug was found. Many of the
shipments of commodities in which residues of chloramphenicol were found orig-
inated in south-east Asia.
The Food Standards Agency of the United Kingdom, for example, has pub-
lished a table with test results (Food Standards Agency, 2002/2003) obtained with
samples of honey that were on sale in the United Kingdom. Using a method with
a“reporting limit” (RL) of 0.3 mg/kg, the results ranged from “none detected above
the RL set” to a maximum of 7.2mg/kg. Several samples also contained strepto-
mycin, for which the RL was 50mg/kg. A group of 20 samples of honey that were
analysed in the Netherlands (Voedsel en Waren Autoriteit, 2004) gave an average
mass concentration of 1.9 mg/kg (range, 0.06–5.9 mg/kg). Positive findings of
residues of chloramphenicol in honey from different geographic regions have also
been reported in the scientificliterature (Verzegnassi et al., 2003). Most of the con-
taminated honey originated from China. Reybroeck (2003) analysed samples of
honey available on the Belgian market; samples were screened using an enzyme-
linked immunosorbent assay (ELISA) (LOD, 0.1–0.3mg/kg, depending on
clean-up). Positive samples were subjected to high-performance liquid chro-
matography–mass spectrometry (HPLC–MS) confirmatory analysis (LOD,
0.1 mg/kg). Of the samples with known origin, only samples of Chinese origin
contained residues of chloramphenicol (31 out of 40 samples). It has been hypo-
thesized that contamination of honey with chloramphenicol could be related to
treatments against foulbrood disease (Dharmananda, 2003).
While some of the positive findings are most likely to be the result of intentional
uses of chloramphenicol rather than of environmental contamination, it has also
been argued that very low concentrations of chloramphenicol detected in certain
foods of animal origin, e.g. in poultry and in products from aquaculture, could
CHLORAMPHENICOL
19
39834 FOOD TEXT 26/5/05 9:52 am Page 19
perhaps be derived from environmental sources—either from chloramphenicol
produced naturally by microorganisms or from residues resulting from past uses,
which still persist in the environment.
Examples of low concentrations from information published by the Food
Standards Agency of Ireland (Food Standards Agency of Ireland, 2002/2003) for
the year 2002 are summarized in Table 1. The Food Standards Agency of Ireland
has placed on the Internet information on alert/non-alert notifications of the
Member States of the European Union concerning residues of chloramphenicol in
shrimps, prawns, fish, fishery products and several other food commodities. A
review of the data shows that at least nine of the Member States had communi-
cated such notifications. In the majority of approximately 110 short summaries on
notifications, no quantitative data on residue concentrations were communicated.
However, an evaluation of a total of 47 quantitative results (33 for shrimp samples,
4for prawn samples, 1 for fish and 9 for crabmeat, crayfish and surimi samples)
showed the following distribution characteristics of the concentrations found:
range, 0.1–34 mg/kg; median: 0.5 mg/kg.
Although these data are not representative and the samples were not all inde-
pendent, it cannot be ruled out that there could exist two distributions of concen-
trations of residues:
—One distribution representing very low concentrations of chloramphenicol,
which could be explained either by environmental contamination (e.g. from nat-
urally produced chloramphenicol or from residues attributable to previous uses
of the drug), or by intentional uses of the drug followed by long withholding
times before harvesting;
—A second distribution representing higher concentrations of chloramphenicol
that are more likely to result from recent intentional uses and failure to observe
long withdrawal times before harvesting.
20
CHLORAMPHENICOL
Table 1. Range of concentrations of
chloramphenicol found in samples of aquaculture
products
Lower class limit Upper class limit Number of results
(mg/kg) (mg/kg)
0.1 0.5 25
>0.5 1.0 7
>1.0 1.5 2
>1.5 2.0 0
>2.0 2.5 2
>2.5 3.0 0
>3.0 3.5 3
>3.5 4.0 1
>4.0 4.5 1
>4.5 5.0 1
>5.0 34.0 5
From Food Standards Agency of Ireland (2002/2003).
39834 FOOD TEXT 26/5/05 9:52 am Page 20
The countries involved were not equally represented and the above numbers
of samples are too low for any valid comparison between countries of origin.
Another set of results was made available for evaluation by the Committee: the
average value of a population of 50 samples of shrimp in which the presence of
chloramphenicol was confirmed indicated an average value of 0.25 mg/kg, (range,
0.06–0.69 mg/kg), with two outlying values of 3.0 and 3.7 mg/kg (Voedsel en Waren
Autoriteit, 2004).
The Centre of Analytical Services and Experimentation of Ho Chi Minh City
conducted a validation study of GC and HPLC–MS methods for detection of chlo-
ramphenicol; a number of shrimp samples were analysed. During the first three
quarters of 2002, a total of 44 samples were found to contain chloramphenicol
(range of concentrations, 0.4–1.4mg/kg) (Ngoc Son, 2002).
The Fourteenth Session of the FAO/WHO Codex Alimentarius Committee for
Residues of Veterinary Drugs in Foods (CCRVDF) discussed the possibility that
such traces of chloramphenicol found in food-producing animals could originate
from environmental contaminations, rather than from intentional use. The report of
the session reflects the discussion as follows (Joint FAO/WHO Food Standards
Programme, 2003):
114. The request from Indonesia to consider the elaboration of an MRL for chloramphenicol
in shrimp was addressed by the Joint Secretariat who discussed the possibility that this com-
pound could find its way into animal tissues via other routes than its use as a veterinary drug.
Limited data showed that chloramphenicol may persist in the environment or even be formed
by soil microorganisms. Hypothetically,very low levels found in animal products could there-
fore not be related to the use of chloramphenicol as a veterinary drug. Several delegations
stressed that it would be premature to draw any conclusions or to discuss a possible clas-
sification as a contaminant and that illegal use of the drug was a primary concern. It was
noted that international trade had been disrupted severely during the past year by the rejec-
tion of products which had been contaminated at very low levels with chloramphenicol and
some other veterinary drugs. The Committee noted the offer of the FAO Secretariat to JECFA
to examine the potential persistence of chloramphenicol in the environment or its formation
by soil microorganisms on the basis of data to be provided by Indonesia.
An attempt to investigate these possibilities has been made in the present
monograph. After discussion of the development and current status of analytical
methods, essentially two hypotheses for a possible environmental origin for very
low concentrations of residues in foods were tested. In the first hypothetical sce-
nario it is assumed that:
—Chloramphenicol is naturally produced in the soil;
—Farm animals (e.g. pigs, chickens) ingest certain amounts of soil in a certain
proportion of their daily intake of dry matter;
—This may result in an uptake of chloramphenicol and subsequently in residues
of chloramphenicol in tissues and products of pigs and chickens, which are not
related to veterinary uses of chloramphenicol as a drug.
The second hypothetical scenario assumes that food-producing animals may
currently still occasionally be exposed to persisting environmental residues of chlo-
ramphenicol resulting from historical veterinary uses.
CHLORAMPHENICOL
21
39834 FOOD TEXT 26/5/05 9:52 am Page 21
This monograph also assesses the hypothetical dietary intakes resulting from
low-level contamination of seafood with residues of chloramphenicol and com-
pares these intakes with the lowest known human therapeutic exposures.
4. ANALYTICAL METHODS
The ideal method for the analysis of residues of chloramphenicol should be
sensitive, accurate and precise, and provide unambiguous information on the iden-
tity of the analyte. Furthermore, it should be as cost-effective and robust as
possible. In practice, it is difficult to develop methods that combine all these char-
acteristics. Therefore, the analytical strategies used for the control of residues of
chloramphenicol in animal tissues frequently include the initial application of a
screening method, followed by a confirmatory analysis of those samples that gave
positive results with the screening method.
Typically, the three basic steps used in the majority of methods of analysis for
chloramphenicol are:
—Preparation of the primary extract of the sample;
—Purification of the primary extract;
—Detection and quantification of residues of chloramphenicol.
4.1 Preparation of the primary extract of the sample
This step usually includes homogenization and extraction of the tissue with suit-
able organic solvents, the separation of liquids and solids and the removal of lipids
from the crude extract. Temperature control during storage and extraction of the
sample is important in order to avoid metabolism in vitro, particularly in samples
of liver and kidney, respectively, owing to the action of metabolizing enzymes
(Parker & Shaw,1988; Sanders et al., 1991). Analysis of liver and kidney requires
enzymatic hydrolysis of conjugates of chloramphenicol; this step can apparently
be omitted when working with trout tissues (Baradat et al., 1993; Mottier et al.,
2003).
Use of the following organic solvents has been described for the extraction of
chloramphenicol:
—Ethyl acetate (van Ginkel et al., 1990; Van der Heeft et al., 1991; Sanders
et al., 1991; Nagata & Saeki, 1992; Keukens et al., 1992; Kijak, 1994; Epstein,
1994; Munns et al., 1994; Li et al., 2001; Neuhaus et al., 2002; Gantverg
et al., 2003; Impens et al., 2003; Stuart et al., 2003);
—Acetonitrile (Borner et al., 1995; Pfenning et al., 1998);
—A mixture of acetonitrile and acetate buffer pH 5.0 (Posyniak et al., 2003);
—A mixture of ethyl acetate and acetonitrile (Pfenning et al., 2002a);
—A mixture of chloroform and acetone (Perez et al., 2002).
22
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 22
The lipids were removed through solvent partition, using:
—
n
-Hexane (Nagata & Saeki, 1992; Kijak, 1994; Epstein, 1994; Chevalier et al.,
1995; Gude et al., 1995; Li et al., 2001; Perez et al., 2002; Pfenning et al.,
2002a; Turnipseed et al., 2002; Storey et al., 2003; Gantverg et al., 2003;
Pfenning et al., 2003);
—A mixture of
n
-hexane and chloroform (1 : 1) (Sanders et al., 1991);
—
n
-Heptane (Rupp et al., 2003; Stuart et al., 2003).
4.2 Purification of the primary extract
There are numerous procedures used to purify the primary extract in order to
remove substances interfering with the detection and quantification step. Solid-
phase extraction is the most widely used technique for purification in the analysis
of residues of chloramphenicol in food matrices (Chevalier et al., 1995; Neuhaus
et al., 2002; Turnipseed et al., 2002; Storey et al., 2003; Gantverg et al., 2003;
Pfenning et al., 2003; Posyniak et al., 2003; Mottier et al., 2003; Impens et al.,
2003).
There are, however,other purification techniques, for example, immunoaffinity
chromatography (van de Water et al., 1989; Gude et al., 1995), which takes advan-
tage of highly selective hapten–antibody interactions.
4.3 Detection and quantification of residues of chloramphenicol
In past decades, several analytical methods have been developed and
reviewed for the detection and quantification of chloramphenicol in foods and
biological fluids.
Gas chromatography
:the presence of polar functional groups in the chloram-
phenicol molecule requires a derivatization step, usually through a sylilation reac-
tion, before gas chromatography analysis. The attachment of particular functional
groups onto the chloramphenicol molecule may also lower the LOD of the elec-
tron capture detector (ECD) and MS. The silylation reaction is usually catalysed
by acids or bases. Frequently used silylation reagents include:
—A mixture of hexamethyldisilazane (HMDS), trimethylchlorosilane (TMCS) and
pyridine (Berry, 1987; Gude et al., 1995);
—
N
,
O
-bis(trimethylsilyl)-trifluoroacetamide (BSTFA) (Bories et al., 1983; Costa
et al., 1993);
—A mixture of BSTFA and TMCS (van Ginkel et al., 1990; Keukens et al., 1992;
Gantverg et al., 2003);
—
N
-methyl-
N
(trimethylsilyl)-trifluoroacetamide (MSTFA) (Impens et al., 2003).
ECD has been widely used for the analysis of chloramphenicol. The GC–ECD
method for analysis of chloramphenicol in muscle of prawns, described by Munns
et al. (1994) for example, reached a LOD of 1mg/kg.
CHLORAMPHENICOL
23
39834 FOOD TEXT 26/5/05 9:52 am Page 23
When GC is coupled with MS, the most frequently applied ionization techniques
are chemical ionization (CI) and electron impact (EI).
Negative chemical ionization (NCI) presents a limited number of fragments;
however, the molecular ion is always part of the spectrum. Owing to the presence
of two chlorine atoms in the chloramphenicol molecule, GC–MS in NCI mode is
one of the most reliable techniques, and it is the most commonly used method for
the confirmation of residues of chloramphenicol. The LOD can be <0.1 mg/kg in
muscular tissue (van Ginkel et al., 1990; Epstein, 1994; Borner et al., 1995).
GC–MS in EI mode is less sensitive; however, it produces spectra of fragments,
which are reproducible with different instruments, and can therefore be stored in
electronic databases for reference purposes.
HPLC
:The development of atmospheric pressure ionization (API) mass detec-
tors, coupled HPLC, has become one of the most reliable and widespread tech-
niques in the analysis of residues of chloramphenicol. This combination of liquid
chromatography and mass spectrometry (LC–MS) enables the detection and
quantification, without derivatization, of polar non-volatile analytes, such as
chloramphenicol.
Neuhaus et al. (2002) have described an LC–MS/MS method with a LOD of
0.08 mg/kg and an LOQ of 0.3 mg/kg in prawns. Mottier et al. (2003) have devel-
oped a method for meat (chicken, turkey,pork and beef) and aquatic products
(crab, prawn and fish), using liquid chromatography (electrospray ionization)
tandem mass spectrometry (LC(ESI)–MS/MS), with isotopic dilution, reaching LOD
and LOQ values of 0.003 mg/kg and 0.01 mg/kg, respectively.
Impens et al. (2003) have described an analytical strategy for the screening
and confirmation of residues of chloramphenicol in prawn tissue, using ELISA for
screening and GC–MS/MS and LC–MS/MS for confirmation; both selective tech-
niques reached LODs of 0.1 mg/kg.
Gantverg et al. (2003) have developed a very sensitive method for the detec-
tion and confirmation of chloramphenicol in pork and beef muscle and in urine.
After extraction, chloramphenicol was determined through LC–MS/MS in CI mode
at negative atmospheric pressure, and by GC–MS in EI mode.
In summary,GC–MS and LC–MS/MS are, nowadays, the most reliable tech-
niques for the determination of residues of chloramphenicol in edible animal
tissues.
Selected examples of the development of analytical methods between 1990
and 2003 are listed in Table 2.
The European Union has recently defined minimum required performance
limits (MPRLs) for analytical methods used for the determination of substances for
which no permitted limit has been established, and in particular for those sub-
stances, like chloramphenicol, whose use is not authorized or specifically prohib-
ited by Community legislation. For chloramphenicol, a MRPL of 0.3mg/kg was
established (European Commission, 2003).
24
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 24
CHLORAMPHENICOL
25
Table 2. Overview of the development of analytical methods for residues of chloramphenicol in foods of animal origin
Analytical Food matrix LOD LOQ Levels reported Reference
method (mg/kg) (mg/kg) (mg/kg)
GC(NICI)–MS Muscle/egg 0.1 >0.1 —van Ginkel et al. (1990)
LC/UV Calf muscle 1 — — Sanders et al. (1991)
LC–MS Some aquatic species 0.1 0.3 — Van de Riet et al. (1992)
GC(NICI)–MS Bovine muscle 0.6 — — Epstein (1994)
GC(NICI)–MS Cows’ milk 0.5a— — Kijak (1994)
GC–ECD Shrimp 1 — — Munns (1994)
GC(NICI)–HRMS Egg 0.3 0.5 —Borner et al. (1995)
GC–ECD Egg 0.3 0.5 —
HPLC (RP) Foie gras 2.5 — — Chevalier et al.
LC/UV Pasteurized milk 50a— — Perez et al. (2002)
LC–MS/MS ESI(-)Shrimp <0.5 — — Pfenning et al. (2002b)
LC–MS/MS Shrimp 0.08 0.3 —Neuhaus et al. (2002)
GC–ECD Shrimp 0.05 —0.65–0.72 Ngoc Son (2002)
GC(NCI)–MS Shrimp 0.3 — —
LC–MS/MS APCI(-)Shrimp 0.1 — —
LC–MS/MS APCI Equine, porcine and bovine muscle 0.02 — — Gantverg et al. (2003)
GC–MS/MS Shrimp 0.1 — — Impens et al. (2003)
LC–MS/MS Shrimp 0.1 — —
LC(ESI)–MS/MS Chicken meat 0.003 0.01 —Mottier et al. (2003)
LC–MS/MS (ESI) Shrimp, crab 0.1 — — Storey et al. (2003)
GC–ECD Bovine muscle —0.25 —United States Department of
GC(NICI)–MS Bovine muscle —0.25 —Agriculture (2003)
APCI, atmospheric pressure chemical ionization; ECD, electron capture detection; ESI, ion electrospray; ESI(-), negative ion electrospray; GC,
gas chromatography; HRMS, high-resolution mass spectrometry; LC, liquid chromatography; LOD, limit of detection; LOQ, limit of quantification;
MS, mass spectrometry; NICI, negative ion chemical ionization; RP, reverse phase; UV, ultraviolet.
a(mg/l).
39834 FOOD TEXT 26/5/05 9:52 am Page 25
5. PRODUCTION, OCCURRENCE AND FATE OF CHLORAMPHENICOL
IN THE ENVIRONMENT
5.1 Discovery
Chloramphenicol was first described as a new antibiotic produced by cultures
of an actinomycete isolated from soil by Ehrlich et al. (1947). The soil samples
from which the strains were isolated were collected from a mulched field near
Caracas, Venezuela (strain ATCC 10712) and from a compost soil on the horti-
cultural farm of the Illinois Agricultural Experiment Station at Urbana (strain ATCC
10595), respectively. It was demonstrated by Ehrlich et al. (1948) that this actino-
mycete was a new species. The dynamics of the synthesis of chloramphenicol
were studied under laboratory conditions by Legator & Gottlieb (1953), who
showed that the peak concentration of chloramphenicol in the culture medium was
reached hours after the growth peak of the microorganisms. The antibiotic was not
accumulated intracellularly.Addition of chloramphenicol to the culture medium
inhibited the synthesis of the antibiotic.
Chloramphenicol was also isolated from the soil actinomycete
Streptospo-
rangium viridogriseum
var.
kofuense
by Tamura et al. (1971) and from the marine
snail
Lunatia heros
(moon snail) by Price et al. (1981).
5.2 Biosynthesis
The biosynthetic route of chloramphenicol starts with the general shikimate
pathway for assembling aromatic structures. It then branches at chorismic acid to
generate
p
-amino-phenylalanine, which serves as an advanced precursor of the
p
-nitrophenylserinol moiety of chloramphenicol (He et al., 2001; Lewis et al., 2003).
3¢-
O
-Acetyl-chloramphenicol, which is commonly formed from chloramphenicol by
many resistant bacteria, has also been isolated from the antibiotic-producing
organism. It has been suggested that it is a protected intermediate in chloram-
phenicol biosynthesis, implicating acetylation as a self-resistance mechanism in
the producing organism (Gross et al., 2002). 3¢-
O
-Acetyl-chloramphenicol esterase
activity was detected in cell-free extracts of strains of
Streptomyces venezuela
,
other
Streptomyces
spp. and
Streptosporangium viridogriseum
var.
kofuense
,
which produced chloramphenicol (Nakano et al., 1977).
5.3 Production and stability in soil
Gottlieb & Siminoff(1952) studied the adsorption, stability,and rate of produc-
tion of chloramphenicol in soil under different laboratory conditions. Chloram-
phenicol was poorly adsorbed to soil. When the drug was added to sterilized soil
at a concentration of 50 mg/kg, approximately 80% could be recovered over the
whole observation period of 14 days. When the same experiment was carried out
using non-sterile soil, the antibiotic was slowly degraded. When sterilized soil was
infested with
S. venezuelae
and was incubated for long periods, the authors were
able to show the presence in soil of chloramphenicol formed by the microorgan-
ism following a lag phase of several weeks. The highest concentration measured
was 1.12 mg/kg. Table 3 summarizes some of the results obtained in experiments
26
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 26
CHLORAMPHENICOL
27
Table 3. Production of chloramphenicol in sterilized soil infested with
S. venezuelae
Time Concentration of Number pH Concentration of Number pH Concentration of Number pH
(days) chloramphenicol of cells chloramphenicol of cells chloramphenicol of cells
(mg/g) (105/g) (mg/g) (105/g) (mg/g) (105/g)
Experiment 1 Experiment 2 Experiment 3
0 — 2.00 5.90 —0.39 5.90 0.0 38.7 5.45
70.00 23.30 5.57 0.00 35.50 5.05 0.0 12.0 5.05
20 0.00 28.50 5.10 1.12 48.20 5.60 0.0 37.0 5.63
36 0.58 18.20 5.45 — — — — — —
65 — — — 0.56 62.50 5.63 0.5 30.0 5.45
93 0.50 168.00 5.75 — — — — — —
100 — — — 0.82 945.00 5.85 0.79 1230.0 5.78
39834 FOOD TEXT 26/5/05 9:52 am Page 27
designed to study the interaction of
S.venezuelae
and chloramphenicol-sensitive
Bacillus subtilis
.The table gives the results of the control experiments in which
S. venezuelae
was the only microorganism added.
When organic substrates were added to the soil before sterilization, the pro-
duction of chloramphenicol increased after the addition of
S. venezuelae
.Under
the most favourable conditions of growth (in the presence of tryptone), chloram-
phenicol accumulated in the soil at a concentration of 25.0–27.8 mg/kg during
18–31 days of incubation. Addition of 1% of more “natural” substrates like alfalfa,
corn stover and soybean straw also increased the production of chloramphenicol.
However, only in the presence of alfalfa were significant quantities (concentration,
1.4 mg/kg) observed.
These results should not be interpreted to mean that
S. venezuelae
produces
chloramphenicol in soil in appreciable amounts under natural conditions. Natural
soil is not usually a good substrate for production of antibiotic (Gottlieb, 1976).
Ehrlich’s group has investigated soils from 91 cultivated and grassland sites in nine
states of the USA and from 13 other countries and found that soil samples were
either infested with
Streptomyces venezuelae
or were not infested. No chloram-
phenicol was identified in extracts from either of these soils. Initially, the LOD of
chloramphenicol was 0.3 mg/kg using a test based on the antimicrobial activity of
chloramphenicol. In other experiments with LOD of 0.05mg/kg in a chemical assay
selective for the nitro group in the chloramphenicol molecule, these negative
results were confirmed. If the soils were sterilized before seeding, chlorampheni-
col was found and identified in the infested soils (Ehrlich et al., 1952a, 1952b).
In their soil studies, Ehrlich et al. also investigated the recovery of smaller
amounts of chloramphenicol added to non-sterilized soil. When chloramphenicol
was incubated in sterilized soil at a concentration of 4.6mg/kg for 92 days at 23–
27 °C, recoveries were approximately 40% throughout the observation period.
When the same incubation was performed with non-sterile samples of soil, the
concentrations of chloramphenicol declined as a function of the incubation time as
shown in Table 4. A graph of the same data (see Figure 1) suggests a biphasic
curve for the degradation of chloramphenicol in soil. However, the second phase
could be the result of the closeness to the LOQ of the observed concentrations.
For the values ranging sufficiently above the LOQ (days 0–17 of the experiment),
ahalf-life in the order of 3–4 days was estimated.
Whether antibiotics are produced in soil in appreciable amounts by indigenous
soil organisms has remained a scientific dispute for several decades. Only recently,
it has been demonstrated that an antibiotic can be synthesized in detectable
amounts in soil. Using biosensor methods with very low LODs, Hansen et al.
(2001) have demonstrated the presence of oxytetracycline produced by
Strepto-
myces rimosus
in untreated soil. However, similar studies with chloramphenicol
were not found.
5.4 Environmental fate of chloramphenicol
The Food and Drug Administration of the USA has published an environmen-
tal assessment of chloramphenicol in the context of a proposal made in March
28
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 28
CHLORAMPHENICOL
29
Figure 1. Stability of chloramphenicol in non-sterile soil
0.01
0.1
1
10
0 10 20 30 40 50
Time after addition (days)
Concentration (mg/kg)
Recovery LOQ, limit of quantification
1985 to withdraw approval of new animal drug applications (NADAs) using chlo-
ramphenicoloral solution (Food and Drug Administration, 1985). Further informa-
tion was obtained from the Hazardous Substances Databank, a database of the
National Library of Medicine’s TOXNET system (Hazardous Substances Databank,
2003). The information available from these sources (most of the original literature
cited was not available for this review) is summarized as follows. The solubility of
chloramphenicol in water at 25°C is 2.5 g/l over a wide range of pH. Chloram-
phenicol is not adsorbed to clay or soil to any significant degree and therefore has
Table 4. Recovery of chloramphenicol from non-
sterile soil after the addition of chloramphenicol at
4.6mg/kg
Time (days) Recovery of chloramphenicol from soil
(mg/kg)
1/24 (1 h) 1.900 1.700 2.200
1 1.300 1.300 1.200
2 0.850 1.000 0.890
3 0.770 0.740 0.820
4 0.550 0.240 0.470
5 0.600 0.690 0.600
7 0.250 0.290 0.440
11 0.063 0.069 0.270
17 0.130 0.130 0.150
29 0.041 0.093 0.041
45 <0.027 0.036 0.033
92 <0.027 <0.027 <0.027
39834 FOOD TEXT 26/5/05 9:52 am Page 29
very high mobility in soil. Adsorption to sediment and bioconcentration in aquatic
organisms should not be important processes. Chloramphenicol is degraded by
biological, chemical, and photolytic means and undergoes oxidation, reduction and
condensation reactions upon exposure to light in aqueous solution. Photochemi-
cal decomposition of chloramphenicol in vitro by ultraviolet-A (UV-A) light leads to
the formation of
p
-nitrobenzaldehyde (pNB),
p
-nitrobenzoic acid (pNBA) and
p
-nitrosobenzoic acid (pNOBA); the latter comprises up to 45% by molarity of the
starting amount of chloramphenicol (de Vries et al., 1994).
The half-life of chloramphenicol in soil at 25 °C is 4.5 days; in pond water the
half-life is 10.3 days at 25°Cand pH 8, and 20.8 days at 37 °Cand pH 6.
The log Kow for chloramphenicol is 1.14. With regard to sorption coefficients to
soil solids (Kd,solid), the range of values for chloramphenicol is in the same group
as, for example, olaquindox, sulfamethazine, sulfathiazole, and metronidazole,
which also appear to have little sorption affinity to soil particles, as is evidenced
by their low values of Kd,solid (0.2–2 l/kg) (Tolls, 2001; Rabolle & Spliid, 2000).
Lai et al. (1995) estimated Kd,solid values of 0.4 l/kg for a freshwater sediment
(salinity, 0g/kg ; pH 7.7; sulfate, 4.8 mmol/l) from an eel pond in Taiwan, China,
and of 0.2 l/kg for a marine sediment (salinity,33g/kg; pH 8.2; sulfate, 25.6 mmol/l)
from a shrimp farm in Taiwan, China. The authors used top sediment (0–5cm).
The typical concentration of chloramphenicol was 60–70 mg/l throughout all exper-
iments. However,possible effects of the concentration of chloramphenicol were
also studied using concentrations of 100, 200, and 400mg/l. The average rates of
chloramphenicol transformation were much higher under anaerobic conditions
than under aerobic conditions. Some selected results are summarized in Table 5.
Chloramphenicol also degraded very slowly in sterilized slurries.
Although the physicochemical mechanism of sorption interactions is not known,
it is possible that chloramphenicol might form charge–transfer complexes with soil
constituents (Haderlein & Schwarzenbach, 1993).
Lai et al. (1997) added sodium chloride to brackish water top sediment
(0–5 cm) slurries (10% slurry; salinity,24g/kg; pH 7.9) of a shrimp pond to obtain
salinities of 30 and 36 g/kg and conducted sorption and transformation experiments
at final concentrations of chloramphenicol of 60–70 mg/l and temperatures
30
CHLORAMPHENICOL
Table 5. Rate of degradation (mg/l per day) of chloramphenicol in slurries of
aquaculture pond soils
Condition Sediment Concentration of chloramphenicol (mg/l)
of
incubation 100 200 400
Aerobic Freshwater eel pond 6.4 9.2 9.7
Marine shrimp pond 1.6 1.8 1.6
Anaerobic Freshwater eel pond 20.7 21.1 20.4
Marine shrimp pond 20.3 21.3 15.6
39834 FOOD TEXT 26/5/05 9:52 am Page 30
of 20–25 °C. The experiments were carried out under either anaerobic or aerobic
conditions. While sorption to soil of chloramphenicol was not influenced by
changes in salinities and by aerobic or anaerobic conditions, the compound was
much more stable under aerobic conditions. Increasing salinities also slowed down
the degradation process under aerobic conditions but not under anaerobic condi-
tions. Selected results from this study are summarized in Table 6.
Chien et al. (1999) studied the degradation of chloramphenicol in aquaculture
pond sediment. Freshwater (salinity,0g/kg) eel pond sediment slurries (10% w/v)
were treated with sodium chloride to obtain salinities of 12, 24 and 36g/kg. There
were no significant differences in sorption rate either between aerobic and anaer-
obic conditions or among various salinities. Degradation of chloramphenicol fitted
well to an exponential curve. The degradation rates under anaerobic conditions
were significantly greater than those under aerobic conditions. As salinity
increased, the degradation rates decreased under both aerobic and anaerobic con-
ditions in this experiment. Selected results are summarized in Table 7.
These studies demonstrate that chloramphenicol can be quite stable under
suitable aerobic and ionic conditions and at normal pH.
5.5 Results of environmental monitoring for chloramphenicol
Hirsch et al. (1999) have estimated that 20.1 million daily doses of chloram-
phenicol were prescribed in 1995 in Germany for human medical use (indications
and doses not given). They estimate that 5–10% of the doses were excreted
unchanged and 70–90% were excreted as the glucuronide. When they analysed
10 samples of sewage treatment plant effluents with a LOQ of 0.02mg/l, they found
one sample containing 0.56 mg/l of chloramphenicol. Of 52 samples of surface
water,four contained chloramphenicol at concentrations greater than the LOQ,
with a maximum of 0.06 mg/l in one sample. As a general rule, concentrations of
antibiotic residues in sewage treatment plant effluents were approximately one
order of magnitude higher than the concentrations found in surface water.In 59
samples of ground water, no chloramphenicol residues at concentrations greater
than the LOQ were found. Chloramphenicol residues were not found in samples
CHLORAMPHENICOL
31
Table 6. Influence of salinity and oxygen on sorption and stability of
chloramphenicol in slurries of pond soils (brackish water)
Salinity % Chloramphenicol -
k
at1/2 -
k
at1/2
(g/kg) adsorbed within 1 h (days) (days)
Aerobic Anaerobic Aerobic Anaerobic
24 22 25 0.067 10.0 0.573 1.2
30 18 24 0.031 23.0 0.642 1.1
36 17 18 0.012 57.8 0.578 1.2
From Lai et al. (1997).
a
k
is the first order rate constant of the degradation of chloramphenicol. Its dimension is
1/day.
39834 FOOD TEXT 26/5/05 9:52 am Page 31
taken during a study conducted in the USA (Kolpin et al., 2002). It was also not
found in samples of groundwater,surface water and drinking-water analysed in a
recent study conducted in the Netherlands (Stolker et al., 2003) and using sensi-
tive analytical methods with a LOQ for chloramphenicol of 0.005mg/l (Versteegh
et al., 2003).
Hamscher et al. (2003) studied sedimentation dust collected between 1981 and
2000 in a pig finishing unit (350–420 animals). Each year, 10–15 samples were
collected over periods of 14–30 days. One randomly selected sample was
analysed for each year.Chloramphenicol was detected in three out of 20 samples
(representing the years of sampling 1989, 1991, and 1992) at concentrations of
1.96, 0.07, and 5.49 mg/kg, respectively.The samples had been stored for more
than 10 years before analysis.
5.6 Microbial resistance to chloramphenoicol in the environment—is it
an argument for the presence of the drug?
The mere isolation of chloramphenicol-resistant microorganisms from the envi-
ronment, including soil, can probably not be used as an argument for the pres-
ence of the drug. The phenomenon of resistance is too complex and its occurrence
does not need to be related to any history of the use of chloramphenicol itself. For
example, Kardavy et al. (2000) isolated chloramphenicol-resistant species of
Prov-
idencia rettgeri
from the gut of larvae of the oil fly inhabiting the 40 000-year-old
asphalt seeps of Rancho La Brea in California. They found a correlation between
antibiotic resistance and organic solvent tolerance, which could be explained by
the presence of an active efflux pump maintained by the constant selective pres-
sure of the solvent-rich environment. These efflux pumps expel a broad range of
comparatively hydrophobic antibiotics (chloramphenicol, erythromycin, nitrofuran-
toin, novobiocin, rifampin, spectinomycin, and vancomycin), most of which contain
aromatic ring systems.
Providencia
spp. are also known as agents of nosocomial
infections. Efflux pumps play also an important role in resistant strains of other
bacterial species (Malléa et al., 2003).
32
CHLORAMPHENICOL
Table 7. Influence of salinity and oxygen on sorption and stability of
chloramphenicol in slurries of pond soils (eel pond)
Salinity % Chloramphenicol -
k
at1/2 -
k
at1/2
(g/kg) adsorbed within 1 h (days) (days)
Aerobic Anaerobic Aerobic Anaerobic
0 28 23 0.297 2.4 1.915 0.4
12 25 21 0.155 4.5 0.957 0.7
24 27 25 0.080 8.9 0.495 1.4
36 28 23 0.039 18.4 0.286 2.4
From Chien et al. (1999).
a
k
is the first order rate constant of the degradation of chloramphenicol. Its dimension is
1/day.
39834 FOOD TEXT 26/5/05 9:52 am Page 32
Resistance to chloramphenicol in
Salmonella enterica
serovar
typhimurium
iso-
lated from cattle in the USA has drastically increased over the years (Davis et al.,
1999) owing to sharply increased occurrence of isolates displaying DT104-linked
resistance. Although the use of chloramphenicol is prohibited in the USA, it was
never authorized for use in food-producing animals and monitoring results do not
suggest widespread illegal use. A gene conferring cross-resistance to florfenicol
and chloramphenicol has been isolated from
Salmonella enterica
serovar
typhimurium
(
S. typhimurium
)DT104 (Bolton et al., 1999). A conjugative plasmid,
pOLA52, conferring resistance to the antibiotic growth promoter olaquindox has
been isolated from
Escherichia coli
from swine manure. It also confers resistance
to ampicillin and chloramphenicol and has a high frequency of transfer between
strains of
E. coli
(Sørensen et al., 2003).
Petersen et al. (2002) have studied the development of antibiotic resistance in
integrated fish farms in Asia. The farms used antimicrobial agents and animal
manure was shed directly into fish ponds as fertilizer in these farms. Three of the
farms were using chloramphenicol in ducks and pigs. The impact of the use of
antibiotics on the development of antimicrobial resistance among the indicator
microorganisms was greatest at the beginning of a fish production cycle. However,
the most significant increase in resistance to chloramphenicol occurred on a farm
where this antibiotic was not used (amoxicillin, enrofloxacin, norfloxacin, tylosin
were used on this farm).
For such reasons, the many reports dealing with resistance phenomena dis-
covered in the environment have not been used here as an argument for the pres-
ence of chloramphenicol in the environment.
6. FEED AND SOIL INTAKES AND GROWTH OF SOME
TERRESTRIAL FARM ANIMALS
6.1 Pigs
Table 8 provides an example and short summary of the relationship between
age, live weight, feed intake and daily live-weight gain in pigs raised in the western
hemisphere (Peer et al., 2001).
Areview of recent research papers indicates that the situation in south-east
Asia could differ significantly from that observed in, for example, certain agricul-
tural areas of the USA. Figure 2 summarizes the results of this review.More details
are given in the Appendix I at the end of this document. From these details it can
be seen that the typical daily dry matter intake of the animals is in the same order
in the different hemispheres. However, the growth rates of the pigs used in the
studies in south-east Asia were comparatively lower.
The data for the pigs in Iowa in Figure 2 were retrieved from the Internet (The
pig site, 2003). The data for pigs in south-east Asia were taken from the studies
summarized in the tables given in Appendix I at the end of this monograph. These
data were collected from published results of research projects carried out in south-
east Asia. They may give an incomplete picture and real conditions may vary
largely from country to country, and between regions and provinces of a given
CHLORAMPHENICOL
33
39834 FOOD TEXT 26/5/05 9:52 am Page 33
country,and may also be subject to rapid changes. However,acomplete review
of animal feeding practices is outside the scope of this monograph. The informa-
tion provided in the Appendix I is limited to the minimum necessary to derive suit-
able relationships between live weight, live-weight gain and feed intake since this
information is needed to estimate soil ingestion as function of growth and intake
of dry matter of the animals, and to relate hypothetical environmental doses of
chloramphenicol to estimated soil ingestion.
As a result of the data discussed in this section, one can assume for simple
model calculations that pigs generally eat approximately 35 gof dry matter per kg
bw per day. Using the data in Figure 2, the average daily live-weight gain is esti-
mated as a function of body weight (within the limits of 20 g and 75 kg body weight)
according to the formula:
34
CHLORAMPHENICOL
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0 25 50 75 100 125
Body weight (kg)
Average daily gain (kg)
Pigs in south-east Asia
Pigs in Iowa
Predicted body-weight gain (kg)
Body weight is the mean of the initial and the final body weight of a feeding period.
Average daily gain is the average over the whole feeding period.
Figure 2. Comparison of growth rates of pigs raised in different regions of the
world
Table 8. Typical feed intakes and live-weight gain in pigs raised in the western
hemisphere
Production Live weight Average daily Dry matter intake
class (kg) gain (kg)
(kg/animal per day) (kg of dry matter/kg
average daily gain)
Starter 10–20 0.450 0.80–0.84 1.78–1.87
Grower 20–50 0.700 1.61–1.91 2.04–2.73
Finisher 50–100 0.820 2.63–3.29 2.94–4.01
From Peer et al. (2001).
39834 FOOD TEXT 26/5/05 9:52 am Page 34
Average daily live-weight gain (g) =0.164g +0.00693 (g/kg) ¥Body weight (kg)
6.2 Chickens
It is not within the scope of this monograph to describe the range of different
production systems. An example of data that have been gathered in the western
hemisphere can be found in tabular form in a publication of the National Academy
of Sciences of the USA (National Academy of Sciences, 1994). However, under
the hypothesis that soil ingestion could be the cause of chloramphenicol residues
in tissues and edible products, extensive systems—as they still exist, for example,
in south-east Asia, with free-ranging scavenging chickens receiving supplemen-
tary feeds—are of particular interest. Local breeds may play an important role, at
least regionally (Nguyen Dang Vang & Le Viet Ly, 2000). Some of these breeds
have small bodies and growth rates and feed conversion may vary largely (Tran
Thi Mai Phuong et al., 2003). A limited amount of data from south-east Asia were
available from published results of research projects. These results, which are not
necessarily representative, are summarized in more detail in Appendix I. Selected
data are presented in Figure 3. The study of Duong Duy Dong (2003) provided
useful data for model calculations.
As a result of the evaluation of the data discussed in this section, the daily live-
weight gain of chickens with a body weight of between 150 and 1000 gwas cal-
culated according to the formula:
Average daily live-weight gain (g) =3.599 g+0.01623 (g/kg) ¥Body weight (kg)
The intake of dry matter is approximately 3 g per g of average daily live-weight
gain.
6.3 Cattle
Chloramphenicol is not highly systemically bioavailable after per-oral adminis-
tration to ruminating cattle. The drug is largely degraded by microflora in the rumen.
Corresponding calculations have not, therefore, been performed for cattle.
7. HYPOTHETICAL INTAKE OF CHLORAMPHENICOL FROM
THE ENVIRONMENT BY SOIL INGESTION
7.1 Soil ingestion by farm animals
Soil ingestion varies seasonally and according to farm management. Using
the titanium content of faeces as a stable indicator of soil ingestion, Thornton &
Abrahams (1983) found that grazing cattle involuntarily ingest from 1% to nearly
18% of their dry matter intake as soil; sheep may ingest up to 30%. Abrahams et
al. (2003) studied rates of soil ingestion by sheep grazing on metal-enriched flood-
plain soils and found very high rates of soil intake during the winter/spring season
with maximum rates during March, when soil ingestion exceeded 30% of the dry
matter intake at two of the 11 sites investigated. No detailed quantitative data on
soil ingestion of chickens and pigs were available for evaluation, although the
CHLORAMPHENICOL
35
39834 FOOD TEXT 26/5/05 9:52 am Page 35
phenomenon of soil ingestion in (food) animals is well recognized and frequently
described in the literature.
Fries et al. (1982) investigated soil ingestion by dairy cattle using quantitative
analysis of titanium in faecal samples and in soils to which the animals had access.
Selected results are summarized in Table 9.
7.2 Intake of chloramphenicol and resulting residues in tissues
7.2.1 Pigs
Using the information collected in section 6, hypothetical intakes of chloram-
phenicol were calculated as a function of intake of dry matter and corresponding
soil intake of the animals. It was assumed that soil represented 2% of dry matter
intake. The concentration of chloramphenicol in soil was set at one of the follow-
ing concentrations:
—£0.05 mg/kg, which corresponds to the LOD of the methods used by
researchers from Parke-Davis who were unable to detect chloramphenicol
above this limit when they analysed a large number of soil samples from dif-
ferent countries; or
—1 mg/kg, which roughly corresponds to the highest concentration produced in
soil samples to which “natural” organic matter was added, and which were then
sterilized and infested with
S. venezuelae
;or
—25 mg/kg, which roughly corresponds to the highest concentration found in
laboratory experiments with soils treated with tryptone, and under the most
favourable conditions.
36
CHLORAMPHENICOL
Figure 3. Growth rate of chickens under different feeding conditions
0
10
20
30
40
0 500 1000 1500
Average live weight during treatment (kg)
Average daily live weight gain (g)
Hong Samnang 1999
Duong Duy Dong 2003—trial 1
Duong Duy Dong 2003—trial 2
Du Thanh Hang 2003
Average of trial 1
39834 FOOD TEXT 26/5/05 9:52 am Page 36
The following steps were performed in the calculations1:
—Calculation of body weight for every day of growth from 20 kg to 75 kg, using
the formula for the average daily live-weight gain developed in section 6.1;
—Calculation of daily dry matter intake as a function of body weight;
—Calculation of soil intake as 2% of dry matter intake;
—Multiplication of the soil intake with the assumed chloramphenicol concentra-
tions in soil;
—Summing up of the individual results obtained for days 1–119 of the theoreti-
cal period of growth of the animals, from 20 to 75 kg of body weight.
The hypothetical cumulative intake of chloramphenicol by a single animal
whose live weight increases from 20 kg to 75 kg during 119 days (the average time
required to achieve this body-weight gain) varies from £183 mgto 91.3 mg under
these conditions. The results are summarized in Table 10. The cumulative intake
overestimates the amount of chloramphenicol in the body of the animal. This value
is much smaller since—even if the drug were 100% bioavailable—every daily dose
is partly eliminated before the next dose is ingested.
In order to correctly estimate the amount of chloramphenicol in the body,
bioavailability and elimination rate must be known. Unfortunately,the pharmaco-
kinetic behaviour of low doses of chloramphenicol in pigs is not known. The elim-
ination half-life for high doses is not well understood because quantitative
determinations of chloramphenicol in plasma have usually not been extended to
CHLORAMPHENICOL
37
1Adetailed description of the model used for the calculations is given in Appendix II
Table 9. Soil ingestion by dairy cattle
Description of the group of animals Range of mean soil ingestion (% of dry
matter intake)
Lower bound Upper bound
Mean Standard Mean Standard
error error
Lactating cows
Confined to concrete 0.14 0.02 0.53 0.05
Housed in freestall barns with soil bedding 0.35 0.06 0.64 0.18
Access to unpaved lots with no vegetation 0.60 0.07 0.96 0.22
Yearling heifers and dry cows
Confined to concrete 0.52 0.11 0.81 0.19
Access to unpaved lots with no vegetation 0.25 0.04 2.41 0.26
Access to unpaved lots with sparse vegetation 1.56 0.21 3.77 1.50
On pasture but receiving supplemental feed 1.38 0.33 2.43 0.50
From Fries et al. (1982).
39834 FOOD TEXT 26/5/05 9:52 am Page 37
sufficiently long time periods after the administration of the dose. Boertz (1984)
and Boertz et al. (1985) have carried out a residue study using 24 pigs each with
abody weight of approximately 100 kg. The animals were given a single subcuta-
neous injection of chloramphenicol of 30 mg/kg bw. Two animals were slaughtered
at each of 12 time-points between 4 h and 30 days after dosing. The kinetics in
plasma and in all tissues examined suggest that there are at least two elimination
phases, the first one characterized by a half-life of 6–10 h and a second one with
ahalf-life of up to 100 h. There was excellent agreement between the results
obtained with radioimmunoassay and with GC–ECD. However,the number of data
points covering the terminal phase was too small to estimate the parameters of
this phase with sufficient accuracy.A study using the same dose was carried out
later in the same laboratory with the aim of producing reference material (Balizs
&Arnold, 1989). Blood samples from five pigs were taken to predict the appropri-
ate time of slaughter in order to obtain a muscle sample with a concentration of
chloramphenicol of approximately 10 mg/kg. The seven time-points used covered
the period between 1 h and 107 h. The following half lives were found under these
conditions in the five animals: 10.6, 7.4, 6.5, 10.9 and 14.2 h, respectively. The
data obtained in these two studies are summarized in Figure 4.
The following assumptions were made and corresponding calculations were
performed in order to obtain a crude estimate of the hypothetical amounts in the
bodies of the animals corresponding to the cumulative intake shown in Table 10:
—Oral bioavailability was assumed to be 100%.
—The conditions defined in section 6, which are summarized in Appendix I, result
in an oral dose of £0.035 or 0.7 or 17.5 mg/kg bw per day in pigs, depending
on the hypothetical concentration of chloramphenicol in the soil.
—Two different models concerning the elimination half-life were then tested. In
the first model, a single exponential term was used represented by half-lives
of 2, 4, 6, 8, 10, or 100 h. In the second model, it was assumed that 95% of a
daily dose is eliminated with a half-life of 10h, and 5% is eliminated with a half-
life of 100 h.
The results are summarized in Table 11.
38
CHLORAMPHENICOL
Table 10. Hypothetical cumulative intake through ingestion of soil containing
chloramphenicol, in pigs
Average Dry matter Soil Day Body Concentration of Cumulative intake of
daily gain intake intake weight chloramphenicol chloramphenicol
(g) (g/kg bw) (kg) in soil (mg/g) (mg)
120 £0.05 £0.7
2% of 114
0.164 +dry 25 350
0.00693 ¥35 matter
bw intake 119 75 £0.05 £183
1 3 651
25 91 267
39834 FOOD TEXT 26/5/05 9:52 am Page 38
CHLORAMPHENICOL
39
Figure 4. Plasma kinetics of parent chloramphenicol in pigs given a single
subcutaneous dose at 30 mg/kg bw
0.01
0.1
1
10
100
1 000
10 000
100 000
0 200 400 600 800
Time after dosing (h)
Concentration of chloramphenicol (mg/l)
Balizs_a1 Balizs_a2 Balizs_a3
Balizs_a4 Balizs_a5 Boertz
From Boertz et al. (1984) and Balizs & Arnold (1989)
Table 11. Estimated amounts of chloramphenicol in the body resulting from
soil ingestion, in pigs
a
Concentration of £0.05 1 25
chloramphenicol in soil (mg/g)
Cumulative intake of £183 3651 91 267
chloramphenicol (mg/animal)
Daily dose (mg/kg bw) 0.035 0.7 17.5
Half-life I (h) Half-life II (h) Estimated amount of chloramphenicol in the bodies
of the pigs after 119 days (mg)
2—£0.0006–£2.62 0.013–52.5 0.32–1312
4—£0.042–£2.66 0.84–53.3 21–1333
6— £0.17–£2.80 3.5–55.9 87–1399
8— £0.37–£2.99 7.4–59.9 186–1498
10 — £0.61–£3.23 12.1–64.6 303–1615
10 100 £1.26–£3.88 25.2–77.7 630–1942
100 — £12.8–£16.3 274–326 6838–8150
aResults are given as the range between the minimum amounts (calculated for the time-
point immediately before the last dose) and the maximum amounts (calculated for the
time-point immediately after the last dose).
39834 FOOD TEXT 26/5/05 9:52 am Page 39
The apparent volume of distribution for chloramphenicol in pigs is given as
1.4 l/kg (Kroker, 1994). The studies of Boertz et al. (1984) have shown that con-
centrations of chloramphenicol in muscle were directly proportional to the con-
centrations found in plasma. Assuming 100% bioavailability of the ingested
chloramphenicol, a crude estimate of maximum residue concentrations expected
in pig muscle would result in the values presented in Table 12.
For a given dose and all other conditions remaining constant the values of the
minima and maxima and the differences between the extreme values depend only
on the half-lives of elimination. This is illustrated in Figure 5 for constant multiple
doses of 17.5 mg/kg bw per day and hypothetical elimination half-lives of 4, 10 and
100 h, respectively.
The uncertainties of the calculations are:
—The values used for development of body weight and intake of dry matter are
likely to have a narrow range of variability.
—The amount of soil ingested by pigs is not known, but the estimate used here
(2% of dry matter intake) is probably realistic or somewhat too low for free-
ranging animals.
—The most influential factor is the production and resulting hypothetical (steady-
state) concentration of chloramphenicol in soil. There is no evidence to assume
that it is greater than 0.05 mg/kg in non-amended soil, and the possibility that
it is much lower cannot be excluded. However,the effect of organic matter
(straw, manure, compost, etc.) reaching the soil is totally unpredictable.
40
CHLORAMPHENICOL
Table 12. Estimated muscle concentrations of chloramphenicol derived from
soil ingestion, in pigs
a
Concentration of £0.05 1 25
chloramphenicol in soil (mg/g)
Cumulative intake of £183 3651 91 267
chloramphenicol (mg/animal)
Half-life I (h) Half-life II (h) Estimated concentration of chloramphenicol in
muscle (mg/kg)
2 — <0.000–£0.025 0.000–0.5 0.003–12.5
4— <0.000–£0.025 0.008–0.51 0.2–12.7
6— £0.002–£0.027 0.033–0.53 0.83–13.3
8— £0.004–£0.029 0.070–0.57 1.77–14.3
10 — £0.006–£0.031 0.115–0.62 2.89–15.4
10 100 £0.012–£0.037 0.24–0.74 6–18.5
100 — £0.12–£0.16 2.6–3.1 60.8–77.6
From Boertz et al. (1984).
aResults are given as the range between the minimum amounts (calculated for the time-
point immediately before the last dose) and the maximum amounts (calculated for the
time-point immediately after the last dose).
39834 FOOD TEXT 26/5/05 9:52 am Page 40
—The pharmacokinetics of low oral doses of chloramphenicol in pigs are not
known. Should it be justified to use parameters derived from the kinetics of
high doses—as has been done here—then the maximum hypothetical con-
centration in muscle tissue could be in the order of 0.04mg/kg for chloram-
phenicol concentrations of £0.05 mg/kg in soil (see Table 12).
—Only assuming approximately 100% bioavailability and an extremely long elim-
ination half-life of very small, ingested amounts of chloramphenicol, could
residues exceed concentrations of 0.1 mg/kg for chloramphenicol concentra-
tions of £0.05 mg/kg in soil (see Table 12).
—It is not known whether the addition of organic material (straw, bedding mate-
rial, manure, slurry,etc. could enhance production of chloramphenicol by soil
bacteria. If this were the case, as has been shown under laboratory conditions,
residues in the above calculations could reach or even exceed concentrations
of 1 mg/kg in muscle tissue according to Table 12.
7.2.2 Chickens
The calculations performed for chickens are similar to those described in
section 6.1 for pigs. Therefore the description of the individual steps of the calcu-
lations already explained is not repeated here. The formulae describing live-weight
gain and dry matter intake were developed in section 4.2. The basic assumptions
CHLORAMPHENICOL
41
Figure 5. Effect of elimination half-life on steady-state concentrations
0.1
1
10
100
0 20 40 60 80 100 120
Time (days)
Concentration (mg/l)
C
max
(half-life = 4 h)
C
max
(half-life = 10 h)
C
max
(half-life = 100 h)
C
min
(half-life = 4 h)
C
min
(half-life = 10 h)
C
min
(half-life = 100 h)
39834 FOOD TEXT 26/5/05 9:52 am Page 41
42
CHLORAMPHENICOL
Table 13. Hypothetical muscle concentrations of chloramphenicol derived from ingestion of soil, in chickens
Average Dry Soil Concentration of Body weight Cumulative intake Amount in body Concentration in
daily matter intake chloramphenicol (kg) of chloramphenicol (mg) muscle (mg/kg)
gain (g) intake in soil (mg/g) (mg)
Day 1 Day 75 Day 1 Day 75
Day 1 Day 75 Day 1 Day 75
3.599 +3¥2% of £0.05 150 1002 £0.018 £2.6 —£0.02 —£0.02
0.01623 ¥average dry 0.02
bw daily matter 1150 1002 0.362 52 —0.45 —0.30
gain intake 25 150 1002 9.050 1308 — 11.30 —8.10
Using a half-life of 7 h and a bioavailability of 35%.
39834 FOOD TEXT 26/5/05 9:52 am Page 42
and the results are summarized in Table 12. Only the maximum amounts and con-
centrations calculated for the time-point immediately after the last dose are given
in Table 13.
A half-life of 7h and a bioavailability of 35% were used for the above calcula-
tions on the basis of data published by Anadon et al. (1994). These authors
have studied bioavailability, pharmacokinetics and residues of chloramphenicol in
chickens. The pharmacokinetic properties (on the basis of a two-compartment
open model) of chloramphenicol were determined in broiler chickens after intra-
venous and after oral administration. After oral administration at a dose of 30 or
50 mg/kg bw, chloramphenicol was absorbed rapidly (time to maximal concentra-
tion, 0.72 or 0.60 h, respectively) and eliminated with a mean half-life (t1/2 beta) of
6.87 or 7.41 h, respectively. The bioavailability was 29% at a concentration of chlo-
ramphenicol of 30 mg/kg bw and 38% at 50 mg/kg bw.
The uncertainties of the calculations are similar to those described for the
model in pigs:
—Again, the major uncertainty is associated with the estimates of likely concen-
trations of chloramphenicol in the soil.
—The well-established pharmacokinetic parameters given in the publication of
Anadon et al. might not adequately describe the behaviour of chlorampheni-
col at very low doses. As has been noted for pigs, the kinetics of chloram-
phenicol at low doses is not known.
8. HYPOTHETICAL EXPOSURE TOPERSISTING
ENVIRONMENTAL RESIDUES
This section discusses the hypothetical possibility that residues resulting from
past treatments of (humans and) animals could persist in the environment. Chlo-
ramphenicol was widely used in food producing animals in nearly all regions of the
world until, within about the past 10 years, many countries and regions, including
the European Union, imposed a complete ban on all uses in such animals in order
to protect the health of consumers. A wide range of formulations, dosages and
routes of administration, which cannot be reviewed here, were in use in terrestrial
animals. Table 14 provides some additional examples of historical uses in
aquaculture in Asia (Arthur et al., 2000). In Asia, chloramphenicol was widely
used as a veterinarian antibiotic in aquaculture, according to a contemporary view
(Somjetlertcharoen, 2002).
Environmental residues of chloramphenicol in farm animals are most likely to
originate from excreta of treated animals and a significant risk of secondary con-
tamination could be assumed for farming systems in which manure is used as
fertilizer.
Integrated farming of fish or shrimp and livestock, for example, combines aqua-
culture with production of pigs, ducks, chicken, and/or other livestock animals.
Farming of such animals produces manure that may be used as soil fertilizer;
however, it is also possible to make use of the nutrients contained in this manure
CHLORAMPHENICOL
43
39834 FOOD TEXT 26/5/05 9:52 am Page 43
44
CHLORAMPHENICOL
Table 14. Some historical uses of chloramphenicol in aquaculture in Asia
Country Type of culture or product Examples of uses for disease control Reference
Bangladesh Coastal shrimp culture Occasional use, in a small percentage of—mainly Phillips (2000)
semi-intensive—farms; no further details given
China Valuable broodstock, larval shrimp Bath treatment, 1–1.8 mg/kg Jiang (2000)
Other species of high value, such Injection at 20mg/kg bw; oral treatment at
as eel and soft-shelled turtle 25–100 mg/kg bw
India Extensive and semi-intensive No details given Pathak et al. (2000)
carp farms and semi-intensive
shrimp farms
Indonesia Shrimp culture Immersion therapy at 5 mg/kg Supriyadi & Rukyani (2000)
Malaysia and Aquaculture; no further details “It is usually administered through feed at 3–5g/kg.” Shariff et al. (2000)
Singapore given
Philippines
Penaeus monodon
hatcheries Every other day from Z1to harvest, long bath, at Cruz-Lacierda et al. (2000)
1mg/kg; or 3 days, long bath, at 2–4 mg/kg
Penaeus monodon
grow-out ponds Medicated feed, 2–2.5g/kg of feed; five times daily
for 3 days
Spotted scat (
Scatophagus argus
)Bath for 10 h, 50 mg/kg or oral administration,
500–750 mg/kg of feed given at 3–10% body
weight for 5–7 days, or by injection at 15 mg/kg
of fish
Sri Lanka Larvae and post-larvae in shrimp 10–15 mg/kg; no further details given Wijegoonawardena &
hatcheries Siriwardena (2000)
Eel Daily for 21 days by oral administration at 100 mg/kg bw Liao et al. (2000)
Taiwan, China Shrimp For bath, at 1–10 mg/kg
From Arthur et al. (2000).
39834 FOOD TEXT 26/5/05 9:52 am Page 44
infish or shrimp ponds. These nutrients are taken up by bacteria and microalgae,
which themselves are food for filtrating organisms, mostly zooplankton. Some of
these organisms are then consumed by fish or shrimp.
8.1 Examples of integrated farming
According to the literature (Vincke, 1991), the number of pigs required per
10 000 m2of pond area varies from 40 to 300. Typically, about 100 weaned piglets
(aged 2 months; average body weight, 12–15 kg) may be used per 10 000 m2
(ponds are frequently much smaller than 10 000 m2). The pigs reach a body weight
of 70–85 kg after 6–7 months. The pigsty may be constructed near the fish pond
in traditional systems. Manure is then washed down to the pond.
If production of duck and fish is combined, ponds provide living and foraging
space for both. A variety of strains of duck are used, each having a different fat-
tening period. About 750–4000 ducklings may be stocked per 10000 m2, these
animals reaching slaughter weight within 7–9 weeks. Both ducks and chickens
(broilers or layers, 1000–6000 animals per 10 000 m2)are traditionally reared in
pens beside or over the ponds.
If, in such systems, the terrestrial animals were to be treated with chloram-
phenicol, drug residues contained in their excreta would constantly be added to
and diluted by the pond water, and would disappear according to the rate of degra-
dation discussed in previous sections (half-life, 10–20 days in pond water; see
section 5.4), and also according to the extent to which the water of the pond is
exchanged.
However, it is also possible that fresh manure may be either directly applied to
soil or that it remains in the housing or in a specificstorage area before further
use. In cases where manure is stored or processed, potential residues of chlo-
ramphenicol would be subject to degradation processes; however, published infor-
mation about the kinetics of degradation of chloramphenicol under various
conditions of storage and processing of animal excreta is extremely limited (see
section 8.5). De Liguoro et al. (2003) demonstrated that processes that occur
between the production of faeces and the application of manure to the soil are
very effective in reducing the load of tylosin and oxytetracycline in the environ-
ment. Tylosin degraded rapidly in manure of treated Simmental calves, and was
no longer detected 45 days after the last treatment. However, the half-life of oxy-
tetracycline in manure was 30 days, and after 5 months maturation, oxytetracy-
cline at a concentration of 820mg/kg of manure was still detected.
In outside storage areas in particular,chloramphenicol would also be washed
out and diluted by rainfall and possibly end up in basins retaining urine and manure
fluids, where the conditions of stability of this compound are unknown and might
be different from those prevailing in solid manure.
8.2 Processing and use of manure
There are many ways of processing manure before its use as fertilizer. In some
regions, farmyard manure is the traditional manure. It is a decomposed mixture of
CHLORAMPHENICOL
45
39834 FOOD TEXT 26/5/05 9:52 am Page 45
cattle dung and urine, together with straw and litter used as bedding material and
feed not consumed by the animals. The waste material is collected regularly and
placed in trenches finally plastered over with cow dung or earth slurry. It becomes
ready for application as fertilizer after 3–4 months (Indiaagronet, 2003).
Frequently, the processing of livestock manure by anaerobic digestion in “bio-
digesters” is a key component in integrated aquaculture systems. The main prod-
ucts from the biodigester are biogas and effluent, which is a potential fertilizer
because the anaerobic digestion process results in conversion of organic nitrogen
of the manure to ionized ammonia (NH4+)(San Thy & Preston, 2003). Effluent may
be superior to raw manure in supporting a higher yield of biomass in agricultural
crops (Le Ha Chau, 1998a, 1998b). Fish may also grow faster when ponds are
fertilized with biodigester effluent instead of unprocessed manure (Pich Sophin &
Preston, 2001). Chloramphenicol is not likely to be stable under the described con-
ditions of processing of manure.
The literature offers a wide range of numbers characterizing the quantity of
manure produced by different species of animal under different conditions of hus-
bandry, according to the way of processing the manure (e.g. capacity, initial
loading, daily volumes added, water addition and retention times in biodigesters),
and the amounts added to soil and/or ponds either in terms of dry matter or nitro-
gen per 10 000 m2.The amount of manure or biodigester solids or effluents added
also largely depends on the aquatic species and its density in the pond. It may be
added directly or suspended in special manure bags. Fertilization is a basic part
of pond preparation since plankton has to be available in adequate quantities
before stocking with fish or shrimp.
8.3 Production of excreta by farm animals
The values given for production of excreta by terrestrial farm animals in the
western hemisphere in Table 15 have been transformed into metric units from the
non-metric units used in the original literature (Barker et al., 2003). Other sources
give different values that are up to 25% higher or lower.Unfortunately, the term
“manure” is rarely defined.
Manure output by domestic animals is affected by many factors, which could
differ widely from region to region in the world. In the tropics, a common method
of comparing farm livestock is the tropical livestock unit (TLU) (LEAD Virtual
Center, 2004). The TLU is based on the cow with a body weight of 250 kg and
other animals are compared with it using (weight)3/4 for scaling. The TLUs for
selected tropical livestock are given in Table 16.
The annual production of manure by one TLU (250kg live weight) in an exten-
sive system is roughly estimated to be about 1000 kg of dry matter. This estimate,
which is not greatly different from the values given in Table 15, is based on the
assumptions of a daily feed intake varying from 2 to 2.5% of body weight and a
digestibility of feed varying from 40–60% (LEAD Virtual Center, 2004b).
46
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 46
8.4 Residues in manure after therapeutic treatment of farm animals
In order to avoid over-sophisticated calculations performed using a purely
hypothetical background, the following simplifying assumptions may be made.
When pigs or cattle are treated with chloramphenicol they receive a dose of
50 mg/kg bw (per-oral, intramuscular or subcutaneous administration in pigs, and
intramuscular or subcutaneous administration in cattle, except non-ruminating
calves in which the per-oral route is useful) daily over 7 days. Chicken may be
treated orally with drinking-water containing chloramphenicol (250 mg/l) over 7
days. Water intake (Guyer, 1996) by chickens is approximately 0.3 l/day per animal.
The resulting total doses would be approximately 87.5 g for a cow with a body
weight of 250 kg, 26.25 g for a pig with a body weight of 75 kg, and 0.525 g per
chicken. Assuming that a maximum of 50% of the dose is excreted as parent drug
or hydrolysable conjugate of the parent drug in the combined mixed excreta within
the treatment period plus an additional 3 days, these amounts would be contained
CHLORAMPHENICOL
47
Table 15. Production of faeces and urine by farm animals
Species or Live Faeces and urine productionaTotal solids
production weight (tonnes/year per
class (kg) (kg/head (tonnes/ (tonnes/year tonne of liveweight)
per day) head per tonne of
per year) liveweight
Dairy cows 635.00 55.50 20.20 31.9 4.43
Beef cattle 362.90 22.00 7.53 20.8 3.05
Pigs 61.20 5.03 1.72 28.1 2.90
Laying hens 1.81 0.12 0.04 23.5 5.85
Broiler chicken 0.91 0.07 0.02 24.0 6.14
Duck 1.36 0.15 0.05 33.3 9.00
From Barker et al. (2003).
aAs voided.
Table 16. TLU equivalents of some farm animals
Animal TLU
Cow 1.00
Bull 1.20
Heifer 0.70
Calf 0.50
Asian Buffalo 1.20
Goat 0.15
Sheep 0.15
Sow 0.20
100 Chickens 0.60
TLU, tropical livestock unit.
39834 FOOD TEXT 26/5/05 9:52 am Page 47
inapproximately 152 kg of beef cattle excreta, 62 kg of pig excreta and 0.7–1.5 kg
of chicken excreta.
The expected concentrations of chloramphenicol equivalents, therefore, would
range in the order of 0.29 g equivalents (chloramphenicol plus conjugates) per kg
of bovine excreta, 0.21 g per kg of pig excreta and 0.18–0.38 g per kg of chicken
excreta. Therefore one could expect to find chloramphenicol equivalents at a con-
centration of roughly 0.3 g per kg of combined liquid and solid excreta from some
major farm animals.
8.5 Stability of chloramphenicol in manure
The degradation of chloramphenicol in manure has not been studied system-
atically.Since the molecule has a number of functional groups (e.g. the aromatic
nitro group, the dichloro-acetyl side-chain) that could be attacked by known biotic
processes, the behaviour of the compound cannot be predicted. As with other
aromatic nitro compounds, the nitro group is expected to be particularly sensitive
under anaerobic conditions (Hallas & Alexander, 1983). Chloramphenicol—like
several other antibiotics (Johnson, 1994; Sanz et al., 1996; Lallai et al., 2002)—
is, on the other hand, itself a powerful inhibitor of many anaerobic degradation
processes. There are a few examples in the literature of situations in which the
concentrations and persistence of other antibiotics and feed additives have been
determined in various kinds of manure.
Runsey et al. (1977) conducted experiments in which chlortetracycline was
used in a combination of feed additive for feedlot beef cattle. Fresh manure, stored
manure, runoffwater,manure weathered on pasture, and soil from pasture fertil-
ized with manure were analysed for the additives. Seventeen percent of the
chlorotetracycline fed to cattle appeared in fresh manure and 11% appeared in
manure stored for 12 weeks. Aga et al. (2003) used an ELISA method to screen
manure samples collected from hog lagoons and cattle feedlots for the presence
of tetracycline residues. The concentrations measured varied from below the LOD
(0.5 ng/kg) to 200 mg/kg. The degradation of tetracyclines in soil-applied manure
was also followed using ELISA.; detectable concentrations were found for up to
28 days. Analysis of selected manure extracts by liquid chromatography with mass
spectrometry (LC–MS) showed lower concentrations of total tetracyclines com-
pared with the values obtained by ELISA, indicating the presence of other struc-
turally related compounds or transformation products of tetracyclines. De Liguoro
et al. (2003) followed the levels of oxytetracycline and tylosin over time in faeces,
bedding and manure, and then in the soil of a manured field and surrounding
drainage courses, after oral treatment of calves. Fifty Simmental calves were
treated for 5 days with oxytetracycline at 60 mg/kg bw per day. After 15 days, the
animals were treated for 5 days with tylosin at 20 mg/kg bw per day. Tylosin
degraded rapidly and was no longer detected in manure 45 days after cessation
of treatment, and no trace of the compound was detected in soil or surrounding
water (LOD, 10 mg/l). The half-life of oxytetracycline in manure was 30 days, and
the compound was still detectable in this matrix (concentration, 820mg/kg) after 5
months maturation. Hamscher et al. (2002) investigated the distribution and per-
sistence of tetracyclines and tylosin in a field fertilized twice with liquid manure.
48
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 48
Onthe first fertilization, the manure contained tetracycline at 4.0 mg/kg and chlor-
tetracycline at 0.1 mg/kg. Similar concentrations were applied again 1 year later.
Soil sampling was performed 1 and 7 months after the first application and 1 month
after the second application. At the third sampling time, the highest average con-
centrations of tetracycline of 86.2 (soil sublayer, 0–10cm), 198.7 (10–20 cm), and
171.7 mg/kg (20–30 cm) and chlortetracycline at 4.6–7.3 mg/kg (all three sublayers)
were found, indicating that tetracylines persisted and accumulated in the soil.
Oxytetracycline and tylosin could not be detected in any sample analysed.
Campagnolo et al. (2002) analysed samples from swine waste storage lagoons
and surface water and groundwater obtained from sites proximal to large-scale
swine and poultry operations for multiple classes of antimicrobial compounds, and
found multiple antimicrobial residues (commonly at concentrations of >100 mg/l) in
storage lagoons. Schlusener et al. (2003) developed sensitive methods for the
analysis of macrolides and ionophores and tiamulin in manure. The maximum con-
centrations found in manure samples were tiamulin at 43 mg/kg and salinomycin
at 11mg/kg. Ingerslev & Halling-Sorensen (2001) studied the biodegradability of
olaquindox, metronidazole, and tylosin, in soil–manure slurries with 50 g of soil per
litre. None of these substances persisted in the biodegradation experiments.
Degradation half-lives for the primary degradation were: tylosin, 3.3–8.1 days;
olaquindox, 5.8–8.8 days; and metronidazole, 13.1–26.9 days. Loke et al. (2000)
studied the stability of tylosin A in manure under methanogenic conditions. Tylosin
A is the major component (usually about 90% and not less than 80%) of tylosin.
The half-life was less than two days. The authors could not determine whether the
decrease in the concentration of tylosin A under aerobic and anaerobic consitions
is caused by sorption, or by abiotic or biotic chemical degradation.
Haller et al. (2002) analysed six grab samples taken in Switzerland from
manure pits on farms where medicinal feed had been applied and found total sul-
fonamide concentrations of up to 20 mg/kg of liquid manure.
The feed additive roxarsone is excreted unchanged by poultry.In experiments
conducted by Garbarino et al. (2003) it was also found to be stable in fresh dried
litter. However, when water was added to litter at about 50% w/w and the mixture
was allowed to compost at 40 °C, roxarsone disappeared and arsenate was formed
within about 30 days. Increasing the amount of water and the incubation temper-
ature increased the rate of degradation. The degradation process was most likely
to be biotic.
8.6 Uptake by farm animals of residues from manure
According to the calculations performed in section 7, a concentration of
0.3 g/kg of manure as estimated in section 8.4 would be high enough to cause
significant residues in tissues of, for example, chickens scavenging on
unprocessed manure within approximately ten half-life periods of the chloram-
phenicol residues. In practice, however,the excreta of treated animals would prob-
ably be diluted with excreta from untreated animals.
Assuming half-lives of <1day to several days (depending on conditions such
as temperature, water content, content of bedding material and particles), manure
CHLORAMPHENICOL
49
39834 FOOD TEXT 26/5/05 9:52 am Page 49
should no longer play a role as a potential source of contamination several weeks
after discontinuation of the use of chloramphenicol in terrestrial animals. Since
chloramphenicol is relatively unstable under anaerobic conditions, it would most
likely not survive the process of farmyard manure production described above and
the biodigester process. However, the compound could probably survive for
several weeks or longer if administered to soil or grassland shortly after excretion
by treated animals. Quantifiable amounts of residues could be taken up by free-
ranging animals for a certain period of time. As mentioned in section 5.5, chlo-
ramphenicol could persist for many years in dry dusts formed during the mixing of
chloramphenicol with dry feeds. The high concentrations of chloramphenicol
present in small quantities of dust could occasionally cause residues in some
animals, even a long time after the last use of chloramphenicol on a farm.
If unprocessed manure were to be directly added to aquatic systems, two dif-
ferent “worst-case” scenarios could be discussed:
Hypothetical “worst case” scenario 1
:the daily excreta of 10 pigs with a body
weight of 75 kg are washed directly into a pond with an area of 1000 m2and a depth
of 1 m. After treatment of all animals as assumed in section 5.4, 0.5 ¥26.25 ¥10
=0.13 kg of chloramphenicol equivalents (parent drug plus conjugates) would be
added by this means to the pond during the days following treatment, resulting in
amaximum concentration of £0.13 kg/1000 m3or £130 mg/l. The half-life would be
£10–20 days. Water exchange rates need also be considered in this scenario.
There are no data enabling an estimate to be made of the quantities that could be
taken up, e.g. through the gills, by aquatic species under these conditions.
However, one cannot exclude the formation of traces of detectable residues in
tissues. The problem would no longer exist several months after discontinuation
of treatment of terrestrial animals.
Hypothetical “worst case” scenario 2
:unprocessed undiluted manure of treated
animals is used in pond preparation. In practice the amounts would vary widely
depending on, for example, the nitrogen requirements of the particular system.
Assuming, for example, that in the preparation phase of a pond with an area of
10 000 m2amaximum primary dose of 3000 kg of unprocessed manure contami-
nated with chloramphenicol is applied when the water depth is 10 cm, followed by
two maximum secondary doses of 400 kg each applied when the water depth is
30 cm and 100 cm, respectively (e.g. Pathak et al., 2000), the maximum total dose
of chloramphenicol would be £0.3 ¥3800, that is, £1140g, depending on the
degree of decomposition of active chloramphenicol residues. This amount would
probably be quickly dissolved in the water and result in an initial concentration of
£1.14 kg/10 000 m3or £114 mg/l, which would decrease owing to degradation and
water exchange. In this example, the true concentrations of chloramphenicol could
be much less than 114mg/l since the excreta would have been collected over a
certain period of time, which would favour decomposition of chloramphenicol.
Again, one could not exclude the possibility that the remaining chloramphenicol
could lead to concentrations of residues in aquatic species at greater than the
LOQ. However, such problems would rapidly disappear after discontinuation of the
therapeutic use of chloramphenicol in terrestrial animals.
Another source of environmental contamination is the direct therapeutic use of
chloramphenicol in aquatic species. In particular,its use in medicated feed had
50
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 50
the potential to leave residues in the pond environment. Addition of medicated feed
containing chloramphenicol at 2.5 g/kg of feed, five times per day for 3 days could
mean, in practice, the introduction of up to 30 kg of feed/day per 10 000m2(e.g.
Cruz-Lacierda et al., 2000) depending on the density of the aquatic species. With
this amount of feed, 22.5 g of chloramphenicol would be introduced into a pond
with an area of 1000 m2,for example; at least 15% of this dose would not be con-
sumed (Primavera, 1994) by the aquatic species. Depending on the stability of the
feed particles in water (Obaldo, 2001), and of the coating in particular, chloram-
phenicol could leach out at a rate of <0.5–5% per h. Assuming more stable
particles and good quality coating, all the chloramphenicol contained in the feed
could also fall down to the mud on the pond bottom and persist there with half-
lives of up to several weeks, depending on conditions, such as oxygen content
and salinity.
In summary,all the hypothetical considerations performed in this section
suggest that after the implementation of a complete ban on the use of chloram-
phenicol in farm animals, the problems discussed in this section would vanish
within several months.
The problems of potential significant carry-over in, for example, feed mills are
not discussed in this document.
9. HUMAN INTAKES RESULTING FROM THE CONSUMPTION OF
CONTAMINATED FISH AND SHELLFISH
Assuming occasional contamination of fish or shellfish containing chloram-
phenicol at a concentration of 0.5 mg/kg, the additional chloramphenicol burden for
average and preferential eaters of fish and shellfish could be estimated using data
on consumption habits. Such data are not available at the international level.
However, some data have been published for certain regions and for certain
populations with very high consumption of fish and shellfish.
Asurvey of 212 people living in Singapore was conducted by Burger et al.
(2002) to examine the relative importance of fish, shellfish, and other meat in the
diet. From the authors’ discussion of their findings in the context of international
surveys on fish consumption, it appears that people in the Far East eat signifi-
cantly more fish than do most people whose families have lived for generations in
industrialized societies. In the study by Burger et al., it was found that people ate,
on average, fish for about ten meals per week, chicken for eight meals per week,
and shrimp and pork for about six meals each per week. While only 8% of people
never ate fish, 18% ate fish at all 21 meals per week, and >20% ate shellfish for
all 21 meals. Therefore, it seems to be appropriate to base an estimate of high
seafood intake by preferential eaters on data obtained in surveys of people of Asian
origin.
Sechena et al. (2003) described and quantified rates of seafood consumption,
and acquisition and preparation habits of 202 first- and second-generation
Asian–American and Pacific Islanders from 10 ethnic groups (Cambodian,
Chinese, Phillippine, Hmong, Japanese, Korean, Lao, Mien, Samoan, and
CHLORAMPHENICOL
51
39834 FOOD TEXT 26/5/05 9:52 am Page 51
Vietnamese) in King County, Washington in 1997. Participants in the study were
all consumers of seafood; only one person did not eat shellfish, which was other-
wise the predominant seafood consumed by these people (45.9% of all seafood
consumed). Rates of fish consumption were skewed considerably for all fish
groups, indicating that a few respondents had a larger consumption rate than other
respondents. The 90th percentile of all consumption rates for “all seafood” con-
sumption was 3.928 g/kg bw per day.
Using this conservative estimate of seafood intake and multiplying it by the
median concentration (0.5 mg/kg) of chloramphenicol found in the published alerts
from the Food Standards Agency of Ireland, mentioned above, would result in
an estimated daily intake of chloramphenicol of approximately 2 ¥10-9g/kgbw, or
0.12 mgfor a person with a body weight of 60 kg. This estimate of intake could be
slightly low since other products of animal origin could also occasionally contain
traces of chloramphenicol.
10. COMPARISON OF DIETARY INTAKES WITH LOW-LEVEL
EXPOSURE FROM OPHTHALMIC FORMULATIONS
Systemic drug absorption after ocular administration is well known and has
been reported in hundreds of research papers for a large number of substances
by numerous research groups. For a better understanding of these variable find-
ings, it is important to consider the anatomy and physiology of the eye.
After topical ocular administration of drugs, the highly vascularized conjuncti-
val and nasal mucosa are the major sites of systemic absorption. Drug absorption
by this route bypasses the first-pass effects in the gastrointestinal tract and in the
liver.However,local ophthalmic bioavailability can be very low,since the tear fluid
is rapidly drained from the lower conjunctival sac through the puncta and the
lachrymal duct into the lachrymal sac, from where it passes through the naso-
lachrymal duct into the inferior nasal meatus. From here, the fluid moves to the
nasopharynx where it is swallowed into the gastrointestinal tract. It has been
reported that drainage of the administered dose via the nasolacrimal system into
the nasopharynx and the gastrointestinal tract takes place when the volume of fluid
in the eye exceeds the normal lacrimal volume of 7–10ml. Thus, the portion of the
dose that is not eliminated by spillage is drained quickly and the time that the dose
is in contact with the surfaces of the cornea and sclera is reduced to approximately
2 min (Saettone, 2002). According to Saettone (2003), the rate of loss of drug from
the eye can be such that only 1–5% or less of the drug applied topically as a solu-
tion reaches the inner eye. For example, using timolol as a probe, Alvan et al.
(1980) found that 12–88% of the dose administered was lost when 16 volunteers
received two drops of 0.5% timolol ophthalmic solution in each eye, twice daily for
2weeks. These anatomical and physiological properties of the eye explain the
short pre-corneal residence time and the poor bioavailability of many eyedrop solu-
tions that do not contain a viscosity agent in their formulation to prolong residence
time (Sirbat et al., 2000).
52
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 52
Insummary, there are three possible systemic absorption sites for drugs admin-
istered topically to the eye—conjunctival, inferior nasal, and gastrointestinal
mucosa—and total bioavailability, therefore, should be assessed by estimating
drug concentration in plasma or urine.
10.1 Systemic effects after ocular administration of drugs as
evidence for systemic bioavailability
Part of the current knowledge of systemic bioavailability of drugs administered
topically to the eye has accumulated from observations of systemic adverse
effects after the use of topical ophthalmic preparations (Gerber et al., 1990; Flach,
1994; Jones et al., 1996; Shiuey & Eisenberg, 1996; Diamond, 1997). Urtti &
Salminen (1993) emphasize the need to take into account the problem of systemic
drug absorption in designing ocular drug and dosage forms to minimize systemic
absorption and increase the oculospecificity of drugs, for example, reducing
volume and increasing viscosity of eyedrops, controlling drug release from
depot preparations, prodrug-derivatization, and addition of vasoconstrictive
agents.
10.2 Pharmacokinetic evidence of systemic absorption of
ophthalmic drugs
In many other studies in humans and animals, the systemic availability of oph-
thalmic drugs has been convincingly demonstrated by pharmacokinetic research.
A few examples of hundreds of papers may be given here. Anderson (1980) deter-
mined that systemic absorption of epinephrine and dipivefrin hydrochloride was
55–65% of the ocularly applied dose. Chiang et al. (1983) gave d9-tetrahydro-
cannabinol to rabbits by ophthalmic administration, measured plasma concentra-
tions, and compared with intravenous data to establish bioavailability. Kumar et al.
(1985) studied the systemic absorption, plasma concentrations (maximum plasma
concentrations are achieved within 10–20 min after topical instillation) and cardio-
vascular effects of ophthalmic solutions of phenylephrine hydrochloride. Salminen
(1990) reviewed literature on human plasma concentrations after instillation of
ocular timolol, levobunolol, atropine, cyclopentolate, scopolamine, phenylephrine,
betamethasone and technetium-99. Kaila et al. (1999) determined the mean
bioavailability of ocularly administered atropine to be 63.5% (
n
=6; range,
19–95%). Sasaki et al. (2000) using tilisolol as a model substance and car-
boxymethylcellulose sodium salt as viscous polymer developed an in vivo phar-
macokinetic model that accounts for corneal diffusion in albino rabbits and predicts
the concentration of beta-blockers in the anterior segments, and characterizes the
systemic absorption of instilled drug with ophthalmic viscous vehicle. Vainio-Jylha
et al. (2001) studied the concentration of betaxolol in plasma after its topical ocular
use. The drug showed a biphasic concentration–time curve in plasma, the first
peak occurring already after several minutes, and concentrations were detectable
even at 12 h after dosing. Korte et al. (2002) estimated the systemic bioavailabil-
ity of timolol in eyedrops containing 0.5% timolol, and compared the cardiopul-
monary effects of intravenous and ophthalmic timolol. The peak concentration of
CHLORAMPHENICOL
53
39834 FOOD TEXT 26/5/05 9:52 am Page 53
ophthalmic timolol in plasma was measured in most subjects within 15 min after
drug administration. The systemic bioavailability was 78.0% (
n
=8). Ophthalmic
timolol resembled intravenous timolol in terms of systemic bioavailability, plasma
kinetics, and cardiopulmonary effects. A recent article reviews the principles of
systemic absorption of insulin applied topically to the eye. The physiological and
pharmaceutical considerations for formulation development and the strategy of
improving the systemic absorption and bioavailability of insulin are also discussed
(Lee et al., 2002).
10.3 Results obtained with ophthalmic formulations of chloramphenicol
The above examples were given since with chloramphenicol alone, a sub-
stance that typically easily passes through all biological membranes and barriers,
the systemic bioavailability after topical application is a controversial subject of dis-
cussion. However, this discussion has taken place in the absence of adequate
studies using sensitive analytical methods.
In an early study by Trope et al. (1979), five children aged <9years received
eyedrops containing chloramphenicol, which were administered every 2hto each
eye for 5–7 days. Systemic absorption was not detected with the available assay
methods. Walker et al. (1998) used HPLC with a limit of detection of 1mg/l to inves-
tigate whether serum accumulation of chloramphenicol occurred after topical
therapy in 40 patients. The mean dose of chloramphenicol received from eyedrops
after 1 week of treatment was 8.0 mg, and after 2 weeks, 15.3 mg. As the authors
had expected, chloramphenicol failed to accumulate to detectable levels. Contrary
to these findings, chloramphenicol applied topically to the eye in ointment produced
bacteriostatic concentrations of chloramphenicol in the aqueous humor, which
lasted for several hours (George & Hanna, 1977). Hanna et al. (1978) reported
that repeated drops of solutions containing 0.5% chloramphenicol for several hours
were required to produce a concentration of chloramphenicol of 1mg/ml in the
aqueous humor.Yamada & Hiraki (1995) studied the ocular pharmacokinetics in
rabbits of a combination formulation containing 0.25% chloramphenicol (CP) under
various experimental conditions. When they sealed the cornea with cyanoacrylate
glue to block transcorneal absorption, the absorbed fraction of chloramphenicol
was <10% of that in the control, indicating that most of the chloramphenicol in the
aqueous humor was derived from the transcorneal route. Ismail & Morton (1995)
evaluated the bioavailability of three commercial chloramphenicol ophthalmic prod-
ucts supplemented with [14C]chloramphenicol. Samples of 50mlwere applied to the
corneas of isolated bovine eyes. Their results indicate a greater bioavailability of
chloramphenicol in ophthalmic ointments than in a liquid preparation, which gave
extremely low levels of chloramphenicol in the aqueous humour and corneal.
10.4 Quantitative considerations
Typical concentrations of chloramphenicol in eyedrops and ointments are
5mg/ml(0.5%) and 10 mg/ml(1%), respectively. The recommended frequency of
application varies. A dosage regimen that has been recommended on the basis of
clinical trial suggests four daily treatments. Under these conditions, acute bacter-
ial conjunctivitis was 88% healed within 9 days of treatment (Laerum et al., 1994).
54
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 54
The locally absorbed fraction of the drug dose enters the anterior chamber by
penetration through the three layers and two membranes of the cornea. When
adrop (50–75 ml) is applied to the eye it becomes diluted owing to reflex tearing,
and the volume that is in excess of the normal lacrimal volume is drained from the
eye. The average maximum capacity of the human conjunctival sac is 25–30ml
(Peterson, lecture notes). In consequence, it can be estimated that 66–75% of the
administered dose is lost immediately, and that a maximum of 0.33 ¥5¥50 =
82.5 mgper application would be available for possible absorption through the
cornea. Ointments have prolonged contact with the cornea, which improves
absorption. Chloramphenicol apparently exhibits good penetration if the residence
time is sufficiently long. Beasley et al. (1975) gave topical applications of an oph-
thalmic solution containing 0.5% chloramphenicol to patients at various times
before cataract surgery. Aqueous humor obtained at the time of surgery contained
intact chloramphenicol at a concentration of 3.5–6.7mg/ml 1–2 hafter topical
administration. Aqueous humor is the watery fluid produced by the ciliary body that
fills the space between the lens and cornea of the eye, which serves as a nutri-
ent delivery system for the avascular cells in the cornea and eventually drains into
avein or lymphatic vessel. The normal human aqueous humor production during
daytime is 2.75 ±0.65 ml/min (mean ±standard deviation (SD)), while at night pro-
duction is approximately half that amount (Larsson, 1998). The volume of the ante-
rior chamber is dependent on age. In normal healthy subjects in two age groups,
the volume of the anterior chamber was 247 ±39 mlin the younger group (aged
20–30 years,
n
=51) and 160 ±39 mlin the older group (aged ≥60 years,
n
=53)
(Toris et al., 1999).
Using these values, the fraction of the bioavailable dose that is absorbed
through the cornea per application of one drop (0.6–1.6mgor 2.4–6.4 mgper day)
during a treatment period can be calculated. This value probably represents a low
estimate of systemic absorption, as it does not include absorption occurring at
other possible sites described above. Nevertheless, this low estimate of systemic
absorption of chloramphenicol from eyedrops is up to 50 times higher than the
intake estimate calculated in section 7 and is of about the same order of magni-
tude as the intake corresponding to the highest contaminated seafood sample
found in 2002.
11. COMMENTS
No toxicological data on chloramphenicol were submitted to the Committee at
its present meeting. The current evaluation was made on the basis of an exten-
sive review of the scientificliterature, particularly that published since the forty-
second meeting, and with a focus on the toxicological data in humans.
Reports on uptake and metabolism in humans and animals showed that chlo-
ramphenicol is rapidly absorbed when administered orally and that it is extensively
metabolized. Astudy with human bone marrow in vitro also showed evidence of
metabolism in this tissue.
A number of studies with chloramphenicol and several metabolites of chlo-
ramphenicol have shown that they are cytotoxic to bone marrow in vitro.
CHLORAMPHENICOL
55
39834 FOOD TEXT 26/5/05 9:52 am Page 55
Inorder to assess the genotoxicity of chloramphenicol, the Committee
reassessed the results of tests reported at its thirty-second and forty-second meet-
ings, and also considered new studies available in the published literature. Chlo-
ramphenicol was shown to cause DNA damage in a human fibroblast cell line and
in primary cultures of rat hepatocytes, but not in human bone-marrow cells in vitro.
The results of tests for reverse mutation in bacteria were mostly negative. In mam-
malian cells in vitro, chloramphenicol consistently gave positive results in tests for
chromosomal aberrations, but results of tests for gene mutations and for sister
chromatid exchange were inconsistent. Overall, these results indicated that chlo-
ramphenicol was genotoxic in vitro.
In tests for genotoxicity in vivo, chloramphenicol caused chromosomal aberra-
tions in the bone marrow of mice, but gave negative results in tests for micronu-
cleus formation in the bone marrow of mice and rats. It is not clear why contrasting
results were obtained in these two assays, but the Committee considered that it
was prudent to regard chloramphenicol as a mutagen in somatic cells in vivo.
According to data on heritable mutation reviewed by the Committee at previ-
ous meetings, chloramphenicol gave negative results in tests for dominant lethal
mutation in mice and in
Drosophila melanogaster
.
At its present meeting, the Committee reviewed studies on genotoxicity with
chloramphenicol and its metabolites in human bone marrow cells or peripheral
blood lymphocytes in vitro. Only nitrosochloramphenicol and dehydrochloram-
phenicol induced DNA strand breaks, while chloramphenicol and other metabo-
lites were without effects. This confirmed the results of previous studies that
showed that some of the metabolites of chloramphenicol are genotoxic.
No adequate studies were available to evaluate the carcinogenicity of chlo-
ramphenicol in experimental animals. Chloramphenicol has been classified as
“probably carcinogenic in humans” by IARC (IARC, 1990).
Anumber of toxicological studies in rodents were conducted in an effort to
develop a model for chloramphenicol-induced aplastic anaemia in humans. While
bone-marrow depression was confirmed in these studies, it did not progress to the
characteristic aplastic anaemia of humans and was therefore not considered to be
asuitable model for the disease in humans. The reversible bone-marrow depres-
sion that is seen in animals and humans receiving chloramphenicol can be attrib-
uted to its cytotoxicity.
A number of reports of epidemiological studies on the oral and injectable use
of chloramphenicol in humans were reviewed; they confirmed that chlorampheni-
col was toxic to the bone marrow. In many cases, the toxic effects could be
reversed by reducing or discontinuing treatment with chloramphenicol. There are,
however, cases of aplastic anaemia that appear to be unrelated to dose and that
are associated with a high mortality rate. In humans, the aplastic anaemia that is
attributable to treatment with chloramphenicol is often fatal and is an idiosyncratic
reaction that may have an immunological component. There is also evidence that
some of the survivors of aplastic anaemia induced by chloramphenicol subse-
quently develop leukaemia.
56
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 56
The ophthalmic use of chloramphenicol represents the lowest therapeutic dose
of the compound. Epidemiological data relating to the ophthalmic use of chloram-
phenicol in humans suggest that this form of administration is unlikely to be asso-
ciated with aplastic anaemia. While any occurrence of aplastic anaemia associated
with this form of administration is extremely rare, it is not possible to quantify the
absolute risk of the ophthalmic use of chloramphenicol in humans because of the
low background occurrence of idiopathic aplastic anaemia.
No adequate studies were available to fully assess potential reproductive
toxicity with chloramphenicol. However, chloramphenicol has been shown to be
embryotoxic and fetotoxic in a number of laboratory animal species.
In a case–control study in humans, the authors concluded that oral treatment
with chloramphenicol in the second and third months of pregnancy presents little,
if any,teratogenic risk. However, it is difficult to determine if any effects might occur
during the first month of pregnancy.
Residue data
Most countries in the world do not permit the use of chloramphenicol in
food-producing animals, in order to protect the health of consumers. Despite
such restrictions, chloramphenicol has been detected in food samples collected
in national monitoring programmes during the past 2 years and these residues
have caused safety concerns. Shrimps, prawns, food products from aquatic
animals, honey, royal jelly, meat and offal, sausage casings, rabbit and poultry
meat and milk powder were among the commodities in which the drug was
detected.
Chloramphenicol—an environmental contaminant?
While the results of monitoring clearly indicate intentional uses of chloram-
phenicol in some cases, it has also been argued that very low levels of chloram-
phenicol, such as those found in poultry and in products from aquaculture, could
result from environmental contamination. The possibility that chloramphenicol
could persist in the environment, or even be formed by soil microorganisms was
discussed by the Fourteenth Session of CCRVDF, held in 2003 (Joint FAO/WHO
Food Standards Programme, 2003).
Chloramphenicol was first described as an antibiotic produced by cultures of
an actinomycete isolated from soil by Ehrlich et al. (1947). The soil samples were
collected from a mulched field near Caracas, Venezuela, and from a compost soil
on the horticultural farm of the Illinois Agricultural Experiment Station at Urbana.
In studies conducted in 1952, the adsorption, stability, and rate of production of
chloramphenicol in soil under different laboratory conditions were determined.
When sterilized soil was inoculated with
Streptomyces venezuelae
and was incu-
bated for long periods, the presence in soil of chloramphenicol formed by the
microorganism after a lag phase of several weeks was demonstrated. The highest
concentration measured was 1.12 mg/kg. However, when workers of the same
group and in the same year analysed samples of normal soils collected from 91
CHLORAMPHENICOL
57
39834 FOOD TEXT 26/5/05 9:52 am Page 57
cultivated and grassland sites from nine states of the USA and from 13 other coun-
tries, no chloramphenicol was identified in extracts from these soils. In this initial
study (1952), the limit of detection of chloramphenicol was 0.3 mg/kg (turbidimet-
ric assay using
Shigella sonnei
). In other experiments with an improved LOD
of 0.05 mg/kg, and including the 91 samples of the previous study, these results
were confirmed. Chloramphenicol was found and identified in soils only when
organic material was added before sterilization and seeding with
Streptomyces
venezuela.
Whether antibiotics are produced in soil in detectable amounts by indigenous
soil organisms has remained a subject of scientific dispute for several decades. It
was only recently demonstrated that an antibiotic could be synthesized in
detectable amounts in soil. Using biosensor methods with very low LODs,
Strep-
tomyces rimosus
was found to produce oxytetracycline in untreated soil. However,
similar studies have not been carried out for chloramphenicol.
With this background information and on the basis of an extensive search of
the current literature, the Committee at its present meeting examined the follow-
ing two hypothetical scenarios to explain potential environmental contamination of
foods of animal origin with chloramphenicol:
Scenario 1
Assuming that:
—Chloramphenicol is naturally produced in the soil;
—Farm animals (e.g. pigs, chickens) ingest certain amounts of soil in their daily
intake of dry matter;
—This may result in an uptake of chloramphenicol and subsequently in residues
of chloramphenicol in tissues and products of those animals that are not asso-
ciated with uses of chloramphenicol as a veterinary drug.
The Committee conducted a number of simple model calculations to estimate
hypothetical intakes of chloramphenicol as a function of soil intake of animals. On
the basis of data in the literature, it was assumed that 2% of the dry matter intake
of pigs and chickens was soil. The concentration of chloramphenicol in soil was
set at one of the following values:
—£0.05 mg/kg, corresponding to the LOD of the methods used by the authors of
the historical studies, who were unable to detect chloramphenicol above this
limit when they analysed a large number of soil samples from different coun-
tries; or
—1 mg/kg, roughly corresponding to the highest concentration of chlorampheni-
col produced by
S. venezuelae
in inoculated sterilized soil samples supple-
mented with organic matter; or
—25 mg/kg, roughly corresponding to the highest concentrations of chloram-
phenicol produced under experimental conditions with soils enhanced with
tryptone and under the most favourable conditions.
58
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 58
The following steps were performed in the calculations:
—Calculation of average daily live-weight gain;
—Calculation of daily dry matter intake as function of body weight/live-weight
gain;
—Calculation of soil intake as a fixed fraction of dry matter intake;
—Calculation of chloramphenicol intake using the above assumed chloram-
phenicol concentrations in soil;
—Estimation of the resulting tissue concentrations on the basis of the known
pharmacokinetic behaviour of chloramphenicol.
The Committee concluded that concentrations of chloramphenicol in soil, as
they were found under laboratory conditions in the presence of organic material,
would suffice to explain occasional traces of chloramphenicol in tissues and prod-
ucts of free-ranging and/or scavenging livestock animals. With the LOD achieved
in the 1950s, however, it was not possible to demonstrate the production of
detectable amounts of chloramphenicol in soil. No further empirical data have been
obtained since 1952. The possibility that chloramphenicol, produced naturally by
soil microorganisms, could lead to the residues found in food-producing animals
cannot be ruled out, but remains an unexplored hypothesis that is currently not
supported by experimental data.
Scenario 2
Assuming that:
—Residues observed are caused by the exposure of some food-producing
animals to chloramphenicol that persists in the environment. Such environ-
mental sources result from historical uses as veterinary drug.
—Any persisting residues of chloramphenicol in farm environments are most
likely to originate from excreta of treated animals, and a possible source of
contamination could be farming systems in which manure is used as fertilizer,
e.g. in integrated farming. Integrated farming of fish/shrimp and livestock com-
bines aquaculture with production of pigs, ducks, chickens, and/or other live-
stock animals. Manure produced by livestock may be used as soil fertilizer.
Additionally, it is possible that manure may be used as a nutrient in fish/shrimp
ponds. The nutrients contained in manure are taken up by bacteria and micro-
algae, which themselves feed filtrating organisms, mostly zooplankton. Some
of these organisms are then consumed by fish or shrimp.
The Committee reviewed published literature in order to investigate the condi-
tions of integrated farming as a potential cause of chloramphenicol residues in food
of animal origin. Chloramphenicol was in use in farm animals as a veterinary drug
before authorizations were withdrawn in many countries and regions. Before these
restrictions, significant amounts of manure, probably containing intact chloram-
phenicol, had been used as fertilizers. Concentrations of chloramphenicol in fresh
manure and certain patterns of its use in integrated farming of aquatic species
could, in principle, also explain low concentrations of residue in certain farm
CHLORAMPHENICOL
59
39834 FOOD TEXT 26/5/05 9:52 am Page 59
animals, such as scavenging chickens, free-ranging pigs and in aquatic animals.
However, when reviewing the available information on the half-life of chloram-
phenicol under different environmental conditions, no evidence was found to show
that chloramphenicol could persist in the environment for periods longer than
several months, except in dry dusts. Therefore, if there was any risk of food con-
tamination resulting from historical use in the farm environment these problems
should disappear within several months of cessation of the use of chlorampheni-
col. Similar considerations apply to the persistence of chloramphenicol in aqua-
culture after past uses of the drug as medicated feed that had been directly applied
in ponds.
Analytical methods
In the past decade, several methods have been developed for the screening,
quantification and confirmation of chloramphenicol in foods.
Screening for chloramphenicol could be performed with validated ELISA kits.
The majority of these kits had a LOD of <1mg/kg. However, confirmatory methods
needed to be used in order to avoid false-positive results. For confirmatory pur-
poses, highly sensitive methods based on GC–MS, either electron impact or
negative chemical ionization mode, have been used. More recently, LC–MS/MS
methods allow the determination and identification of chloramphenicol in food com-
modities such as honey, meat (chicken, turkey, pork and beef), fish and shellfish,
at concentrations of <1mg/kg. The LOD and LOQ are as low as 0.05mg/kg and
0.1 mg/kg, respectively.
Conclusions
The Committee concluded that:
—There was no evidence supporting the hypothesis that chloramphenicol is
synthesized naturally in detectable amounts in soil. Although this possibility
is highly unlikely,data generated with modern analytical methods would be
required for confirmation.
—There was evidence that the low concentrations of chloramphenicol detected
by food monitoring programmes in the year 2002 could not originate from
residues of chloramphenicol persisting in the environment after historical vet-
erinary uses of the drug in food-producing animals. Owing to the high vari-
ability in the half-life of chloramphenicol under different environmental
conditions, however, such a mechanism might occasionally cause low-level
contamination in food.
Valid analytical methods are available to monitor low concentrations of chlo-
ramphenicol in foods; however, confirmatory methods require sophisticated and
expensive equipment.
Since the advent of sensitive routine analytical methods for the quantitative
determination of residues of chloramphenicol in foods of animal origin at concen-
trations far less than 1 mg/kg, illegal use of this drug is no longer attractive. Although
60
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 60
only limited kinetic residue data exist that describe the terminal elimination from
“deep compartments” (Arnold & Somogyi, 1986), these data suggest that the with-
holding times necessary to allow residues to deplete below 1mg/kg with reason-
able statistical certainty are already in the order of 15 to much longer than 30 days,
depending on species, product, dose and route of administration. Therefore, the
relatively frequent observation of residues far less than 1mg/kg in monitoring pro-
grammes has stimulated a discussion on whether traces of chloramphenicol in
foods could occasionally originate from environmental contamination.
The possible production of chloramphenicol in natural soils was investigated
50 years ago at the time of the discovery of chloramphenicol as a product of a soil
microorganism. With the methodologies of that era it was not possible to con-
vincingly demonstrate the production of appreciable amounts of chloramphenicol
in soil. The question has never again been examined using adequate analytical
methods. However,reliable laboratory experiments conducted by the group that
discovered chloramphenicol have shown that in the presence of organic material
as it may well occur on farmland chloramphenicol could be formed in concentra-
tions up to 1 mg/kg. However no further empirical data have been generated since
that time. These concentrations in soil which were found under laboratory condi-
tions would suffice to explain occasional traces of chloramphenicol in tissues and
products of free ranging and/or scavenging livestock animals.
Chloramphenicol was in common use as a veterinary drug before authoriza-
tions were withdrawn in many countries and regions. Before such restrictions,
enormous amounts of manure likely to contain active chloramphenicol were used
as fertilizers. Concentrations of chloramphenicol in fresh manure and certain pat-
terns of its use could in principle explain low residue concentrations in certain farm
animals, e.g. in scavenging chickens, free-ranging pigs and in aquatic animals.
However, no convincing evidence has been found to show that chloramphenicol
could persist in the environment for long times—except in dry dusts.
The occasional daily dietary intake of chloramphenicol by preferential eaters
of fish and shellfish contaminated at the levels reported in the year 2002 (median
value, 0.5 mg/kg) is more than one order of magnitude lower than the systemically
bioavailable fraction of a daily dose of a typical ophthalmic formulation used in
human medicine.
12. EVALUATION
As there is evidence that chloramphenicol is a genotoxin in vivo, it is prudent
to assume that chloramphenicol could cause some effects, such as cancer,through
agenotoxic mechanism for which there is no identifiable threshold dose.
Epidemiological studies in humans show that treatment with chloramphenicol
is associated with the induction of aplastic anaemia, which may be fatal. It was
not possible to establish any dose–response relationship or threshold dose for the
induction of aplastic anaemia.
The Committee noted that aplastic anaemia induced by chloramphenicol is
arare idiosyncratic response in humans, which may have an immunological
CHLORAMPHENICOL
61
39834 FOOD TEXT 26/5/05 9:52 am Page 61
component. In common with many other idiosyncratic immune system-mediated
adverse reactions, no animal model could be developed. As a consequence of
these considerations, and because the mechanism of chloramphenicol-induced
aplastic anaemia remains unknown, the Committee could not identify any studies
in animals or epidemiological studies that would assist the further toxicological
evaluation of chloramphenicol.
The Committee concluded that it was not appropriate to establish an ADI for
chloramphenicol.
Taking into account the present gaps in scientific knowledge, the Committee
could not completely rule out the possibility that occasionally foods are contami-
nated from environmental sources. The easiest way to rule out this possibility
would be a thorough investigation of chloramphenicol concentrations in soil using
modern analytical methods.
The Committee was unable to propose options for regulating traces of chlo-
ramphenicol in foods. The human exposure which may have resulted from con-
sumption of contaminated seafood in the years 2001–2003 was probably lower
than the systemic exposure resulting from the use of ophthalmic formulations.
However, the resulting risk could not be estimated.
13. REFERENCES
Abrahams, P.W. & Steigmajer, J. (2003) Soil ingestion by sheep grazing the metal enriched
floodplain soils of mid-Wales.
Environ. Geochem. Health
,25,17–24.
Adams, H.R. (1995)
Veterinary Pharmacology and Therapeutics
,7th Ed. Ames: Iowa State
Press, pp. 820–824.
Aga, D.S., Goldfish, R. & Kulshrestha, P. (2003) Application of ELISA in determining the fate
of tetracyclines in land-applied livestock wastes.
Analyst
,128,658–662.
Alnigenis, M.N., Nalcaci, M., Pekcelen, Y., Atamer, T. & Sargin, D. (2001) Possible etiologic
factors in 151 Turkish patients with aplastic anemia.
Am. J. Hematol
., 68,60–61.
Alvan, G., Calissendorff, B., Seideman, P., Widmark, K. & Widmark, G. (1980) Absorption of
ocular timolol.
Clin. Pharmacokinet
., 5,95–100.
Ambekar,C.S., Cheung, B., Lee, J., Chan, L.C., Liang, R. & Kumana, C.R. (2000) Metabo-
lism of chloramphenicol succinate in human bone marrow.
Eur.J. Clin. Pharmacol
., 56,
405–409.
Anadon, A., Bringas, P., Martinez-Larranaga, M.R. & Diaz, M.J. (1994) Bioavailability, phar-
macokinetics and residues of chloramphenicol in the chicken.
J. Vet. Pharmacol. Ther
.,
17,52–58.
Anderson, J.A. (1980) Systemic absorption of topical ocularly applied epinephrine and
dipivefrin.
Arch. Ophthalmol.
,98,350–353.
Arnold, D. & Somogyi, A. (1986) Chloramphenicol residues in edible tissues of food animals.
Proc. Second World Congress on Foodborne Infections and Intoxications
,Vol. II, pp.
832–836.
Arthur, J.R., Lavilla-Pitogo, C.R. & Subasinghe, R.P., eds. (2000)
Use of Chemicals in Aqua-
culture in Asia
.
Proceedings of the Meeting on the Use of Chemicals in Aquaculture in
Asia, 20–22 May 1996; Tigbauan, Iloilo, Philippines
.Southeast Asian Fisheries Devel-
opment Center, Aquaculture Department, Tigbauan, Iloilo, Philippines.
62
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 62
Baig, J., Sharma, M.C. & Lal, S.B. (1994) Haemato-biochemical and the bone marrow
changes in chloramphenicol-induced toxicosis in dogs.
Indian J. Anim. Sci.
,64, 712–
715.
Balizs, G. & Arnold, D. (1989) Reference standards for residue analysis of chloramphenicol
in milk and meat: a critical study.
Chromatographia
,27,489–494.
Baradat, M., Alary, J. & Cravedi, J.P. (1993) Residues of chloramphenicol in rainbow trout.
In:
Proceedings of the Euroresidue II Conference. Veldhoven, Netherlands, 3–5 May,
1993
.
Barker, J.C., Hodges, S.C. & Walls, F.R. (2003) Livestock manure production rates and nutri-
ent content. In:
2003 North Carolina Agricultural Chemicals Manual
,Chapter X. The
College of Agriculture and Life Sciences, North Carolina State University, Raleigh, North
Carolina (http://ipm.ncsu.edu/agchem/chptr10/1011.pdf, accessed 18 May 2004).
Beasley, H., Boltralik, J.J. & Baldwin, H.A (1975) Chloramphenicol in aqueous humour after
topical application.
Arch. Ophthalmol
., 93,184–185.
Berry,D.J. (1987) Reversed-phase high-performance liquid chromatographic determination
of chloramphenicol in small biological samples.
J. Chromatogr.
,385,337–341.
Boertz, A.K. (1984)
Radioimmunologische und gaschromatographische Untersuchungen
zum Rückstandsver-halten von Chloramphenicol beim Schwein
.Dissertation (in
German), Technische Universität, Berlin, Germany.
Boertz, A.K., Arnold, D. & Somogyi, A. (1985) [Behaviour of chloramphenicol residues fol-
lowing intramuscular administration in swine] (in German)
Z. Ernährungswiss
.24,
113–119.
Borner, S., Fry, H., Balizs, G. & Kroker, R. (1995) Confirmation of chloramphenicol residues
in egg by gas chromatography/high-resolution mass spectrometry and comparison of
quantitation with gas chromatography—electron capture detection.
J. AOAC Int
., 78,
1153–1160.
Bolton, L.F., Kelley, L.C., Lee, M.D., Fedorka-Cray, P.J. & Maurer, J.J. (1999) Detection of
multidrug-resistant
Salmonella enterica
serotype
typhimurium
DT104 based on a gene
which confers cross-resistance to florfenicol and chloramphenicol.
J. Clin. Microbiol
., 37,
1348–1351.
Bories, G.F., Peleran, J.C. & Wal, J.M. (1983) Liquid chromatographic determination and
mass spectrometric confirmation of chloramphenicol residues in animal tissues.
J. AOAC
Int.
,66,1521–1526.
Bui Van Chinh, Nguyen Huu Tao & Do Viet Minh (1993) Growing and ensiling soybean forage
between rice crops as a protein supplement for pigs in north Vietnam.
Livestock Research
for Rural Development
,5(1) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Burger, J., Fleischer, J. & Gochfeld, M. (2002) Fish, shellfish, and meat meals of the public
in Singapore.
Environ. Res.,
92,254–261.
BVL (2003) Communication from the Bundesamt fuer Verbraucherschutz und Lebensmittel-
sicherheit, Berlin, Germany to the FAO JECFASecretariat.
Campagnolo, E.R., Johnson, K.R., Karpati, A., Rubin, C.S., Kolpin, D.W., Meyer,M.T.,
Esteban, J.E., Currier, R.W., Smith, K., Thu, K.M. & McGeehin, M. (2002) Antimicrobial
residues in animal waste and water resources proximal to large-scale swine and poultry
feeding operations.
Sci. Total Environ
., 299,89–95.
Chevalier,M., Pochard, M.F.&Bel, B. (1995) Determination of chloramphenicol residues by
reverse phase high-performance liquid chromatography in foies gras.
Food Addit.
Contam
., 12, 101–106.
CHLORAMPHENICOL
63
39834 FOOD TEXT 26/5/05 9:52 am Page 63
Catalan, J., Moreno, C. & Arruga, M.V. (1993) Sister-chromatid exchanges induced by chlo-
ramphenicol on bovine lymphocytes.
Mutat. Res
., 319,11–18.
Chiang, C.W., Barnett, G. & Brine, D. (1983) Systemic absorption of delta 9-tetrahydro-
cannabinol after ophthalmic administration to the rabbit.
J. Pharm. Sci
., 72,136–138.
Chien, Y.H., Lai, H.T. & Liu, S.M. (1999). Modelling the effects of sodium chloride on degra-
dation of chloramphenicol in aquaculture pond sediment.
Sci. Total Environ
., 239,81–87.
Costa, M.H., et al. (1993) Evaluation of residues of chloramphenicol in liver, kidney, muscle
and blood of rabbits and stability studies during storage and after a cooking procedure.
In:
Proceedings of the Euroresidue II Conference. Veldhoven, Netherlands, 3–5 May,
1993
,pp. 246–250.
Cravedi, J., Perdu-Durand, E., Baradat, M., Alary, J., Debrauwer, L. & Bories, G. (1995) Chlo-
ramphenicol oxamylethanolamine as an end product of chloramphenicol metabolism in
rat and humans: evidence for the formation of a phospholipid adduct.
Chem. Res. Toxicol
.,
8,642–648.
Cruz-Lacierda, E.R., de la Peña, L.D. & Lumanlan-Mayo, S.C. (2000) The use of chemicals
in aquaculture in the Philippines. In: Arthur,J.R., Lavilla-Pitogo, C.R., and Subasinghe,
R.P., eds.,
Use of Chemicals in Aquaculture in Asia. Proceedings of the Meeting on the
Use of Chemicals in Aquaculture in Asia, 20–22 May 1996
,
Tigbauan, Iloilo, Philippines
.
Published by: Southeast Asian Fisheries Development Center, Aquaculture Department,
Tigbauan, Iloilo, Philippines.
Czeizel, A., Rockenbauer, M., Sorensen, H. & Olsen, J. (2000) A population-based
case–control teratologic study of oral chloramphenicol treatment during pregnancy.
Eur.
J. Epidemiol
., 16,323–327.
Davis, M.A., Hancock, D.D., Besser,T.E., Rice, D.H., Gay,J.M., Gay,C., Gearhart, L. & Di
Giacomo, R. (1999) Changes in antimicrobial resistance among
Salmonella enterica
serovar
typhimurium
isolates from humans and cattle in the north-western United States,
1982–1997.
Emerg. Infect. Dis
., 5(6), (http://www.cdc.gov/ncidod/eid/vol5no6/davis.htm,
accessed 18 May 2004).
De Liguoro, M., Cibin, V., Capolongo, F., Halling-Sorensen, B. & Montesissa, C. (2003) Use
of oxytetracycline and tylosin in intensive calf farming: evaluation of transfer to manure
and soil.
Chemosphere
,52,203–212.
de Vries, H., Hemelaar, P.J., Gevers, A.C. & Beyersbergen van Henegouwen, G.M. (1994)
Photoreactivity of chloramphenicol in vitro and in vivo.
Photochem. Photobiol
., 60,
249–252.
Dharmananda, S. (2003) Traces of chloramphenicol in Chinese bee products: origin,
development, and resolution. Institute for Traditional Medicine, Portland, Oregon
(http://www.itmonline.org/arts/bees.htm, accessed 18 May 2004).
Diamond, J.P
.(1997) Systemic adverse effects of topical ophthalmic agents. Implications for
older patients.
Drugs Aging
,11,352–360.
Dollery, C. (1999)
Therapeutic Drugs
.Edinburgh: Churchill Livingstone, pp. C168–C172.
Doona, M. & Walsh, J.B. (1995) Use of chloramphenicol as topical eye medication: time to
cry halt?
BMJ
,310,1217–1218.
Durosinmi, M. & Ajayi, A. (1993) A prospective study of chloramphenicol induced aplastic
anaemia in Nigerians.
Trop. Geogr.Med
., 45,159–161.
Du Thanh Hang (2003) Effect of level of fresh duckweed (
Lemna minor
)in diets of chickens
raised in confinement. In: Preston, R. & Ogle, B., eds,
Proceedings of Final National
Seminar-Workshop on Sustainable Livestock Production on Local Feed Resources
.
64
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 64
HUAF-SAREC, Hue City, 25–28 March, 2003
(http://www.mekarn.org/sarec03/
hanghue.htm, accessed 18 May 2004).
Duong Duy Dong (2003) Use of rubber seed meal in diets for colored feather chickens. In:
Preston, R. & Ogle, B., eds,
Proceedings of Final National Seminar-Workshop on
Sustainable Livestock Production on Local Feed Resources
.
HUAF-SAREC, Hue City,
25–28 March, 2003
(http://www.mekarn.org/sarec03/donguaf.htm, accessed 18 May
2004).
Ehrlich, J., Bartz, Q.R., Smith, R.M., Joslyn, D.A. & Burkholder, P.R. (1947) Chloromycetin,
anew antibiotic from a soil actinomycete.
Science
,106,417.
Ehrlich, J., Gottlieb, D., Burkholder, P.R., Anderson, L.E. & Pridham, D.G. (1948)
Strepto-
myces venezuelae
,n. sp., the source of chloromycetin.
J. Bacteriol
., 56,456–467.
Ehrlich, J., Anderson, L.E., Coffey, G.L. & Gottlieb, D. (1952a)
Streptomyces venezuelae
:
soil studies.
Antibiot. Chemother
., 2,595–596.
Ehrlich, J., Anderson, L.E., Coffey, G.L. & Gottlieb, D. (1952b)
Streptomyces venezuelae
:
further soil studies.
Antibiot. Chemother
., 3, 1141–1148.
European Committee for Veterinary Medicinal Products (1994) Chloramphenicol sum-
mary report. European Agency for the Evaluation of Medicinal Products
(http://www.emea.eu.int/pdfs/vet/mrls/chloramphenicol.pdf, accessed 18 May 2004).
Epstein, R. (1994) International validation study for the determination of chloramphenicol in
bovine muscle.
J. AOAC Int.
,77,570–576.
European Commission (2003) Commission Decision 2003/181/CE, 13 March 2003.
Official
Journal of the European Communities
., L71,pp. 17–18.
European Commission (2004) Communication from the Health and Consumer
Protection Directorate-General of the European Commission to the FAO JECFA
Secretariat.
Farooq, M., Mian, M.A., Durrani, F.R. & Syed, M. (2002) Feed consumption and efficiency
of feed utilization by egg type layers for egg production.
Livestock Research for Rural
Development
,14(1) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Food and Drug Administration (1985) Chloramphenicol oral solution; opportunity for hearing.
Federal Register
,50, 27059–2706 (also http://www.fda.gov/cvm/efoi/ea/Agency_
Initiated_Agency/Chloramphenicol_EA.pdf, accessed 18 May 2004).
Festing, M.F., Diamanti, P. & Turton, J.A. (2001) Strain differences in haematological
response to chloramphenicol succinate in mice: implications for toxicological research.
Food Chem. Toxicol
., 39,375–383.
Flach, A.J. (1994) Systemic toxicity associated with topical ophthalmic medications.
J. Fla.
Med. Assoc
., 81,256–260.
Food Standards Agency (2002/2003) Results of FSA testing programme for chlorampheni-
col in honey.Tuesday, 19 February 2002 (http://www.foodstandards.gov.uk/multimedia/
webpage/resultshoneytest, accessed 18 May 2004).
Food Standards Agency of Ireland (2002/2003) Archive Alert Notifications
(http://www.fsai.ie/alerts/archive/index.asp, accessed 18 May 2004).
Fraunfelder, F.T., Morgan, R.L. & Yunis, A.A. (1993) Blood dyscrasias and topical ophthalmic
chloramphenicol.
Am. J. Ophthamol.
,115,812–813.
Friedman, Y
., Weismann, Y
., Avidar,Y. & Bogin, E. (1998) The toxic effects of monensin and
chloramphenicol on laying turkey breeder hens.
Avian Pathol
., 27,205–208.
CHLORAMPHENICOL
65
39834 FOOD TEXT 26/5/05 9:52 am Page 65
Fries, G.F., Marrow, G.S. & Snow, P.A. (1982) Soil ingestion by dairy cattle
.J. Dairy Sci
., 65,
611–618.
Gantverg, A., Shishani, I. & Hoffman, M. (2003) Determination of chloramphenicol in animal
tissues and urine liquid chromatography–tandem mass spectrometry versus gas chro-
matography–mass spectrometry.
Anal. Chim. Acta
,483,125–135.
Garbarino, J.R., Bednar, A.J., Rutherford, D.W., Beyer, R.S. & Wershaw, R.L. (2003) Envi-
ronmental fate of roxarsone in poultry litter. I. Degradation of roxarsone during compost-
ing.
Environ. Sci. Technol
., 37,1509–1514.
Gassner, B. & Wuethrich, A. (1994) Pharmacokinetic and toxicology aspects of the medica-
tion of beef-type calves with an oral formulation of chloramphenicol palmitate.
J. Vet. Phar-
macol. Ther
., 17,279–283.
Gerber, S.L., Cantor, L.B. & Brater, D.C. (1990) Systemic drug interactions with topical glau-
coma medications.
Surv. Ophthalmol.
,35,205–218.
George, F.J. & Hanna, C. (1977) Ocular penetration of chloramphenicol. Effects of route of
administration.
Arch. Ophthalmol.
,95,879–882.
Gottlieb, D. & Siminoff, P. (1952) The production and role of antibiotics in soil II.
Chloromycetin.
Phytopathology
,42,91–97.
Gottlieb, D. (1976) The production and role of antibiotics in soil.
J. Antibiot. (Tokyo)
,29,
987–1000.
Greenwood, D. (2000)
Antimicrobial Chemotherapy
,4th Ed., New York: Oxford University
Press.
Gross, F., Lewis, E.A., Piraee, M., van Pee, K.H., Vining, L.C. & White, R.L. (2002) Isolation
of 3¢-O-acetylchloramphenicol: a possible intermediate in chloramphenicol biosynthesis.
Bioorg. Med. Chem. Lett
., 12,283–286.
Gude, T., Preiss, A. & Rubach, K. (1995) Determination of chloramphenicol in muscle, liver,
kidney and urine of pigs by means of immunoaffinity chromatography and gas chro-
matography with electron capture detection.
J. Chromatogr. B
,673,197–204.
Guyer, P.Q. (1996) Livestock water quality (Report No. G79-467-A). University of Nebraska,
Institute of Agriculture and Natural Resources (http://www.ianr.unl.edu/pubs/beef/
g467.htm#as, accessed 18 May 2004).
Haderlein, S.B. & Schwarzenbach, R.P. (1993)
Environ. Sci. Technol
., 27,316–326.
Haller,M.Y., Muller, S.R., McArdell, C.S., Alder, A.C. & Suter, M.J. (2002) Quantification
of veterinary antibiotics (sulfonamides and trimethoprim) in animal manure by liquid
chromatography-mass spectrometry.
J. Chromatogr. A
,952,111–120.
Hamscher,G., Sczesny,S., Hoper, H. & Nau, H. (2002) Determination of persistent tetracy-
cline residues in soil fertilized with liquid manure by high-performance liquid chromatog-
raphy with electrospray ionization tandem mass spectrometry.
Anal. Chem
., 74,
1509–1518.
Hamscher,G., Pawelzick, H.T., Sczesny,S., Nau, H. & Hartung, J. (2003) Antibiotics in dust
originating from a pig-fattening farm: a new source of health hazard for farmers?
Environ.
Health. Perspect
., 111,1590–1594 (also available at http://ehpnet1.niehs.nih.gov/
members/2003/6288/6288.pdf, accessed 18 May 2004).
Hallas, L.E. & Alexander,M. (1983) Microbial transformation of nitroaromatic compounds in
sewage effluent.
Appl
.
Environ. Microbiol.
,45,1234–1241.
Hanna, C., Massey, J.Y., Hendrickson, R.O., Williamson, J., Jones, E.M. & Wilson, P. (1978)
Ocular penetration of topical chloramphenicol in humans.
Arch. Ophthalmol
., 96,
1258–1261.
66
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 66
Hansen, L.H., Ferrari, B., Sorensen, A.H., Veal, D. & Sorensen, S.J. (2001) Detection of oxy-
tetracycline production by
Streptomyces rimosus
in soil microcosms by combining whole-
cell biosensors and flow cytometry.
Appl. Environ. Microbiol.
,67,239–244.
He, J., Magarvey, N., Piraee, M. & Vining, L.C. (2001) The gene cluster for chloramphenicol
biosynthesis in
Streptomyces venezuelae
ISP5230 includes novel shikimate pathway
homologues and a monomodular nonribosomal peptide synthetase gene.
Microbiology
,
147,2817–2829.
Hendrix, D.V.H., Ward, D.A & Barnhill, M.A. (2001) Effects of antibiotics on morphologic char-
acteristics and migration of canine corneal epithelial cells in tissue culture.
Am. J. Vet.
Res
., 62,1664–1669.
Hirsch, R., Ternes, T., Haberer, K. & Kratz, K.L. (1999) Occurrence of antibiotics in the aquatic
environment.
Sci. Total Environ
., 225,109–118.
Holt, D.E. (1995) The identification and characterisation of chloramphenicol-aldehyde, a new
human metabolite of chloramphenicol.
Eur. J. Drug Metab. Pharmacokinet
., 20, 35–42.
Holt, D.E. & Bajoria, R. (1999) The role of nitro-reduction and nitric oxide in the toxicity of
chloramphenicol.
Hum. Exp. Toxicol.
18, 111–118.
Holt, D.E., Ryder, T.A., Fairbairn, A., Hurley, R. & Harvey, D. (1997) The myelotoxicity of chlo-
ramphenicol: in vitro and in vivo studies. I. In vitro effects on cells in culture.
Hum. Exp.
Toxicol
., 16,570–576.
Holt, D.E., Andrews, C.M., Payne, J.P., Williams, T.C. & Turton, J.A. (1998) The myelotoxi-
city of chloramphenicol: in vitro and in vivo studies. II. In vivo myelotoxicity in the B6C3F1
mouse.
Hum. Exp. Toxicol
., 17,8–17.
Hong Samnang (1999) Duckweed versus ground soya beans as supplement for scavenging
native chickens in an integrated farming system.
Livestock Research for Rural Develop-
ment
11(1) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Hazardous Substances Databank (2003) Data generated from the Hazardous Substances
Databank, a database of the National Library of Medicine’s TOXNET system on October
31 2003 (http://toxnet.nlm.nih.gov, accessed 18 May 2004).
IARC (1990)
IARC Monographs on the evaluation of carcinogenic risk of chemicals to
humans
,Vol. 50, Chloramphenicol
.
Lyon: IARCPress, pp. 169–193.
Impens, S., Reybroeck, W., Vercammen, J., Courtheyn, D., Ooghe, S., De Wasch, K.,
Smedts, W.&De Brabander,H. (2003) Screening and confirmation of chloramphenicol
in shrimp tissue using ELISA in combination with GC–MS2 and LC–MS2.
Anal. Chim.
Acta
,483,153–163.
Indiaagronet (2003) Farm yard manure (definition) (http://www.indiaagronet.com/
indiaagronet/Manuers_fertilizers/contents/farm_yard_manure.htm, accessed 18 May
2004).
Ingerslev, F. & Halling-Sorensen, B. (2001) Biodegradability of metronidazole, olaquindox,
and tylosin and formation of tylosin degradation products in aerobic soil-manure slurries.
Ecotoxicol. Environ. Saf
., 48,311–320.
Ismail, S. & Morton, D. (1985) Comparative bioavailability of chloramphenicol ophthalmic
product. Honours Project Publications, University of Zimbabwe, Department of Pharmacy
(http://uzweb.uz.ac.zw/medicine/pharmacy/pubs/1985.html, accessed 18 May 2004).
Jiang, Y.L. (2000) The use of chemicals in aquaculture in the People’s Republic of China. In:
Arthur,J.R., Lavilla-Pitogo, C.R. & Subasinghe, R.P
., eds, (2000)
Use of Chemicals in
Aquaculture in Asia. Proceedings of the Meeting on the Use of Chemicals in Aquaculture
in Asia, 20–22 May 1996, Tigbauan, Iloilo, Philippines
.Southeast Asian Fisheries Devel-
opment Center,Aquaculture Department, Tigbauan, Iloilo, Philippines, pp. 141–153.
CHLORAMPHENICOL
67
39834 FOOD TEXT 26/5/05 9:52 am Page 67
Johnson, R.I. (1994) Effects of antibacterial agents on transformation of fatty acids in
sediment from a marine fish farm site.
Sci. Total Environ
., 152,143–152.
Joint FAO/WHO Food Standards Programme (2003). Report of the Fourteenth Session of
the Codex Committee on Residues of Veterinary Drugs in Foods (ALINORM 03/31A)
(ftp://ftp.fao.org/docrep/fao/meeting/006/y9015e.pdf, accessed 18 May 2004).
Jones, A.L., Keighley, J.E., Gold, W. & Good, A.M. (1996) Eye drops—the hidden poison.
Scott. Med. J
., 41,110–112.
Kadavy, D.R., Hornby, J.M., Haverkost, T. & Nickerson, K.W. (2000) Natural antibiotic resist-
ance of bacteria isolated from larvae of the oil fly,
Helaeomyia petrolei
.
Appl. Environ.
Microbiol
., 66,4615–4619.
Kaila, T., Korte, J.M. & Saari, K.M. (1999) Systemic bioavailability of ocularly applied 1%
atropine eyedrops.
Acta Ophthalmol. Scand
., 77,193–196.
Keukens, H.J., Aerts, M.M.L. & Traag, W.A. (1992) Analytical strategy for the regulatory
control of residues of chloramphenicol in meat: preliminary studies in milk.
J. AOAC Int.
,
75,245–256.
Kijak, P.J. (1994) Confirmation of chloramphenicol residues in bovine milk by gas chro-
matography/mass spectometry.
J. AOAC Int
., 77,34–40.
Khieu Borin, Sim Chou & Preston, T.R. (2000) Fresh water fish silage as protein source
for growing-fattening pigs fed sugar palm juice.
Livestock Research for Rural
Development
,12(1) (http://www.cipav.org.co/lrrd/lrrd12/1/bori121.htm, accessed 18 May
2004).
Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. & Buxton,
H.T. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in
U.S. streams, 1999–2000: a national reconnaissance.
Environ. Sci. Technol
., 36,
1202–1211.
Kong, C.T., Holt, D.E., Ma, S.K., Lie, A.K.W. & Chan, L.C. (1999) Effects of antioxidants and
acaspase inhibitor on chloramphenicol-induced toxicity of human bone marrow and HL-
60 cells.
Hum. Exp. Toxicol
., 19,530–510.
Korte, J.M., Kaila, T. & Saari, K.M. (2002) Systemic bioavailability and cardiopulmonary
effects of 0.5% timolol eyedrops.
Graefes Arch. Clin. Exp. Ophthalmol
., 240,430–
435.
Kroker,R. (1994) [Chloramphenicol (CP)]. In: Löscher, W., Ungemach, F.R., and Kroker, R.,
eds,
Grundlagen der Pharmakotherapie bei Haus- und Nutztieren
,2nd Ed. (in German),
Berlin and Hamburg: Paul Parey, p. 226.
Kucers, A., Crowe, S.M., Grayson, M.L. & Hoy, J.F. (1997) Chloramphenicol and
thiamphenicol. In:
The Use of Antibiotics
.Oxford: Butterworth-Heinemann, pp. 548–
599.
Kumar, V., Schoenwald, R.D., Chien, D.S., Packer, A.J. & Choi, W.W. (1985) Systemic
absorption and cardiovascular effects of phenylephrine eyedrops.
Am. J. Ophthalmol
.,
99,180–184.
Laerum, E., Fiskaadal, H.J., Erdal, J.E. & Loberg, R.M. (1994) [Chloramphenicol eyedrops
in acute bacterial conjunctivitis. A comparison of two dosage regimes in general practice]
[Abstract only, article in Norwegian]
Tidsskr Nor Laegeforen
,114,671–673.
Lafarge-Frayssinet, C., Robbana-Barnat, S., Frayssinet, C., Toucas, L. & Decloitre, F. (1994)
Cytotoxicity and DNA damaging potency chloramphenicol and six metabolites: a new
evaluation in human lymphocytes and Raji cells.
Mutat. Res.
,320,207–215.
Lai, H.T., Liu, S.H. & Chien, Y.H.J. (1995) Transformation of chloramphenicol and oxytetra-
cycline in aquaculture pond sediments.
Environ. Sci. Health
,A30,1897–1923.
68
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 68
Lai, H.T., Chien, Y.H. & Liu, S.M. (1997) Transformation of chloramphenicol and oxytetracy-
cline in brackish water sediment under various salinities and aerobic and anaerobic con-
ditions.
J. Fish. Soc. Taiwan
,24,49–61.
Lallai, A., Mura, G. & Onnis, N. (2002). The effects of certain antibiotics on biogas produc-
tion in the anaerobic digestion of pig waste slurry.
Bioresour. Technol
., 82,205–208.
Larsson, L.I. (1998) Techniques for measuring aqueous humor inflow and outflow.
Glaucoma
World
,12 (http://www.glaucomaworld.net/english/012/e012a04t.html, accessed 18 May
2004). The original paper cited by Larsson is: Brubaker, R.F. (1991) Flow of aqueous
humor in humans. The Friedenwald lecture.
Invest. Ophthalmol. Vis. Sci
., 32,3145–3166.
LEAD Virtual Center (2004a) Livestock, Environment and Development (LEAD) Initiative.
Livestock and Environment Toolbox (http://lead.virtualcenter.org/en/dec/toolbox/
homepage.htm, accessed 18 May 2004). Note: this toolbox provides generic advice on
various aspects of the interactions between livestock and the environment).
LEAD Virtual Center (2004b) Livestock, Environment and Development (LEAD) Initiative.
Livestock and Environment Toolbox (http://lead.virtualcenter.org/en/dec/toolbox/
Index.htm, accessed 18 May 2004).
Lee, Y.C., Simamora, P., Pinsuwan, S. & Yalkowsky, S.H. (2002) Review on the systemic
delivery of insulin via the ocular route.
Int. J. Pharm
., 233,1–18.
Legator, M. & Gottlieb, D. (1953) The dynamics of chloramphenicol synthesis.
Antibiot.
Chemother
., 3,809–817.
Le Ha Chau (1998a) Biodigester effluent versus manure from pigs or cattle as fertilizer for
production of cassava foliage (
Manihot esculenta
).
Livestock Research for Rural Devel-
opment
,10(3) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Le Ha Chau (1998b) Biodigester effluent versus manure, from pigs or cattle, as fertilizer
for duckweed (
Lemna
spp.).
Livestock Research for Rural Development
,10(3)
(http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Le Thi Men, Huynh Huu Chi, Ngo Vi Nghia, Nguyen Thi Kim Khang, Ogle B. & Preston, T.R.
(2003) Utilization of catfish oil in diets based on dried cassava root waste for crossbred
fattening pigs in the Mekong delta of Vietnam.
Livestock Research for Rural Develop-
ment
,15(4) (http://www.cipav.org.co/lrrd, accessed 18 May 2004).
Lewis, E.A., Adamek, T.L., Vining, L.C. & White, R.L. (2003) Metabolites of a blocked chlo-
ramphenicol producer.
J. Nat. Prod.
,66,62–66.
Li, T.L., Chung-Wang, Y.J. & Shih, Y.C. (2001) Determination and confirmation of chloram-
phenicol residues in swine muscle and liver.
J. Food Science
,67,21–28.
Liao, I.C., Guo, J.J. & Su, M.S. (2000) The use of chemicals in aquaculture in Taiwan,
Province of China. In: Arthur,J.R., Lavilla-Pitogo, C.R. & Subasinghe, R.P., eds. (2000)
Use of Chemicals in Aquaculture in Asia. Proceedings of the Meeting on the Use of
Chemicals in Aquaculture in Asia, 20–22 May 1996; Tigbauan, Iloilo, Philippines
.
Southeast Asian Fisheries Development Centre, Aquaculture Department, Tigbauan,
Iloilo, Philippines. pp. 193–206.
Loke, M.L., Ingerslev, F., Halling-Sorensen, B. & Tjornelund, J. (2000) Stability of tylosin A
in manure containing test systems determined by high-performance liquid chromatogra-
phy.
Chemosphere
,40,759–765.
Ly,J. (2002) The effect of methionine on digestion indices and N balance of young Mong
Cai pigs fed high levels of ensiled cassava leaves.
Livestock Research for Rural Devel-
opment
,14(6) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Ly, J. & Pok Samkol (2001) The nutritive value of ensiled cassava leaves for young Mong
Cai pigs fed high levels of protein.
Livestock Research for Rural Development
,13(4)
(http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
CHLORAMPHENICOL
69
39834 FOOD TEXT 26/5/05 9:52 am Page 69
Ly, J., Chhay Ty, Chiev Phiny & Preston, T.R. (2001) Some aspects of the nutritive value of
leaf meals of
Trichanthera gigantea
and
Morus alba
for Mong Cai pigs.
Livestock
Research for Rural Development
,13(3). (http://www.cipav.org.co/lrrd/, accessed 18 May
2004).
Ly, J., Hean Pheap, Keo Saeth & Pok Samkol (2002) The effect of DL-methionine supple-
mentation on digestibility and performance traits of growing pigs fed broken rice and
water spinach (
Ipomoea aquatica
).
Livestock Research for Rural Development
,14(5)
(http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Maluf, E. (2002) Aplastic anemia in Brazil: incidence and risk factors.
Am. J. Hematol
., 71,
268–274.
Malléa, M., Mahamoud, A., Chevalier, J., Alibert-Franco, S., Brouant, P., Barbe, J. & Pagès,
J.M. (2003). Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-
resistant clinical isolates.
Biochem J
., 376,801–805.
Matsuhashi, T., Liu, X., Nishizawa, Y., Usukura, J., Wozniak, M. & Wakabayashi, T. (1996)
Mechanism of the formation of megamitochondria in the mouse liver induced by chlo-
ramphenicol.
Toxicol. Lett
., 86, 47–54.
Matsumoto, J., Natsuaki, M., Kitano, Y. & Kitagawa, K. (1998) Two cases of skin ulcer due
to chloromycetin (R) cream.
Hifu
,40,576–581.
Mottier, P., Parisod, V., Gremaud, E., Guy, P.A., Stadler, R.H. (2003) Determination
of the antibiotic chloramphenicol in meat and seafood products by liquid chromatogra-
phy—electrospray ionisation tandem mass spectrometry.
J. Chromatogr. A
., 994, 75–
84.
Munns, R.K., Holland, D.C., Roybal, J.E., Storey, J.M., Long, A.R., Stehly, G.R. & Plakas,
S.M. (1994) Gas chromatographic determination of chloramphenicol residues in shrimp:
Interlaboratory study.
J. AOAC Int
., 77,596–601.
Nagata, T. & Saeki, M. (1992) Simultaneous determination of thiamphenicol, florfenicol, and
chloramphenicol residues in muscles of animals and cultured fish by liquid chromatogra-
phy.
J. Liq. Chromatogr
., 15,2045–2056.
Nakano, H., Matsuhashi, Y., Takeuchi, T. & Umezawa, H. (1977) Distribution of chloram-
phenicol acetyltransferase and chloramphenicol-3-acetate esterase among
Streptomyces
and
Corynebacterium
. J
.Antibiot. (Tokyo
), 30,76–82.
National Academy of Sciences (1994) Subcommittee on Poultry Nutrition, National Research
Council, National Academy of Sciences. Nutrient Requirements of Poultry,Ninth Revised
Edition, pp. 19–34 (http://books.nap.edu/books/0309048923/html/19.html#pagetop,
accessed 18 May 2004).
Neuhaus, B.K., Hurlbut, J.A. & Hammack, W. (2002) LC/MS/MS analysis of chloram-
phenicol in shrimp.
U.S. FDA—Laboratory Information Bulletin No. 4290
,18(9)
(http://www.cfsan.fda.gov/~acrobat/lib4290.pdf, accessed 18 May 2004).
Ngoc Son, C.P
.(2002) Chloramphenicol analysis in shrimp. CASE study of GC and
HPLC–MS validation at the Centre of Analytical Services and Experimentation (CASE) of
Ho Chi Minh City. Viet Nam: CASE (http://www.hcmuaf.edu.vn/CdHoiThao/ELISA-7-
2002/CLORAMSHRIMP
.pdf, accessed 18 May 2004).
Nguyen Thi Thuy & Ly, J. (2002) Ashort-term study of growth and digestibility indices in Mong
Cai pigs fed rubber seed meal.
Livestock Research for Rural Development
,14(2)
(http://www.cipav.org.co/lrrd, accessed 18 May 2004).
Nguyen Dang Vang & Le Viet Ly (2000) A review on poultry production in Vietnam.
The National Institute of Animal Husbandry (NIAH) (http://www.vcn.vnn.vn/sp_pape/
spec_00_9_1.htm, accessed 18 May 2004).
70
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 70
Nguyen Thi Loc & Le Khac Huy (2003) Effects of DL-methionine supplementation levels in
ensiled cassava root-based diets on the performance and economic efficiency of F1 (large
white ¥Mong Cai) fattening pigs. In: Preston, R. & Ogle, B., eds,
Proceedings of Final
National Seminar-Workshop on Sustainable Livestock Production on Local Feed
Resources, HUAF-SAREC, Hue City, 25–28 March, 2003
(http://www.mekarn.org/
sarec03/lochue.htm, accessed 18 May 2004).
Nguyen Van Lai (1998) On-farm comparison of Mong Cai and large white pigs fed ensiled
cassava root, rice bran and duckweed.
Livestock Research for Rural Development
,10(3)
(http://www.cipav.org.co/lrrd, accessed 18 May 2004).
Obaldo, L.G. (2001) Manufacturing different feed sizes and growth of three size classes of
Pacific white shrimp,
Litopenaeus vannamei
.World Aquaculture Society, January 2001
(http://www.oceanicinstitute.org/research/abstrfeeds_differentfeedsizes.html, accessed
18 May 2004).
Parfitt, K. (1999) Martindale:
The Complete Drug Reference
,32nd Ed., London: Pharma-
ceutical Press, pp. 182–184.
Pathak, S.C., Ghosh, S.K. & Palanisamy, K. (2000). The Use of chemicals in aquaculture in
India. In: Arthur, J.R., Lavilla-Pitogo, C.R. & Subasinghe, R.P., eds. (2000)
Use of Chem-
icals in Aquaculture in Asia. Proceedings of the Meeting on the Use of Chemicals in Aqua-
culture in Asia, 20–22 May 1996; Tigbauan, Iloilo, Philippines
.Southeast Asian Fisheries
Development Center, Aquaculture Department, Tigbauan, Iloilo, Philippines, pp. 87–112.
Parker, R. & Shaw, I.C. (1988) Determination of chloramphenicol in tissues—problems with
in vitro
metabolism.
Analyst
,113,1875–1876.
Peer, D.J., Ball, R. & Young, L. (2001) Practical diets for pigs. Ministry of Agriculture
and Food, Government of Ontario (http://www.gov.on.ca/OMAFRA/english/livestock/
swine/facts/01-013.htm#top, accessed 18 May 2004)
Perez, N., Gutierrez, R., Noa, M., Diaz, G., Luna, H., Escobar, I. & Munive, Z. (2002) Liquid
chromatographic determination of multiple sulfonamides, nitrofurans, and chlorampheni-
col residues in pasteurized milk.
J. AOAC Int
., 85,20–24.
Petersen, A., Andersen, J.S., Kaewmak, T., Somsiri, T. & Dalsgaard, A.(2002). Impact of
integrated fish farming on antimicrobial resistance in a pond environment.
Appl. Environ.
Microbiol
., 68,6036–6042
Peterson, G. School of Pharmacy,University of Tasmania. CSA 311Clinical Pharmacoki-
netics, lecture notes online. (http://www.healthsci.utas.edu.au/pharmacy/kinetics/
index.htm, accessed 18 May 2004).
Pfenning, A.P., Madson, M.R., Roybal, J.E., Turnipseed, S.B., Gonzales, S.A., Hurlbut, J.A.
&Salmon, G.D. (1998) Simultaneous determination of chloramphenicol, florfenicol, and
thiamphenicol residues in milk by gas chromatography with electron capture detection.
J. AOAC Int
., 81,714–720.
Pfenning, A., Turnipseed, S., Roybal, J., Burns, C., Madson, M., Storey, J. & Lee, R. (2002a)
Confirmation of multiple phenicol residues in shrimp by electrospray LC–MS. U
.S. FDA—
Laboratory Information Bulletin No. 4284
,18(5) (http://www.cfsan.fda.gov/~frf/
lib4284.html, accessed 18 May 2004).
Pfenning, A., Turnipseed, S., Roybal, J., Burns, C., Madson, M., Storey, J. & Lee, R. (2002b)
Confirmation of chloramphenicol residues in crawfish by electrospray LC/MS.
U.S. FDA—
Laboratory Information Bulletin No. 4289
,18(8) (http://www.cfsan.fda.gov/~frf/
lib4289.html, accessed 18 May 2004).
Pfenning, A., Turnipseed, S., Roybal, J., Madson, M., Lee, R. & Storey, J. (2003) Confirma-
tion of chloramphenicol residue in crab by electrospray LC/MS.
U.S. FDA—Laboratory
Information Bulletin No. 4294
,19(1) (http://www.cfsan.fda.gov/~frf/lib4294.html, accessed
18 May 2004).
CHLORAMPHENICOL
71
39834 FOOD TEXT 26/5/05 9:52 am Page 71
Phillips, M. (2000) The use of chemicals in carp and shrimp aquaculture in Bangladesh,
Cambodia, Lao PDR, Nepal, Pakistan, Sri Lanka and Viet Nam. In: Arthur, J.R., Lavilla-
Pitogo, C.R. & Subasinghe, R.P., eds. (2000)
Use of Chemicals in Aquaculture in
Asia. Proceedings of the Meeting on the Use of Chemicals in Aquaculture in Asia, 20–22
May 1996; Tigbauan, Iloilo, Philippines
.Southeast Asian Fisheries Development Center,
Aquaculture Department, Tigbauan, Iloilo, Philippines, pp. 75–86.
Philpott, N.J., Scopes, J., Marsh, J.C.W., Gordon-Smith, E.C. & Gibson, F.M. (1995)
Increased apoptosis in aplastic anaemia bone marrow progenitor cells: possible patho-
physiologic significance.
Exp. Hematol
., 23,1642–1648.
Pich Sophin & Preston, T.R. (2001) Effect of processing pig manure in a biodigester as fer-
tilizer input for ponds growing fish in polyculture.
Livestock Research for Rural Develop-
ment
,13(6) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Plumb, D.C. (2002)
Veterinary Drug Handbook
,4th Ed., Ames: Iowa State Press, pp.
166–169.
Posyniak, A., Zmudzki, J. & Niedzielska, J. (2003) Evaluation of sample preparation for
control of chloramphenicol residues in porcine tissues by enzyme-linked immunosorbent
assay and liquid chromatography.
Anal. Chim. Acta
,483,307–311.
Prak Kea, Preston, T.R. & Ly, J. (2003) Feed intake, digestibility and N retention of a diet of
water spinach supplemented with palm oil and/or broken rice and dried fish for growing
pigs.
Livestock Research for Rural Development
,15(8) (http://www.cipav.org.co/lrrd/,
accessed 18 May 2004).
Primavera, J.H. (1994) Shrimp farming in the Asia-Pacific: environmental and trade issues
and regional cooperation.
Nautilus Institute Workshop on Trade and Environment in Asia-
Pacific: Prospects for Regional Cooperation 23–25 September 1994
,East-West Center,
Honolulu (http://www.nautilus.org/papers/enviro/trade/shrimp.html, accessed 18 May
2004).
Price, C.A., Lynch, E.M., Bowie, B.A. & Newman, D.J. (1981). Isolation and identification of
chloramphenicol from the moon snail,
Lunatia heros
.
J. Antibiot. (Tokyo)
,34,118–119.
Rabolle, M. & Spliid, N.H. (2000) Sorption and mobility of metronidazole, olaquindox, oxy-
tetracycline and tylosin in soil.
Chemosphere
,40,715–722.
Rappeport, J.M. & Bunn, H.P. (1994) Bone marrow failure: aplastic anaemia and other
primary bone marrow disorders. In: Isselbacher,K.J. et al., eds,
Harrison’sPrinciples of
Internal Medicine
.New York: McGraw-Hill, pp. 1754–1756.
Reybroeck, W. (2003) Residues of antibiotics and sulphonamides in honey on the Belgian
market.
APIACTA
,38,23–30.
Robbana-Barnat, S., Decloitre, F., Frayssinet, C., Seigneurin, J.M., Toucas, L. & Lafarge-
Frayssinet, C. (1997) Use of human lymphoblastoid cells to detect the toxic effect of chlo-
ramphenicol and metabolites possibly involved in aplastic anemia in man.
Drug Chem.
Toxicol
., 20,239–253.
Rogers, J.M. & Kavlock, R.J. (2001) Developmental toxicology. In: Klaassen, C.D. ed.,
Casarett & Doull’s Toxicology: The Basic Science of Poisons
,6th Ed., New York: McGraw-
Hill, p. 358.
Rowland, M. & Tozer, T.M. (1995)
Clinical Pharmakokinetics, Concepts and Applications
,3rd
Ed., Baltimore: Williams & Wilkins.
Runsey, T.S., Miller, R.W. & Dinius, D.A. (1977) Residue content of beef feedlot manure after
feeding diethylstilbestrol, chlortetracycline and Ronnel and the use of stirofos to reduce
population of fly larvae in feedlot manure.
Arch. Environ. Contam. Toxicol
., 6,203–
212.
72
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 72
Rupp, H.S., Stuart, J.S. & Hurlbut, J.A. (2003) LC/MS/MS analysis of chloramphenicol
in crab meat.
U.S. FDA—Laboratory Information Bulletin No. 430,
19(4)
(http://www.cfsan.fda.gov/~acrobat/lib4302.pdf, accessed 18 May 2004).
Saettone, M.F. (2002) Progress and problems in ophthalmic drug delivery. Business briefing.
Pharmatech
., 167–170.
Saettone, M.F. (2003) New trends in ocular drug delivery.
Archivos de la Sociedad Espanola
de oftalmologia
,2(dated February 2003, editorial).
Sah, S.P., Raj, G.A., Rijal, S. & Karki, P. (1999) Clinico-haematological and management
profile of aplastic anaemia—a first series of 18 cases from Nepal.
Singapore Med. J
., 40,
451–454.
Salminen, L. (1990) Review: systemic absorption of topically applied ocular drugs in humans.
J. Ocul. Pharmacol
., 6,243–249.
Sande, M.A. & Mandell, G.L. (1993) Antimicrobial agents. In: Gilman, A.G., Rall, T.W., Nies,
A.S. & Taylor, P., eds,
Goodman and Gillman’s The Pharmacological Basis Of Thera-
peutics
,8th Ed., New York: McGraw-Hill Inc., pp. 1125–1134.
Sanders, P., Guillot, P., Dagorn, M. & Delmas, J.M. (1991) Liquid chromatographic determi-
nation of chloramphenicol in calf tissues: studies of stability in muscle, kidney and liver.
J. AOAC Int
., 74,483–486.
Sanders, P. & Laurentie, M. (2004) Personal communication to the FAO JECFA Secretariat.
Sanz, J.L., Rodriguez, N. & Amils, R. (1996) The action of antibiotics on the anaerobic diges-
tion process.
Appl. Microbiol. Biotechnol.
,46,587–592.
Sasaki, H., Yamamura, K., Mukai, T., Nishida, K., Nakamura, J., Nakashima, M. & Ichikawa,
M. (2000) Pharmacokinetic prediction of the ocular absorption of an instilled drug with
ophthalmic viscous vehicle.
Biol. Pharm. Bull
., 23,1352–1356.
Sechena, R., Liao, S., Lorenzana, R., Nakano, C., Polissar,N. & Fenske, R. (2003) Asian
American and Pacific Islander seafood consumption—a community-based study in King
County, Washington.
J. Expo. Anal. Environ. Epidemiol.
,13,256–266.
Schlusener,M.P., Bester,K. & Spiteller, M. (2003) Determination of antibiotics such as
macrolides, ionophores and tiamulin in liquid manure by HPLC–MS/MS.
Anal. Bioanal.
Chem
., 375,942–947.
Shariff, M., Nagaraj, G., Chua, F.H.C. & Wang, Y.G. (2000) The use of chemicals in aqua-
culture in Malaysia and Singapore. In: Arthur,J.R., Lavilla-Pitogo, C.R. & Subasinghe,
R.P., eds. (2000)
Use of Chemicals in Aquaculture in Asia. Proceedings of the Meeting
on the Use of Chemicals in Aquaculture in Asia, 20–22 May 1996; Tigbauan, Iloilo, Philip-
pines
.Southeast Asian Fisheries Development Center, Aquaculture Department,
Tigbauan, Iloilo, Philippines, pp. 127–140.
Shiuey,Y
.&Eisenberg, M.J. (1996) Cardiovascular effects of commonly used ophthalmic
medications.
Clin. Cardiol
., 19,5–8.
Sirbat, D., Marchal-Heussler, L., Hoffman, M. & Maincent, P. (2000) Moyens d’amélioration
de la biodisponibilité pour la voie topique [Ways to improve ocular bioavailability for topical
applications].
J. Fr.Ophtalmol
., 23, 505–509.
Sørensen, A.H., Hansen, L.H., Johannesen, E. & Sørensen, S.J. (2003). Conjugative
plasmid conferring resistance to olaquindox.
Antimicrob. Agents Chemother
., 47,
798–799.
Somjetlertcharoen, A. (2002) Chloramphenicol in aquaculture.
AAHRI Newsletter
,11(1)
(http://www.fisheries.go.th/aahri/Health_new/AAHRI/AAHRI/Topics/Newsletter/art54.htm,
accessed 18 May 2004).
CHLORAMPHENICOL
73
39834 FOOD TEXT 26/5/05 9:52 am Page 73
Stolker, A.A.M., Niesing, W., Hogendoorn, E.A., Versteegh, J.F.M., Fuchs, R. & Brinkman,
U.A.T. (2003) Liquid chromatography with triple-quadrupole or quadrupole-time of flight
mass spectrometry for screening and confirmation of residues of pharmaceuticals in
water.
Anal. Bioanal. Chem
., 378,955–963.
Storey, J., Pfenning, A., Turnipseed, S., Nandrea, G., Lee, R., Burns, C. & Madson, M. (2003)
Determination of chloramphenicol residues in shrimp and crab tissues by electrospray
triple quadrupole LC/MS/MS.
U.S. FDA—Laboratory Information Bulletin No
.
4306
,19(6)
(http://www.cfsan.fda.gov/~frf/lib4306.html, accessed 18 May 2004).
Stuart, J.S., Rupp, H.S. & Hurlbut, J.A. (2003) LC/MS/MS Analysis of chloramphenicol
in crawfish meat.
U.S. FDA—Laboratory Information Bulletin No
.
4303
,19(4)
(http://www.cfsan.fda.gov/~frf/lib4303.html, accessed 18 May 2004).
Supriyadi, H. & Rukyani, A. (2000) The use of chemicals in aquaculture in Indonesia. In:
Arthur,J.R., Lavilla-Pitogo, C.R. & Subasinghe, R.P., eds. (2000)
Use of Chemicals in
Aquaculture in Asia. Proceedings of the Meeting on the Use of Chemicals in Aquaculture
in Asia, 20–22 May 1996; Tigbauan, Iloilo, Philippines
.Southeast Asian Fisheries
Development Center,Aquaculture Department, Tigbauan, Iloilo, Philippines, pp. 113–
118.
Tamura, A., Takeda, I., Naruto, S. & Yoshimura, Y. (1971) Chloramphenicol from
Strep-
tosporangium viridogriseum
var.
kofuense
.
J. Antibiot. (Tokyo)
,24,270.
Tean, B., Sath, K., Samkol, P. & Ly, J. (2002a) Utilization by pigs of diets containing
Cambodian rubber seed meal.
Livestock Research for Rural Development
,14(1)
(http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Tean, B., Ly, J. & Preston, T.R. (2002b) A study of N utilization in young Mong Cai and
Large White pigs fed water spinach and graded levels of rubber seed cake.
Livestock
Research for Rural Development
,14(3) (http://www.cipav.org.co/lrrd/, accessed 18 May
2004).
The pig site (2003) This website contains extracts of the book, Carr, J.,
Garth Pig
Stockmanship Standards
,Iowa State University, 5M Enterprises Limited (http://
www.thepigsite.com/stockstds/Default.asp?display=17, accessed 18 May 2004).
Thornton, I. & Abrahams, P. (1983) Soil ingestion—a major pathway of heavy metals into
livestock grazing contaminated land.
Sci. Total Environ
., 28,287–294.
Thy,S. & Preston, T.R. (2003) Effluent from biodigesters with different retention times for
primary production and feed of Tilapia (
Oreochromis niloticus
).
Livestock Research for
Rural Development
15(9) (http://www.cipav.org.co/lrrd/, accessed 18 May 2004).
Tolls, J. (2001) Sorption of veterinary pharmaceuticals in soils: a review.
Environ. Sci.
Technol
., 35,3397–3406.
Toris, C.B., Yablonski, M.E., Wang, Y.L. & Camras, C.B. (1999) Aqueous humor dynamics in
the aging human eye.
Am. J. Ophthalmol
., 127,407–412.
Tran Thi Mai Phuong, Nguyen Van Thien & Tran Long (2003) Study on the productivities and
meat quality of AC chicken (black–bone chicken) in Vietnam. The National Institute of
Animal Husbandry (NIAH) (http://www.vcn.vnn.vn/sp_pape/sp_paper2003/
spaper_5_12_2003_5.htm, accessed 18 May 2004).
Trope, G.E., Lawrence, J.R., Hind, V.M. & Bunney, J. (1979) Systemic absorption of topically
applied chloramphenicol eyedrops.
Br. J. Ophthalmol
., 63,690–691.
Turnipseed, S., Burns, C., Storey, J., Lee, R. & Pfenning, A. (2002) Confirmation of multiple
phenicol residues in honey by electrospray LC/MS.
U.S. FDA—Laboratory Information
Bulletin No. 4281
,18(5) (http://www.cfsan.fda.gov/~frf/lib4281.html, accessed 18 May
2004).
74
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 74
Turton, J.A., Yallop, D., Andrews, C.M., Fagg, R., York, M. & Williams, T.C. (1999) Haemo-
toxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat.
Hum.
Exp. Toxicol
., 18,566–576.
Turton, J.A., Andrews, C.M., Havard, A.C. & Williams, T.C. (2002a) Studies on the haemo-
toxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig.
Int. J. Exp. Pathol
.,
83,225–238.
Turton, J.A., Havard, A.C., Robinson, S., Holt, D.E., Andrews, C.M., Fagg, R. & Williams,
T.C. (2000) An assessment of chloramphenicol and thiamphenicol in the induction of
aplastic anaemia in the BALB/c mouse.
Food Chem. Toxicol.
,38,925–938.
Turton, J.A., Andrews, C.M., Havard, A.C., Robinson, S., York, M., Williams, T.C. & Gibson,
F.M. (2002b) Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover
rat.
Food Chem. Toxicol
., 40,1849–1861.
Urtti, A. & Salminen, L. (1993) Minimizing systemic absorption of topically administered oph-
thalmic drugs.
Surv. Ophthalmol.
,37,435–456.
U.S. Department of Agriculture (2003) Determination and confirmation of chloramphenicol in
bovine muscle. SOP No. CLG—CAM.02 dated April 25, 2003, U.S. Department of Agri-
culture, Food Safety and Inspection Service, Office of Public Health and Science
(http://www.fsis.usda.gov/Frame/FrameRedirect.asp?main=/ophs/clg/clg-cam.02.pdf,
accessed 18 May 2004).
Vainio-Jylha, E., Vuori, M.L., Pyykko, K. & Huupponen, R. (2001) Plasma concentration of
topically applied betaxolol in elderly glaucoma patients.
J. Ocul. Pharmacol. Ther.
,17,
207–213.
van Ginkel, L.A., van Rossum, H.J., Zoontjes, P.W., van Blitterswijk, H., Ellen, G., van der
Heeft, E., de Jong, A.P.J. M. & Zomer,G. (1990) Development and validation of a gas
chromatographic–mass spectrometric procedure for the identification and quantification
of residues of chloramphenicol.
Anal. Chim. Acta
,237,61–69.
van der Heeft, E., de Jong, A.P., van Ginkel, L.A., van Rossum, H.J. & Zomer, G. (1991)
Conformation and quantification of chloramphenicol in cow’surine, muscle and eggs by
electron capture negative ion chemical ionization gas chromatography/mass spectrome-
try.
Biol. Mass Spectrom
., 20,763–770.
Van de Riet, J.M., Potter, R.A., Christie-Fougere, M. & Burns, B.G. (1992) Simultaneous
determination of residues of chloramphenicol, thiamphenicol, florfenicol, and florfenicol
amine in farmed aquatic species by liquid chromatography/mass spectrometry.
J. AOAC
Int
., 86,510–514.
van de Water, C., Tebbal, D. & Haagsma, N. (1989) Monoclonal antibody-mediated clean-
up procedure for the high-performance liquid chromatographic analysis of chlorampheni-
col in milk and eggs
.J. Chromatogr
., 478,205–215.
Versteegh, J.F.M., Stolker,A.A.M., Niesing, W.&Muller, J.J.A. (2003) Geneesmiddelen in
drinkwater en drinkwaterbronnen; Resultaten van het meetprogramma 2002. RIVM
rapport 703719004/2003 (http://www.rivm.nl/bibliotheek/rapporten/703719004.html,
accessed 18 May 2004).
Verzegnassi, L., Royer,D., Mottier, P
.&Stadler,R.H. (2003) Analysis of chloramphenicol in
honeys of different geographical origin by liquid chromatography coupled to electrospray
ionization tandem mass spectrometry.
Food Addit. Contam
., 20,335–342.
Vincke, M.M.J (1991) Integrated farming of fish and livestock: present status and future devel-
opment. In: T.K. Mukherjee, T.K., editor-in-chief; Phang Siew Moi, Jothi M.
Panandam & Yap Siaw Yang, eds,
Integrated livestock—fish production systems. Pro-
ceedings of the FAO/IPT Workshop on Integrated Livestock-Fish Production Systems,
16–20 December 1991, Institute of Advanced Studies, University of Malaya, Kuala
CHLORAMPHENICOL
75
39834 FOOD TEXT 26/5/05 9:52 am Page 75
Lumpur, Malaysia
.University of Malaya, Kuala Lumpur (http://www.fao.org/docrep/004/
ac155E/AC155E01.htm, accessed 18 May 2004).
Voedsel en Waren Autoriteit (2004) Communication of the Voedsel en Waren Autoriteit of the
Netherlands to the FAO JECFA Secretariat.
Walker, S., Diaper, C.J., Bowman, R., Sweeney, G., Seal, D.V. & Kirkness, C.M. (1998). Lack
of evidence for systemic toxicity following topical chloramphenicol use.
Eye
,12,875–879.
Wiholm, B.E., Kelly, J.P., Kaufman, D., Issaragrisil, S., Levy, M., Anderson, T. & Shapiro, S.
(1998) Relationship of aplastic anaemia to use of chloramphenicol eye drops in two inter-
national case–control studies.
BMJ
,316,666–666.
Wijegoonawardena, P.K.M. & Siriwardena, P.P.G.S.N. (2000). The use of chemotherapeutic
agents in shrimp hatcheries in Sri Lanka. In: Arthur, J.R., Lavilla-Pitogo, C.R. &
Subasinghe, R.P., eds. (2000)
Use of Chemicals in Aquaculture in Asia. Proceedings of
the Meeting on the Use of Chemicals in Aquaculture in Asia, 20–22 May 1996; Tigbauan,
Iloilo, Philippines.
Southeast Asian Fisheries Development Center, Aquaculture Depart-
ment, Tigbauan, Iloilo, Philippines, pp. 185–192.
Wu, C., Clift, P., Fry, C.H. & Henry, J.A. (1996) Membrane action of chloramphenicol meas-
ured by protozoan motility inhibition.
Arch. Toxicol
., 70,850–853.
Yallop, D., Andrews, W., Holt, D., York, M., Fagg, R., Williams, T. & Turton, J. (1998) Chlo-
ramphenicol is haematotoxic at high dose levels in the mouse but not in the rat.
Hum.
Exp. Toxicol
., 17, 57.
Yamada, N. & Hiraki, S. (1995) [Pharmacokinetics of subconjunctivally injected drugs in the
anterior segment of rabbit eyes] (In Japanese).
Nippon Ganka Gakkai Zasshi
,99,
262–270 (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
PubMed&list_uids=7732915&dopt=Abstract, accessed 18 May 2004).
Young, N.S. & Alter,B.P.(1994) Epidemiology of acquired aplastic anemia. In: Aplastic
anemia acquired and inherited. Philadelphia: W.S. Saunders, pp. 24–31.
Young, N.S. & Maciejewski, J. (1997) The pathophysiology of acquired aplastic anemia.
N.
Engl. J. Med
., 336,1365–1372.
Young, N.S. (2002) Acquired aplastic anemia.
Ann. Intern. Med
., 136,534–546.
76
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 76
14. APPENDIX I
Summary of data from feeding experiments
Table 1. Feeding experiments with pigs in south-east Asia
Breed or production Feeding scheme Initial Final Duration of Dry matter Average Reference
class body body treatment intake daily body-
weight weight (days) (g/kg LWweight gain
(kg) (kg) per day) (kg)
F1 Large white ¥Rice bran, ensiled cassava 20 88.2 120 £31 0.568 Nguyen Thi Loc
Mong Cai roots, maize, fish meal, 19.9 93.3 (estimated 0.611& Le Khac
soya bean meal, 19.6 97.5 from the 0.649 Huy (2003)
supplemented with 0, 20 95.4 data) 0.628
0.1, 0.2 or 0.3%
DL-methionine (on the
basis of dry matter)
Different Rice bran, fresh water 14–35 150 (5 0.405 Khieu Borin
crossbreeds fish silage (FWFS), sugar months) (0.325– et al. (2000)
palm juice, and water 0.476)
hyacinth (
Eichhornia
crassipes
)
Crossbred pigs Rice bran, maize, fish 0
(local ¥large meal, groundnut 25 20.1 55.6 90 —0.395 Bui Van Chinh
white) cake, soya bean 38 20.1 56.6 90 —0.406 et al. (1993)
meal plus soya 020.2 59.4 90 —0.435
bean foliage silage 25 48.5 84.7 60 —0.601
substituted for 38 (% of total protein) 48.5 84.5 60 —0.600
0–38% of total 48.7 85.3 60 —0.610
protein in the diet
Castrated Water spinach, broken 0
crossbred male rice, dried fish plus 59.5 10 33.6 —Prak Kea et al.
piglets palm oil 10 (8–10) 31.6 —(2003)
15 (% of dry matter) 31.8 —
30.1 —
39834 FOOD TEXT 26/5/05 9:52 am Page 77
Table 1.
(contd)
Breed or production Feeding scheme Initial Final Duration of Dry matter Average Reference
class body body treatment intake daily body-
weight weight (days) (g/kg LWweight gain
(kg) (kg) per day) (kg)
Castrated male Basal diet of cassava 14.5 23.3 4¥10 35 0.22 Ly et al. (2001)
Mong Cai bran, wheat bran
and fishmeal or
basal diet with 30%
of protein replaced
by leaf meal
(Basal diet only, leaf
meal: trichanthera
basal diet only,
leaf meal: mulberry)
Castrated Mong Sugar palm syrup and 012.3 36.6 0.14 Ly & Pok Samkol
Cai male pigs dry fish, substituted 50 (% of dry matter (2001)
by ensiled cassava substituted)
Large white Wheat bran (progressively 13.6 26.4 42 51.0 0.315 Tean et al.
castrated male substituted by 0, 10, 10.6 27.3 (6 weeks) 61.7 0.341 (2002a)
and female pigs 20 and 30% ground 10.1 24.3 61.0 0.364
whole RSM), dried fish 8.5 20.6 64.0 0.310
Large white Broken rice, water 0
castrated male spinach, 0.25 29.2 47.8 56 32.5 0.332 Ly et al. (2002)
and female supplemented with 0.50 26.7 46.8 37.6 0.360
pigs (1 :1) DL-methionine 0.75 (% of dry matter) 28.0 53.8 32.3 0.442
25.1 50.9 36.3 0.459
Castrated Mong Sugar palm syrup, 0.5
Cai male pigs dried fresh water fish 1.0 (% of dry matter) 19.2 Approximately 0.143 ±Ly (2002)
and ensiled cassava 22.5 30 0.025
leaves (73.5% of dry
matter) supplemented
with DL-methionine
39834 FOOD TEXT 26/5/05 9:52 am Page 78
Landrace ¥large Broken rice, rice bran,
white soybean, extracted,
soybean, dehulled, plus
1. Cassava root meal, 57.8 92.4 26.5–30.7 0.685 Le Thi Men et al.
2. Cassava root waste, 57.3 85.5 (estimated 0.598 (2003)
3. Cassava root waste, 57.6 94.0 from the 0.715
catfish oil 5% data)
4. Cassava root waste, 57.3 89.3 0.634
catfish oil 10%
Mong Cai and Cassava bran, rice 022.9 Mong Cai, Nguyen Thi Thuy
Large white bran, dried fresh 27.3 (% dry matter 0.273; & Ly (2002)
female pigs water fish and whole replaced) large
rubber seed white,
replacing part of the 0.533;
dry matter control,
0.377;
rubber
seed,
0.429
Mong Cai piglets Rice bran, plus ensiled Ensiled cassava roots 6.38 22.6 0.200 Nguyen Van Lai
and large white cassava roots or duck Duck weed 11.3 20.7 0.087 (1998)
pigs weed (at libitum)
Castrate male pigs, Fresh, chopped water 030 15.2 Tean et al.
either Mong spinach plus partially 20 17.9 (2002b)
Cai or large defatted rubber 30 20.5
white seeds (rubber seed 40 (% replaced) 23.9
cake) replacing part
of the daily feed
intake . ..
RSM, rubber seeed meal; FWFS, fresh water fish silage; LW, live weight.
39834 FOOD TEXT 26/5/05 9:52 am Page 79
Table 2. Feeding experiments with chickens in south-east Asia
Breed or Feeding scheme Initial age Initial Final body Duration of Daily feed Average daily Reference
production class of the body weight (g) treatment intake body-weight
animals weight (days) (g/bird) gain (g)
(days) (g)
Native chickens Supplements p1 p2 p1 p2 70 p1ap2ap1 p2 Hong Samnang
of both sexes offered in the 607 542 1567 1424 40.5 45.65 13.7 12.6 (1999)
scavenging in evening: 50 g692 523 1814 1344 58.5 63.00 16.0 11.7
two different broken rice, 551 499 1255 241 38.7 43.2 10.1 10.6
places, p1 50 g duckweed
and p2 50g broken rice,
50 g ground
soya beans
50 g of broken
rice
Egg type layers Starter ration 42 27.6 Farooq et al.
(109 flocks) Grower ration 84 49.3 (2002)
Layer ration 241 131.5
Growing and Diets containing Group (% 133.8 128 10.8** Duong Duy
scavenging RSM. The (RSM) 34.0 10.6 Dong (2003)
coloured highest two RS0 (0) 34.4 9.7
feather doses of RS10 (10) 34.4 11.9
chickens rubber seed RS20 (20) 33.8 11.6
(RS) had RS30 (30) 34.1 9.3
negative RS40 (40)
effects on RS50 (50)
survival rates
39834 FOOD TEXT 26/5/05 9:52 am Page 80
Tam Hoang Diets of RSM 0
chickens 5 1 550 1700 1–28 0–70 2.91b3.55b17.9 27.5
10 (% RSM) 570 1829 2.87 3.56 18.7 28.2
554 1747 3.00 3.66 18.1 27.4
Luong Phuong Basal diet based 30 1326c30 70.1d19.2eDu Thanh
chickens on maize and 1380 81.6 23.9 Hang (2003)
concentrate 1395 92.9 29.56
(30 :70 ratio; 1456 99.9 31.96
16% crude 1452 106.5 33.64
protein in the
dry matter)
offered ad libitum
or restricted to 60,
70, 80 or 90% of
the ad libitum
intake. On all the
diets the birds
had free access
to fresh duck weed.
RSM, rubber seeed meal.
aEstimated from the data assuming 90% dry matter for broken rice and soya beans and 5% for duckweed.
bFeed conversion rate (kg of feed/kg gain).
cCarcass weight.
dDry matter intake.
eThe authors report the following relationship between dry matter intake (
x
) and live-weight gain (
y
):
y
=0.415
x
-9.75.
39834 FOOD TEXT 26/5/05 9:52 am Page 81
15. APPENDIX II
Model for the calculation of the concentrations in muscle of chloram-
phenicol ingested with soil.
—Chloramphenicol is administered orally (ingestion with soil). The cumulative
intake is calculated as follows:
• Intake of soil is 2% of the intake of dry matter.
• Intake of dry matter is related to body weight (for pigs) or average daily body-
weight gain (for chickens). The choice of body weight (pigs) and average daily
body-weight gain (chickens) was dictated by the nature of available empirical
data. From the available empirical data, linear relationships were derived that
were valid for a certain period of growth of the animals.
—The site of “measurement” of chloramphenicol within the body is the plasma.
—Concentrations of chloramphenicol in plasma and in muscle are assumed to
be equal (this is strongly supported by experimental data).
—Absorption is the process by which unchanged drug proceeds from the site of
administration to the site of “measurement”.
—The combined processes of distribution and elimination are called disposition,
whereby elimination means the loss of the drug from the site of “measurement”.
—The rate of change of drug in the body is equal to the sum of the rates of
absorption and the rate of elimination.
—For simplification of the model, the following assumptions were made:
The drug is administered as a single daily dose (the amount contained in the
daily dose increases as a function of average daily body weight gain and
increased intake of feed).
The rates of absorption and distribution are short compared with the rate of
elimination.
All drug in the body is expressed as equivalents of parent chloramphenicol.
—Calculations are performed for a range of assumed elimination half-lives (t1/2).
—The amount
A
remaining in the body at time
t
after ingestion of the amount
A
0
is calculated using a mono-exponential term:
Only in one example is the sum of two exponential terms used.
The relationship between the half-life and the elimination rate constant
k
is:
kt
=0 693
12
.
AA e
kt
=¥
-
0
82
CHLORAMPHENICOL
39834 FOOD TEXT 26/5/05 9:52 am Page 82
—The amount remaining in the body just after each of three successive inges-
tions is calculated according to the following scheme:
CHLORAMPHENICOL
83
Time Amount remaining:
from 1st from 2nd from 3rd
ingestion ingestion ingestion
0
A
0,1
t
A
0,1 ¥
e
-
k
t
A
0,2
2t
A
0,1 ¥
e
-
k
2t
A
0,2 ¥
e
-
kt A
0,3
—The daily ingested amount is not constant, but increases as a function
of increasing intake of feed during the growth phase. It is assumed that pigs
grow from 20 to 75 kg of body weight within 119 days; and it is assumed that
chickens grow from 150 to 1000 g of body weight within 75 days. If the ingested
dose is expressed as ingested amount divided by body weight, then it is con-
stant in the model for pigs, since feed intake is related to body weight in that
model. However, in the model for chickens, feed intake is related to growth
rate. Therefore, the dose decreases steadily.
—The amount of the drug remaining in the body at the end of the growth phase
is used to calculate the concentration of chloramphenicol in the plasma accord-
ing to the formula:
where
C
is the concentration,
A
is the amount remaining in the body and
V
is
the volume of distribution. Values for
V
are taken from the literature.
Alternatives:
The average plasma concentration at steady state after multiple doses can be
calculated from (Rowland & Tozer, 1995):
where
F
is the fraction absorbed (dimensionless),
D
is the daily dose
(mg/kg bw), and
Cl
is the body clearance .
Values for
Cl
have to be taken from the literature.
Use of this model has been proposed by Sanders & Laurentie (2004).
Like the present monograph, this alternative model assumes:
mL
Kg
¥
Ê
Ë
Áˆ
¯
˜
min
CF
Cl
Dose
ss av,
=¥
t
CA
V
=
39834 FOOD TEXT 26/5/05 9:52 am Page 83
—The linearity of pharmacokinetics as function of the dose;
—A fraction of dose absorbed by oral route of 100% which is the worst-case
scenario;
—A muscle/plasma ratio of chloramphenicol concentrations equal to 1.
The model gives the following results:
Using the selected model, it can be shown that the conditions described for
pigs in Table 1, while producing an average steady-state concentration of chlo-
ramphenicol of 1 mg/kg, would at the same time cause a fluctuation at steady state
of between approximately 0.06 mg/kg (minimum, shortly before the next dose) and
4.4 mg/kg (maximum, shortly after the last dose).
Clearance, volume of distribution and elimination half-life are linked through
the equation:
Using, for example in the model for pigs, a clearance value of 4.16 (ml/min ¥
kg) and a volume of distribution of 1400 ml would correspond to a half-life of
233 min or 3.89 h.
Cl V
t
=¥0 693
12
.
84
CHLORAMPHENICOL
Table 1. Daily oral dose necessary to maintain an average steady-state
concentration of chloramphenicol of 1
m
g/kg in muscle
Species Clearance Daily doseaDaily intake of Concentration
(ml/min ¥kg) (mg/kg) feed (g) or water (mg/g or mg/ml)
(ml) per kg bw
Feed Water Feed Water
Pigs 4.16 6
40 70 0.15 0.08
Poultry 3.84 5.5 240 150 0.02 0.04
6.62 9.5 0.04 0.06
aIt is assumed that either feed or water is the only source of contamination.
39834 FOOD TEXT 26/5/05 9:52 am Page 84